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Adult hippocampal neurogenesis—a unique form of plasticity in the dentate gyrus 
(DG)—is regulated by experience, and when manipulated can have specific effects on behavior.  
Different methods have been used over the years to study new neurons’ functional role in the 
hippocampus, many of which focus on ablating neurogenesis.  While ablation methods can test 
the necessity of adult-born granule cells (abGCs) for behavior, these techniques remove all 
abGCs from the circuit and thus do not allow one to determine which properties of abGCs are 
required for behavior.  Such information is required to understand the mechanism of their action. 
Thus, new strategies are needed to determine what properties of young abGCs allow them to 
distinguish themselves from their mature counterparts and uniquely impact behavior.   
Recent hypotheses have suggested that the enhanced synaptic plasticity exhibited by 4–6-
week-old abGCs allows them to uniquely contribute to hippocampal circuit function, and thus 
behavior. The primary goal of this thesis was to explore the contribution young abGCs’ 
heightened synaptic plasticity makes to hippocampal function.  This was achieved using a 
transgenic mouse approach that allowed for the conditional deletion of NR2B from abGCs.  
Overall, iNR2BNes mice generated the same number of new neurons in adulthood as control mice 
at baseline.  These neurons survived and matured with only a slight reduction in dendritic 
complexity.  However, a potentially important electrophysiological property of these neurons—
	  
their enhanced synaptic plasticity—had been eliminated.   From an electrophysiological 
standpoint, iNR2BNes mice resemble mice with ablated neurogenesis, while from all other 
neurogenic standpoints examined they most closely resemble wild-type mice.  Consequently, 
these mice provided a novel model to test the extent to which young abGCs’ enhanced plasticity 
contributes to hippocampal-dependent behaviors. The results reveal that eliminating NR2B-
containing NMDA receptors from abGCs does not alter baseline anxiety or antidepressant (AD)-
like behavior.  However, iNR2BNes mice differed from controls in measures of cognitive 
function.  These mice were able to learn in the contextual fear conditioning test, but were 
impaired in the more difficult contextual fear discrimination test.  Mice also exhibited a 
decreased novelty exploration phenotype that impaired their performance in the novel object 
recognition test.  Together, these results indicate that the NR2B-dependent heightened plasticity 
exhibited by 4–6-week-old abGCs is necessary for responses to novelty and fine contextual 
discrimination, but does not contribute to baseline anxiety or emotionality.  
AD treatment increases levels of adult neurogenesis in the hippocampus, and these 
newborn neurons have been shown to be necessary for some of the behavioral effects of ADs 
seen in rodents.  In addition, the maturation timeline of adult neurogenesis correlates with the 
onset of behavioral responses to ADs.  ADs also enhance a neurogenesis-dependent form of 
long-term potentiation (LTP) in the DG evoked by medial perforant path stimulation under intact 
GABAergic tone called ACSF-LTP.  Thus, a potential mechanism by which abGCs may 
contribute to AD behavioral efficacy is by providing extra plastic units to the DG circuit.  This 
theory was tested by once again using the mouse line in which NR2B can be conditionally 
deleted from abGCs in the DG.  Here, we found that deletion of the NR2B subunit significantly 
attenuated a neurogenesis-dependent behavioral response to fluoxetine in the novelty suppressed 
	  
feeding test, and additionally blocked fluoxetine’s ability to enhance young abGCs’ maturation 
and subsequent integration into the hippocampal network.  This suggests that eliminating abGCs’ 
enhanced plasticity decreases their ability to influence DG output resulting in an AD response 
that is less robust than seen in control mice.  Control experiments revealed the specificity of this 
effect, as NR2B deletion did not impact the effect of fluoxetine in a neurogenesis-independent 
behavioral assay (tail suspension test) or in an assay that was insensitive to fluoxetine in this 
strain of mice (elevated plus maze).    
Our efforts to isolate the contribution of abGCs’ unique physiology from the neurogenic 
effects of fluoxetine were not entirely successful as the results presented here also revealed slight 
group differences in neurogenesis between control mice and mice lacking NR2B in young 
neurons.  Yet, this data still supports the idea that fluoxetine increases the ability of abGCs to 
participate in DG output by increasing the chance that new neurons will be activated during DG 
stimulation.  This may be achieved either by increasing their overall number, increasing their 
potential to make synaptic connections, or increasing their ability to strengthen their connections. 
However, due to the close link between activity and maturation that appears to be enhanced with 
fluoxetine treatment, a different approach with greater temporal resolution is needed to separate 
the neurogenic effects of fluoxetine from the physiological contribution abGCs make to 
hippocampal output.  With this in mind, a mouse line in which abGCs could be temporally 
inhibited was also generated.  Cellular and behavioral characterization of mice conditionally 
expressing hM4Di—a mutated muscarinic acetylcholine receptor that is insensitive to 
endogenous acetylcholine, but can be activated by the biologically inert, highly bioavailable 
compound, clozapine N-oxide (CNO)—has begun.  Results show that acute CNO treatment in 
mice expressing this designer receptor exclusively activated by a designer drug (DREADD) in 
	  
DG granule cells can impair encoding of contextual fear memory.  Chronically treating these 
mice had an anxiogenic effect in the open field test, but otherwise anxiety and emotionality in 
these mice were comparable to controls.  Chronic CNO treatment in mice expressing hM4Di in 
young abGCs effectively decreased these cells’ dendritic complexity, but did not alter 
proliferation or early survival. Thus, hM4Di DREADDs represent a novel tool that can be used 
to modulate activity of neurons in a temporally restricted manner, allowing for both acute and 
chronic manipulations of hippocampal granule cells.   
The experiments put forth in this thesis will highlight the importance of abGCs enhanced 
plasticity.  The utility as well as potential pitfalls of the mouse models used here to test theories 
of abGC function will also be explored.  Hopefully this analysis will provide an improved 
framework in which future experiments can be developed with the aim of uncovering novel 
insights into the hippocampal circuitry that underlies learning and memory and discovering new 
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The Hippocampal Formation 
The hippocampal formation is a uniquely organized structure consisting most notably of 
the dentate gyrus (DG) and cornu ammonis subfields (CA1, CA2, and CA3), though several 
other anatomically and functionally connected regions are often included in this nomenclature, 
i.e. the subiculum, presubiculum, parasubiculum, and entorhinal cortex (EC) (Amaral and 
Lavenex, 2007).  It is structurally striking both on a gross anatomical level – resembling to some 
a seahorse (hippocampus (HPC) comes from the Greek word for seahorse) and to others the 
horns of a ram (cornu ammonis refers to the ram-like Egyptian god Ammon) – and on a cellular 
level – principal cells gather densely in single layer while synaptic inputs are arranged in a strict 
laminar fashion.  Simplified circuit diagrams of the HPC highlight the trisynaptic circuit 
(Andersen et al, 1971).  This circuit begins with the EC, which sends sensory inputs via 
projections referred to as the perforant path to the DG (Fig 1.1).  Granule cells (GCs) in the DG 
then send their axons called mossy fibers to CA3, where pyramidal cells connect with each other 
via an autoassociative network and project via Schaffer collaterals to CA1.  CA1 pyramidal cells 
then project back to deep layers of the EC as well as to the subiculum (Amaral et al, 2007).  
More detailed representations of hippocampal processing take into account the direct 
connections the EC makes to both CA3 and CA1 (Amaral et al, 2007).  Evidence also suggests 
CA3 projects back to the DG through cells in the hilus (Scharfman, 2007). 
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Figure 1.1 Hippocampal and local DG circuitry. A. Schematic of the rodent hippocampal 
circuit.  Arrows represent excitatory axonal projections from principal cells within each 
subregion to their downstream targets.  For example, input from the entorhinal cortex (EC) enters 
the dentate gyrus (DG) where granule cells (GCs) project to hilar mossy cells (MC) and 
interneurons (Ints) as well as to CA3.  B. Taking a closer look at the local circuitry within the 
dentate gyrus layer, dendrites spanning the molecular layer (ML) receive excitatory inputs from 
the lateral and medial entorhinal cortex via the perforant path (LPP, MPP), and from mossy cell 
fibers (MCF) projecting from the hilus.  DG GCs project their mossy fiber axons to CA3.  Along 
the way, collaterals branch off in the hilus innervating the MCs and Ints there which project back 
to the GCL and ML. Adapted from Piatti et al (2013) and Drew et al (2013) 
 
Dentate Gyrus 
As one of the areas EC inputs enter the hippocampal formation, the DG is uniquely 
positioned to play a key role in hippocampal function, as it is a gateway through which sensory 
information may pass before traveling to other downstream regions of the HPC.  The DG is a 
trilaminar structure.  The principal cell layer is composed of densely packed GCs and is thus 
named the granule cell layer (GCL) (Fig 1.1).  Above the GCL is the relatively cell-free 
molecular layer, where axons from the EC project and the dendrites of GCs reside (Amaral et al, 
2007).  Below the GCL is the hilus, home to glutamatergic mossy cells and a heterogeneous 
population of GABAergic interneurons (Amaral et al, 2007).  The main input into the DG comes 
predominantly from layer II of the EC via the perforant path (Amaral et al, 2007).  The perforant 
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path can be divided into two parts: the medial perforant path (MPP) and lateral perforant path 
(LPP).  Fibers from the MPP carry spatial context-related information and terminate in the 
middle portion of the molecular layer, while fibers from the LPP carry sensory content-related 
information and terminate in the outer molecular layer (Knierim et al, 2014).  These perforant 
path fibers innervate GCs, which in turn send their unmyelinated mossy fiber axons through the 
hilus to CA3 (Amaral et al, 2007). Mossy fibers traverse the entire proximo-distal length of CA3, 
contacting on average 15 different CA3 pyramidal cells along the way, a number that is quite 
sparse by cortical standards and a fact that will be important later when discussing the proposed 
functions of the DG (Amaral et al, 2007; Schmidt et al, 2012).  A complex local circuitry also 
exists within the DG.  Before mossy fibers enter CA3, collaterals branch off in the hilus 
innervating the mossy cells and interneurons there. In addition to connections existing between 
these hilar neurons, mossy cells and interneurons also project back to the GCL and molecular 
layer where they can activate or inhibit GCs, respectively (Amaral et al, 2007).   
 
Adult Hippocampal Neurogenesis 
Historical Perspective 
Lying at the border between the GCL and hilus is the subgranular zone (SGZ).  In 
contrast to most other areas of the brain, high rates of neurogenesis continuously occur here 
throughout life (the other exception is the subventricular zone which sends newborn interneurons 
to the olfactory bulb). In 1962, Joseph Altman was performing experiments aimed at testing the 
kinetics of glial proliferation after trauma using a newly developed method that allowed dividing 
cells to be labeled with tritiated (3H)-thymidine and then detected with autoradiography (Altman, 
1962).   Surprisingly, he observed the presence of what appeared to be newly generated neurons 
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in areas not necessarily associated with the experimentally lesioned area, which suggested to him 
that neurogenesis might be a “normal” post-natal occurrence. A series of follow-up studies in rat 
and cat brains not subjected to trauma provided additional thymidine autoradiographic evidence 
for new neurons in the neocortex, olfactory bulb, and DG (Altman, 1963, 1966, 1969; Altman 
and Das, 1965, 1966). Suggesting the existence of mammalian adult neurogenesis was an 
extraordinary claim given the prevailing view at the time that no new neurons were born after 
development and subsequently this work was initially dismissed due to technological limitations 
that did not allow for further characterization and unambiguous determination that the adult-
generated cells were in fact neurons. Support for the idea that these cells were neurons came 15 
years later using electron microscopy of ultrathin sections to show that [3H]-thymidine-labeled 
cells found in the olfactory bulb and DG of adult rats had features normally considered to be 
characteristic of neurons, such as synapses and dendrites (Kaplan and Hinds, 1977).   
Further propelling the field forward were advancements made by Fernando Nottebohm 
and colleagues which established the functional integration of adult-born neurons in songbirds 
(Paton and Nottebohm, 1984) as well as new labeling methods that allowed for 
immunohistochemical detection of the synthetic thymidine analog, bromodeoxyuridine (BrdU) 
(Gratzner, 1982), retrograde tracing (Stanfield and Trice, 1988), and the identification of cell-
type specific markers to distinguish neurons (e.g. NSE, PSA-NCAM, NeuN) from glia (e.g. 
GFAP) (Cameron et al, 1993; Kuhn et al, 1996; Seki and Arai, 1993). 
Thirty years after Altman’s initial claims, the idea of a highly plastic brain was beginning 
to gain traction.  With the discovery of neurogenesis in primates (Gould et al, 1998; Kornack and 
Rakic, 1999) and humans (Eriksson et al, 1998) and studies showing that adult hippocampal 
neurogenesis is highly regulated by experience (see Modulation of Adult Neurogenesis below), 
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mammalian adult neurogenesis finally became accepted as a real and potentially functionally 
important phenomenon.   
 
From Stem Cell to Mature Neuron 
The SGZ is a “neurogenic niche” containing precursor cells from which neurons arise 
along with astrocytes, microglia, and a closely associated vasculature that promotes and supports 
neurogenesis.   The first phase of adult neurogenesis begins here with the precursor cell 
population.   While many models of precursor cell behavior have been proposed (Bonaguidi et 
al, 2012), the prevailing view is that radial glia-like cells are the resident neural stem cells in the 
SGZ (i.e. they have the ability to self-renew and the potential to differentiate into different cell 
types) (Fig 1.3A) (Seri et al, 2004; Seri et al, 2001).  They generate highly proliferative 
intermediate progenitor (type 2) cells, which at first maintain glial-like properties (type 2a) and 
then adopt a more neuronal phenotype (type 2b) (Filippov et al, 2003; Steiner et al, 2006).  Type 
2 cells give rise to neuroblasts (type 3) that are committed to a neuronal fate but still capable of 
dividing given a pathological stimulus such as seizure (Jessberger et al, 2005; Kempermann et 
al, 2015).  Upon exit from the cell cycle, new neurons enter into the early survival phase of 
neurogenesis. Under normal conditions, many newborn neurons are lost through apoptosis in the 
4 weeks following division (Kempermann et al, 2003; Sun et al, 2004), while those that survive 
continue developing morphologically and physiologically (Deng et al, 2010; Ming and Song, 
2011; Zhao et al, 2008).  During this process, they display properties that distinguish them from 
their mature counterparts (Fig 1.2).  Young adult-born GCs (abGCs) initially have a depolarized 
resting membrane potential (-60 mV vs -80mV in mature GCs) and high input resistance (>2 GΩ 
vs 0.3 GΩ) (Drew et al, 2013; Esposito et al, 2005; Ge et al, 2006; Liu et al, 1996; Schmidt-
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Hieber et al, 2004; Wang et al, 2000).  As abGCs first begin migrating out of the SGZ into the 
GCL, they have limited processes and their only input comes from ambient GABA released by 
local GABAergic interneurons, which at this phase in their development is excitatory due to high 
intracellular chloride concentrations (Esposito et al, 2005; Ge et al, 2006). In their second week 
after birth, abGCs appear more neuron-like, developing dendrites that extend towards the 
molecular layer and sending axons towards CA3 (Hastings and Gould, 1999; Zhao et al, 2006). 
At this stage, GABAergic synapses appear (Esposito et al, 2005).  Afferent glutamatergic 
connections from the EC occur later in development, first arriving in 2-3 week old abGCs 
(Esposito et al, 2005; Ge et al, 2006). This coincides with GABA switching to its inhibitory role 
and a period of increased excitability and enhanced plasticity during which the threshold for 
long-term potentiation (LTP) is lower than that for mature GCs (Ge et al, 2006; Schmidt-Hieber 
et al, 2004; Wang et al, 2000).   Spines begin to develop on dendrites with the majority being 
formed during a period 3 to 4 weeks after birth (Esposito et al, 2005; Zhao et al, 2006). 4- to 6-
week-old abGCs exhibit even greater enhanced plasticity: they have both a lower induction 
threshold and increased LTP amplitude compared to mature GCs (Ge et al, 2007). It has also 
been shown that 4-week-old abGCs are more likely to spike than mature GCs in response to 
perforant path input due to the elevated excitation to inhibition ratio that these immature neurons 
display (Marin-Burgin et al, 2012).  By 6-8 weeks after birth, new neurons become 
electrophysiologically indistinguishable from developmentally born GCs (Ge et al, 2007).  
Maturation in non-human primates takes considerably longer, requiring a minimum of six 




Figure 1.2 Gene expression patterns, morphological features, and electrophysiological 
properties of abGCs and their precursors over the course of development. Adapted from Li 




Modulation of Adult Neurogenesis 
 In adult mice, levels of neurogenesis vary substantially from strain to strain, suggesting 
intrinsic genetic factors set an animal’s baseline level of neurogenesis.  Indeed, ~70% of the 
variation in adult hippocampal neurogenesis can be accounted for by heritable traits 
(Kempermann et al, 2006).  The underlying source of this variation could be traced to 190 genes 
whose expression patterns covaried with measures of adult hippocampal neurogenesis indicating 
that baseline adult hippocampal neurogenesis levels result from a complex interaction between 
many genes.  In addition, adult hippocampal neurogenesis has been shown to be an extremely 
dynamic process with all phases, from proliferation to maturation, subject to modulation by 
environmental stimuli, leading to either increases or decreases in neurogenesis relative to 
endogenous levels (Fig 1.3B).  
  Initial studies aimed at understanding the regulation of adult neurogenesis took cues 
from what was already known about developmental neurogenesis.  Studies in which rats were 
adrenalectomized or given an acute treatment of the glucocorticoid, corticosterone, revealed that 
adrenal steroids suppressed adult neurogenesis in the DG (Cameron and Gould, 1994; Gould et 
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al, 1992).  To address the role of adrenal steroids under more physiological conditions, adult tree 
shrews were subjected to psychosocial stress to naturally modulate adrenal steroid levels and 
found exposure to a stressful experience decreased cell proliferation in the DG (Gould et al, 
1997).  Ageing also acts as another negative regulator of adult neurogenesis with proliferation 
declining over time (Kuhn et al, 1996).  
Levels of neurogenesis can be enhanced too.  Mice living in an enriched environment 
where they had access to nestling, tunnels, toys, a running wheel, and extra treats exhibited 
increased cell survival (Kempermann et al, 1997), while mice given just a running wheel exhibit 
increased cell proliferation (van Praag et al, 1999).  Additionally, survival of new abGCs is 
increased by hippocampal-dependent associative learning tasks (e.g. trace eyeblink conditioning, 
spatial Morris water maze training) while hippocampal-independent associative learning tasks 
(e.g. delayed eyeblink conditioning, cued Morris water maze training) do not alter neurogenesis 
levels (Gould et al, 1999).  This learning also accelerates the dendritic maturation of the 
surviving new neurons (Tronel et al, 2010).  Furthermore, a variety of antidepressants (ADs) 
given chronically increase adult hippocampal neurogenesis by enhancing proliferation, survival, 
and/or maturation (David et al, 2009; Malberg et al, 2000; Wang et al, 2008). 
 Overall this provides a framework in which interventions associated with negative effects 
on cognition and mood like stress and aging decrease levels of neurogenesis while positive 
interventions like learning, environmental enrichment, exercise, and chronic AD treatment 
enhance neurogenesis suggesting a possible functional role for new neurons.   
 In the decades that have passed since the discovery of newly generated GCs in postnatal 
rat, significant progress has been made in understanding the process of adult neurogenesis.  
Many efforts have been made to link external stimuli to its internal mediators to gain a better 
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mechanistic understanding of the factors that regulate neurogenesis. This on its own is a valuable 
undertaking as understanding neuronal growth and survival in the context of the adult brain has 
significant implications for therapeutic interventions aimed at neuronal repair.  What lags behind 
is a clear picture of how new neurons in the DG contribute to the brain’s normal operation and 
thus an answer to the question of if and why adult neurogenesis is functionally important.  
 
 
Figure 1.3 Maturation and modulation of adult neurogenesis. A. Neural stem cells (type 1) 
and proliferative intermediate progenitor cells reside in the subgranular zone (SGZ).  The 
majority of cells exiting the cell cycle go on to become neurons which migrate up the granule 
cell layer as they differentiate, mature, and integrate into the existing circuitry over the course of 
6-8 weeks.  B. Interventions that have beneficial effects on cognition and mood such as learning, 
exercise, environmental enrichment, and chronic antidepressant (AD) treatment increase levels 
of adult hippocampal neurogenesis while negative interventions and events like stress, increased 
glucocorticoid levels, and aging decrease neurogenesis suggesting a possible functional role for 






Experimental Approaches to Studying Adult Born Neurons 
Different methods have been used over the years to study new neurons’ functional role in 
the HPC, most of which focus on ablating neurogenesis. At first, anti-mitotic agents such as 
methylazoxymethanol acetate (MAM) or radiological methods were used to inhibit neurogenesis 
(Madsen et al, 2003; Shors et al, 2001).  Besides having limited specificity over which 
proliferating cells these treatments target, they are also known to impair overall health and cause 
inflammation (Dupret et al, 2005; Monje et al, 2003).   More targeted approaches where later 
developed that involved expressing genes which promote apoptosis under the control of neural 
stem cell-specific promoters such as glial fibrillary acidic protein (GFAP) or nestin.  An example 
of this is the GFAP-tk mouse, which expresses thymidine kinase (tk) from herpes simplex virus 
in neural precursor cells (NPCs) (Saxe et al, 2006). Treating these mice with ganciclovir (GCV), 
a nucleotide analogue, leads to cell death as tk facilitates GCV’s incorporation into DNA, 
reducing abGCs in the DG. While proliferation and neurogenesis eventually recovers after 
withdrawal from GCV, studies using these methods can only answer questions about chronic 
ablation of neurogenesis.  
An alternative approach is to look at behavior when neurogenesis is increased.  
Interventions that can increase hippocampal neurogenesis include environmental enrichment, 
exercise, and chronic AD treatment (Kempermann et al, 1997; Malberg et al, 2000; Sahay et al, 
2011a; van Praag et al, 1999). Yet, these methods have a wide range of effects within the central 
nervous system; therefore, it is unlikely that all behavioral effects can be attributed to altered 
neurogenesis (David et al, 2009; Meshi et al, 2006).  Again, genetic manipulations provide a 
cleaner alternative.  Deleting the pro-apoptotic gene Bax from neural stem cells and their 
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progeny is as effective at increasing adult hippocampal neurogenesis as the interventions 
mentioned above, but doesn’t involve a plethora of off-target side effects (Sahay et al, 2011a). 
If adult hippocampal neurogenesis is functionally important, then the behaviors it will 
help mediate will be behaviors that rely on the HPC and in particular the DG.  Therefore, before 
we can begin to understand neurogenesis, we must first look to what is known about the region 
in which these new neurons reside. 
 
Function of the Hippocampus 
The Hippocampus’ Role in Cognition 
The HPC plays an essential role in many cognitive functions (Eichenbaum, 2004; 
Eichenbaum and Cohen, 2014; Morris, 2007b; O'Keefe and Nadel, 1978; Squire, 1992; Squire et 
al, 2004).  Its link to memory became tightly fixed following studies of Henry Molaison (patient 
H.M.) who exhibited profound memory deficits after undergoing a bilateral medial temporal 
lobectomy to alleviate his drug-resistant seizures (Scoville and Milner, 1957).  However, the 
medial temporal lobe includes areas other than the HPC such as the amygdala and adjacent 
cortex resulting in uncertainty as to whether or not lesioning the HPC alone would impair 
memory.  The answer to this question came from patient R.B. who became amnesiac following 
an ischemic event.  Post-mortem examination of his brain revealed a bilateral lesion restricted to 
the CA1 region of the HPC (Zola-Morgan et al, 1986).  Furthermore, improvements in magnetic 
resonance imaging (MRI) made it possible to study the HPC in living humans (Press et al, 1989).  
Using this technology, the hippocampi of patients with memory impairments were shown to be 
significantly smaller than normal providing direct evidence of hippocampal damage in these 
patients (Squire et al, 1990).  Additional studies in non-human primates and rodents have further 
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confirmed these findings and directed research on hippocampal function down two different 
paths.   
Work initiated in rodents led to the discovery that certain CA1 pyramidal neurons in 
freely moving rats become active when the rats entered a particular region of their environment 
(O'Keefe and Dostrovsky, 1971).  These neurons were defined as “place cells” while the location 
they fired in was that neuron’s “place field,” and it was theorized that place-cell ensembles 
represent maps of space.  Place cells have since been found in the principal cells of CA3 and the 
DG, firmly establishing the HPC’s role in spatial memory processes (O'Keefe et al, 1971).  
Concurrently, an animal model of human amnesia was developed in monkeys with lesions to 
their medial temporal lobe (Mishkin, 1978).  These monkeys as well as monkeys with lesions 
limited to the HPC were severely impaired in object recognition memory tasks (Mahut et al, 
1982; Mishkin, 1978).  In addition to reproducing a similar type of memory impairment, these 
monkeys displayed other key features that resembled human amnesiac patients in that their 
immediate working memory was spared as was their ability to acquire and retain skills, thereby 
opening up new doors for studying the HPC’s involvement in declarative memory (Squire and 
Zola-Morgan, 1991).   
Together, this work has helped define the types of learning and memory that are mediated 
by the HPC and establish the idea of multiple memory systems in the brain (Squire, 1992).  The 
HPC is required for forming new declarative (episodic and semantic) and spatial memories 
(Morris, 2007b; Nadel, 1991; Squire, 1992).  In contrast, nondeclarative forms of learning and 
memory, such as skill or habit forming, priming, and nonassociative (habituation, sensitization) 
and associative (classical conditioning) learning, occur independently of the HPC (Kandel et al, 
2000; Morris, 2007b; Squire, 1992).  It should be noted that more complicated conditioning 
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paradigms that require complex cognitive processes such as contextual fear conditioning (CFC) 
do rely on the HPC (Phillips and LeDoux, 1992). In relation to the HPC’s involvement in 
processing context, the cognitive mapping and declarative memory roles of the HPC clearly 
align. Episodic memory by definition relies on contextual information. A full contextual 
representation requires information on the where of the context, which can be provided by place 
cells.  Thus, place cells likely underlie episodic memory by contributing to contextual 
representations (Smith and Mizumori, 2006).  While the HPC is necessary for the creation of 
new memories, the phenomenon of temporally graded retrograde amnesia suggests the HPC only 
remains involved in memory storage for a limited time after learning before the memory gets 
stored in the neocortex (Zola-Morgan and Squire, 1990).  Conversely, spatial maps are thought 
to remain in the HPC (O'Keefe et al, 1978). 
  
The Contribution of the Dentate Gyrus to Cognition 
 Anatomical, electrophysiological, behavioral, and computational studies suggest that 
each hippocampal subregion uniquely contributes to the overall process of memory formation 
(reviewed in (Kesner et al, 2004)).  The DG is believed to contribute to this process by acting as 
a pattern separator.  Since its first inception as a computational process aimed at modeling 
activity within a neural network ((Marr, 1971); reviewed in (Kesner and Rolls, 2015)), the term 
pattern separation has been used loosely to describe other phenomena such as single cell activity 
and behavior (Leutgeb et al, 2007; McHugh et al, 2007; Santoro, 2013).  While all potentially 
linked, distinctions need to be made.   
Pattern separation as a computational process evolved from a model in which memories 
are encoded by an ensemble of neurons.  Specifically, it refers to the transformation of similar 
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sensory inputs into discrete, non-overlapping representations (orthogonalization) such that 
interference between separate encoding events is minimized.  There are several properties of the 
DG that make it ideally suited to serve this function.  First, the number of neurons in the DG (~ 1 
million in the rat) is much greater than the number of neurons that project to the DG from the EC 
(~200,000 layer II cells) and greater than the number of neurons downstream from the DG in 
CA3 (~300,000). Projecting EC inputs onto the DG as opposed to just directly onto CA3 allows 
for an expansion of the number of nodes that make up a given representation while at the same 
time still allows the representation to be made sparse.  This sparse coding scheme helps 
decorrelate inputs since only a small fraction of all DG GCs is needed for encoding a memory 
and it is supported by another key feature of the DG – its high level of inhibition.  GCs are 
highly inhibited by local interneurons resulting in activation of only 1-4% of all GCs for a given 
physiological experience (Alme et al, 2010; Chawla et al, 2005; Denny et al, 2014).  The final 
DG output is thus a high-resolution memory that is distinct (non-overlapping) from other 
memories (Burgess, 2007; Deng et al, 2010; Kesner et al, 2015; Rolls, 2013; Trappenberg, 
2010).  The large synapses GC mossy fibers form near the soma of CA3 pyramidal cells 
facilitates the process of effectively transferring the orthogonalized information to CA3.  This 
powerful synapse allows GC input to overcome the activity of recurrent connections in CA3 
pyramidal cells resulting in a new pattern of activity within CA3 that, due to the already sparse 
activity in the DG and the small number of MF connections on each CA3 cell (see Dentate 
Gyrus section), is sparse and distinct as well (Kesner et al, 2015; McNaughton and Morris, 1987; 
Morris, 2007b).  
 In an attempt to validate this model experimentally,  Leutgeb et al (2007) examined the 
transformation of cellular activity in the EC-DG-CA3 circuit of rats while incrementally 
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changing the shape of the enclosure in which an animal ran so that its sensory input was 
gradually and systematically altered.  Activity recorded in cells that resided in the perforant path 
termination area and likely represented inputs from the EC did not detectably change in response 
to the incremental transformation of the enclosure.  Within CA3, decorrelation increased but 
only as the enclosures became more different.  Interestingly, activity within the DG was highly 
sensitive to even small changes in the enclosure shape; however, the decorrelation observed in 
the DG was due to changes in cell firing rates not changes in the population of active cells as 
predicted by the original pattern separation model.  This data suggests that the same hippocampal 
cells participate in many representations and the orthogonalization that occurs in the DG results 
from changes in rate patterns as opposed to changes in the active cell assembly.  However, there 
is also evidence for global remapping as immediate early gene expression studies that have 
examined the DG on a population level have found different environments or tasks activating 
distinct populations of neurons while repeated exposures to the same environment or task 
activated the same or similar subsets of GCs (Chawla et al, 2005; Deng et al, 2013; Denny et al, 
2014; Satvat et al, 2011).   
 More recently, pattern separation has also been used to describe the ability of subjects to 
discriminate between similar stimuli as determined by a measured behavioral response to those 
stimuli.  This behavioral phenomenon has been tested using delayed match/non-match to place 
tasks that parametrically alter degrees of spatial separation during testing such as the 
cheeseboard spatial discrimination task or radial arm maze (Clelland et al, 2009; Gilbert et al, 
2001).  Contextual fear discrimination (CFD), in which the test subject must distinguish between 
a fearful context in which it gets shocked and a similar but distinct safe no-shock context, has 
also been used to assess pattern separation (McHugh et al, 2007; Sahay et al, 2011a).  Pattern 
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separation at the level of the cell ensemble is thought to be a potential mechanism for behavioral 
pattern separation and in support of this, it has been found that interfering in DG function 
impairs the subject’s ability to discriminate between similar stimuli in all these behavioral 
paradigms (Clelland et al, 2009; Gilbert et al, 2001; McHugh et al, 2007; Sahay et al, 2011a).  
Nonetheless, while behavioral pattern separation is consistent with computational pattern 
separation, it does not imply that such computations are indeed occurring.  So far no studies have 
examined population activity in the EC, DG, and CA3 during a behavioral pattern separation task 
and shown cell ensemble pattern separation occurring simultaneously.  Even then causality 
would need to be determined by manipulating the cellular pattern separation during behavior. 
 
The Hippocampus’ Role in Mood 
 In addition to the classical learning and memory function attributed to the HPC, it is also 
implicated in playing a role in emotional behavior.  Likely underlying this function is the link 
between the HPC and the hypothalamus-pituitary-adrenal (HPA) axis, a major part of the 
neuroendocrine system that is involved in mediating both acute and chronic stress responses 
(Morris, 2007a).  Evidence for this link first came with the discovery that corticosteroid receptors 
are highly expressed in the HPC (McEwen et al, 1980; McEwen et al, 1968).   Corticosteroid 
levels are increased during stressful events, thus the presence of corticosteroid receptors in the 
HPC directly links the structure to stress response (Goldstein and McEwen, 2002; Lupien and 
Lepage, 2001). On a behavioral level, this link can be seen in alterations in cognitive ability due 
to stressful experience (Morris, 2007a).  This data highlights the complex relationship between 
stress and the HPC as cognitive ability plotted as a function of stress severity is not a linear 
relationship but instead takes on an inverted U-shape such that at first increasing stress enhances 
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cognitive functions, but after a certain point cognitive ability begins to decrease and with enough 
stress can dip below baseline levels (Morris, 2007a; Yerkes and Dodson, 1908).  This change in 
cognitive ability is likely due to stress’ ability to modulate the excitability and activity-dependent 
synaptic plasticity within the HPC.  High levels of stress impairs potentiation in the DG and CA1 
regions of the HPC (Foy et al, 1987; Shors and Dryver, 1994) while mild stress conditions are 
actually correlated with enhanced potentiation (Diamond et al, 1992) which has led to the theory 
that stress and the associated steroid receptor activity induces “metaplasticity” (i.e. altering the 
degree of plasticity a neuron displays during subsequent events) (Kim and Diamond, 2002; 
Morris, 2007a).  With prolonged exposure to stress, the hippocampal structure itself begins to 
change.  Atrophy of apical dendrites and alterations in synaptic terminal structure in CA3 and 
DG is observed in rodents and tree shrews exposed to stress and high glucocorticoid levels 
(Magarinos and McEwen, 1995; Magarinos et al, 1996; Magarinos et al, 1997; Woolley et al, 
1990).  This dendritic remodeling is accompanied by impairment in learning a spatial reference 
memory task (Luine et al, 1994).  In humans, Cushing’s disease patients who have chronically 
high levels of cortisol show atrophy of the HPC in MRI studies accompanied by cognitive 
impairments.  In these studies, cort levels, extent of atrophy, and cognitive impairments are all 
correlated (Starkman et al, 1992). 
 The HPC reacts to these changes by providing feedback inhibition to the HPA axis.  
Activation of glucocorticoid receptors in the HPC following exposure to a stressor inhibits 
activity within the hypothalamus and in doing so limits the duration of the stress response 
(Feldman and Weidenfeld, 1999; Jankord and Herman, 2008; Morris, 2007a).  Conversely, it has 
also been shown that HPC activity can trigger CORT release as lesions of the ventral subiculum 
reduce the CORT response to novelty (Herman et al, 1998).   Even signals associated with the 
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memory of stressful or potentially stressful experiences are thought to be able to activate the 
hypothalamus leading to the release of stress hormones in anticipation of circumstances in which 
they may be needed (Herman et al, 2003).  
 The HPC’s ability to both trigger and limit the duration of a stress response has profound 
implication for hippocampal involvement in anxiety and depression.   In line with this, lesioning 
the HPC results in a similar pattern of behavioral effects in tests of anxiety as would be seen with 
anxiolytic drug treatment (Bannerman et al, 2004; Gray and McNaughton, 2000). While the 
exact etiology of depression is still a mystery, a major risk factor for developing depression is 
experiencing a stressful life event suggesting alterations in hippocampal function could underlie 
the onset of the disease (Krishnan and Nestler, 2008).  This idea is supported by reports of 
decreased hippocampal volume in depressed patients (Sheline et al, 1996; Videbech and 
Ravnkilde, 2004). Decreased hippocampal volume is seen in patients with Cushing’s disease 
who not only display cognitive impairments as mentioned above but also present with depressed 
mood (Starkman and Schteingart, 1981) and in individuals with psychiatric disorders related to 
anxiety such as PTSD or social anxiety disorder (Irle et al, 2010; Karl et al, 2006; Kitayama et 
al, 2005).  These studies strongly point to the HPC involvement in affective disorders; however, 
whether hippocampal changes are the cause or just an effect is still a matter of debate (Sheline, 
2011).  
 
The Contribution of the Dentate Gyrus to Mood 
The role of the DG in regulating mood, especially AD action, is highly associated with 
adult neurogenesis.  This link will be discussed in more detail later on. Yet it should be noted 
that data supports a role for the entire DG in mediating emotional processes as well.  Stressful 
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events can trigger a depressive episode and DG GCs are extremely sensitive to stress hormone 
levels as adrenalectomy results in a near complete loss of DG GCs while other cell types in the 
DG and surrounding hippocampal formation remain intact (Sloviter et al, 1989).  Infusion of 
signaling proteins that have been found to be upregulated following chronic AD treatment, such 
as brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF), 
directly into the DG is sufficient to induce AD-like behavioral effects (Shirayama et al, 2002; 
Warner-Schmidt and Duman, 2007). Furthermore, knocking out the 5-HT1A serotonin receptor 
(5-HT1AR) from all DG GCs (young abGCs and mature GCs) blocked the behavioral effects of 
chronic AD treatment in a variety of anxiety- and depression-related tasks; however, when this 
manipulation was restricted to just the young abGC population, AD response remained intact 
indicating that mature DG GCs are critically engaged in mediating the response to AD treatment 
(Samuels et al, 2015). 
The DG’s ability to regulate anxiety was recently examined using optogenetic techniques 
to parse out the functional contribution of its dorsal and ventral regions (Kheirbek et al, 2013).  
This study found that stimulating the activity of ventral DG GCs induced a robust and reversible 
anxiolytic effect in mice. It is particularly interesting to note that the same manipulation did not 
impair learning in a hippocampal-dependent CFC task.  Conversely, manipulations to the dorsal 
DG disrupted learning, but had no impact on anxiety levels.  This data supports the theory that 
the reason the HPC is able to modulate both cognition and mood - two seemingly disparate 
processes - is because the HPC is functionally segregated along its dorsoventral axis.  Further 




Regional Heterogeneity Along the Dorsoventral Axis 
Evidence that the HPC is involved in both cognitive and emotional processes has been 
established, yet how can the same structure serve such different functions?  The current theory 
proposes that function varies along the dorsoventral axis of the HPC.  Support for this theory 
comes from studies showing variation in anatomical connectivity along this axis that—together 
with behavioral analysis—suggests the dorsal and ventral HPC are functionally distinct 
structures (Bannerman et al, 2004; Fanselow and Dong, 2010; Moser and Moser, 1998). 
In the classic tri-synaptic circuit, the EC sends information from association cortices via 
the perforant path to the DG. DG GCs then send excitatory mossy fiber projections to CA3 
pyramidal neurons, which project to CA1 via the Schaffer collaterals, and CA1 sends projections 
to the subiculum (SUB). Of these subfields, CA3, CA1, and SUB can send projections outside of 
the HPC. It is these projections out of the HPC that may have differing effects on behavior, as 
dorsal hippocampal targets are primarily involved in spatial memory tasks and context-reward 
associations (Cenquizca and Swanson, 2007; Luo et al, 2011), while ventral hippocampal targets 
impact emotional expression (Fig 1.4). 
The dorsal HPC may directly impact spatial memory tasks by providing contextual 
information via dorsal CA1 projections to the retrospenial area of the anterior cingulate cortex 
(Cenquizca et al, 2007). Indeed, dorsal HPC and retrosplenial lesions have been shown to disrupt 
learning in spatial memory tasks (Moser et al, 1995; Pothuizen et al, 2004; Vann and Aggleton, 
2002, 2004), and dorsal CA1 silencing abolishes behaviorally induced immediate early gene 
expression in the retrosplenial cortex during spatial memory tasks (Kubik et al, 2012). In 
addition to modulating spatial memory, the dorsal HPC may provide contextual information for 
reward-context association tasks involving dopamine release from the ventral tegmental area 
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(VTA) via dorsal CA3 projections to the septum (Risold and Swanson, 1996). Specifically, Luo 
et al (2011) found that dorsal CA3 activity disinhibits dopaminergic VTA neurons by activating 
long-range inhibitory projections in the lateral septum. Although the behavioral relevance of this 
circuit has not been demonstrated, this study provides a specific circuit through which dorsal 
HPC may impact the VTA reward system. Taken together, projections from the dorsal HPC 
serve a functional role in context-dependent cognitive processes.  
The ventral HPC, where ventral CA1 and ventral SUB are the major output centers, has 
also been proposed to impact the VTA reward system as well (Legault and Wise, 2001; Lisman 
and Grace, 2005; Valenti et al, 2011). From this axis, the ventral HPC projects directly to the 
nucleus accumbens (Christie et al, 1987; Totterdell and Smith, 1989), and ventral SUB activity is 
necessary for novelty-evoked and stress-induced VTA dopamine release (Legault et al, 2001; 
Valenti et al, 2011).  Understanding whether dorsal and ventral HPC modulation of VTA 
dopamine release are functionally overlapping pathways or serve behaviorally distinct functions 
will be important for establishing the role of the HPC in reward and novelty processing.   
Another major target of the ventral HPC is the medial prefrontal cortex (mPFC) 
(Cenquizca et al, 2007). Although hippocampal projections to the mPFC have been traditionally 
implicated in cognitive spatial memory tasks and goal-directed behavior (Burton et al, 2009; Hok 
et al, 2005; Seamans et al, 1998; Seamans and Yang, 2004), ventral hippocampal input to the 
mPFC has been shown more recently to play a role in innate anxiety and conditioned fear 
(Adhikari et al, 2010; Sotres-Bayon et al, 2012).   
The ventral HPC also projects to most major subfields of the amygdala (Canteras and 
Swanson, 1992; Cenquizca et al, 2007; Kishi et al, 2006; McDonald, 1998; Pitkanen et al, 2000). 
Recent evidence has implicated ventral HPC-amygdala circuitry in innate anxiety and social 
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behavior (Felix-Ortiz et al, 2013; Felix-Ortiz and Tye, 2014).  There is also considerable 
evidence from pharmacologic inhibition, lesion, and in vivo recording studies suggesting a 
coordinated role between the ventral HPC and amygdala in both contextual and cued fear 
expression processes (Corcoran et al, 2005; Corcoran and Maren, 2001; Maren and Holt, 2004; 
Seidenbecher et al, 2003). 
The bed nucleus of the stria terminalis (BNST) also receives direct projections from the 
ventral HPC (Cullinan et al, 1993), and is heavily interconnected with the amygdala, 
hypothalamus, and VTA (Dong et al, 2001a; Dong et al, 2001b; Dong and Swanson, 2004a, b, 
2006a, b, c; Stamatakis et al, 2014). Recently, a differential function for the BNST in these 
circuits has been implicated in more specific features of anxiety (Jennings et al, 2013; Kim et al, 
2013). Future studies using cell-type and projection specific dissection techniques will elucidate 
not only the differential contribution of each projection field to behavior, but also how the 
ventral HPC modulates local circuits within the amygdala, BNST, and mPFC. 
Given the already established connection between the HPC and HPA axis in the previous 
sections, it is of significant importance to understand how ventral hippocampal projections 
modulate hypothalamic activity to impact stress responses. Both ventral CA1 and ventral SUB 
project extensively to many subnuclei of the hypothalamus, including the anterior (AH), 
premamillary, ventromedial and dorsomedial nuclei, and mammillary bodies, all of which have 
been implicated in the expression of defensive behaviors (Canteras et al, 1997; Cezario et al, 
2008; Dielenberg et al, 2001).  Interestingly, activation of GABAergic lateral septal inputs to 
AH, an extension of the septo-hippocampal axis, has recently been shown to increase 
corticosterone levels and produce persistent anxiety-like behaviors (Anthony et al, 2014). 
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Although hippocampal contribution to this pathway remains unknown, this study provides a 




Figure 1.4 Projections vary along the dorsoventral axis of the hippocampus.  The dorsal 
hippocampus projects to the retrosplenial area (RSP) of the anterior cingulate cortex and to the 
ventral tegmental area (VTA) via the septum.  These projections serve a functional role in 
context-dependent cognitive processes.  Dorsal hippocampus also sends projections to the ventral 
hippocampus.  Projections from the ventral hippocampus include: the medial prefrontal cortex 
(mPFC), hypothalamus, amygdala, bed nuclues of the stria terminalis (BNST), and the VTA via 
the nucleus accumbens (nACC).   Ventral hippocampal projections function to modulate fear 
expression and anxiety.  
 
Given this background on the HPC, and the DG in particular, we can now begin to 
examine the behaviors in which adult hippocampal neurogenesis may be involved.  The theories 
on abGCs’ function and the studies that support them are reviewed below.   
 
Function of Adult Hippocampal Neurogenesis 
The process of neurogenesis is highly regulated by the cognitive and emotional state of 
an animal.  Increased levels of adult hippocampal neurogenesis are correlated with positive 
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experiences such as learning, environmental enrichment, exercise, and AD treatment while 
negative interventions like chronic stress, increased glucocortidoid levels, and aging decrease 
neurogenesis suggesting a possible functional role for adult-generated neurons.  These findings 
along with studies showing decreased hippocampal volume in depressed patients and a similar 
time frame between neuron maturation and delayed efficacy of ADs led to a neurogenic 
hypothesis of depression which postulated that impaired hippocampal neurogenesis is involved 
in the development of the disease. This hypothesis was given even more weight when studies 
showed that some of the behavioral effects of ADs require the presence of intact neurogenesis 
(Santarelli et al, 2003).  However, evidence shows that a lack of neurogenesis alone is not 
sufficient to induce depression, thus neurogenesis is important for the treatment of depression but 
not involved in its etiology (Airan et al, 2007; Surget et al, 2008). 
More recent studies have looked at how new neurons regulate response to stress and it 
may be through this avenue that they modulate mood. Schloesser et al (2009) showed that mice 
with suppressed neurogenesis exhibited an increased corticosterone response after exposure to 
acute restraint stress.  In addition, neuroendocrine and behavioral responses to a mild stressor are 
exaggerated in mice with reduced neurogenesis, linking HPC output with the hypothalamic-
pituitary-adrenal (HPA) axis (Snyder et al, 2011).  Chronic stress produces a dysregulation in 
HPC-HPA connectivity, which can be corrected by AD treatment.  However, suppressing levels 
of adult hippocampal neurogenesis blunts this restorative ability of fluoxetine (FLX) (Surget et 
al, 2011). 
Altered behaviors in HPC-dependent learning tasks have been seen in rodents with 
modified levels of adult neurogenesis highlighting its involvement in learning and memory 
processes.  Upon reduction or ablation of neurogenesis, impairments have been observed in trace 
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and CFC, spatial-navigation learning, and long-term spatial memory retention, clearance of 
hippocampal memory traces, reorganization of memory to extra-hippocampal regions, and 
forgetting (Akers et al, 2014; Arruda-Carvalho et al, 2011; Deng et al, 2009; Drew et al, 2010; 
Dupret et al, 2008; Feng et al, 2001; Hernandez-Rabaza et al, 2009; Imayoshi et al, 2008; 
Jessberger et al, 2009; Kitamura et al, 2009; Ko et al, 2009; Saxe et al, 2006; Shors et al, 2001; 
Snyder et al, 2005; Warner-Schmidt et al, 2008; Winocur et al, 2006; Zhang et al, 2008), while 
enhancement of spatial memory, recognition memory, and pattern separation has been seen in 
animals with increased neurogenesis (Bruel-Jungerman et al, 2005; Nilsson et al, 1999; Sahay et 
al, 2011a; Wojtowicz et al, 2008).  However, these results tend to be conflicting. Taking CFC as 
an example, the task has been studied under many different ablation or enhancement techniques 
and there is no consensus in the field of its reliance on adult neurogenesis.  Some studies show 
that altering adult neurogenesis has no effect on CFC (Clark et al, 2008; Deng et al, 2009; 
Dupret et al, 2008; Sahay et al, 2011a; Shors et al, 2002; Zhang et al, 2008), while the others 
show that it does (Hernandez-Rabaza et al, 2009; Imayoshi et al, 2008; Ko et al, 2009; Saxe et 
al, 2006; Warner-Schmidt et al, 2008).  Still others find neurogenesis only effects behavior in 
some but not all CFC paradigms leading to the proposal that the contribution of adult 
neurogenesis becomes apparent in more difficult testing conditions such as when the training 
period is limited (1 shock CFC vs 3 shock CFC) (Drew et al, 2010; Winocur et al, 2006) 
Results have been more consistent with regard to newborn neurons involvement in 
behavioral pattern separation (see The Contribution of the Dentate Gyrus to Cognition section 
for a review of pattern separation). In separate studies that used a context-discrimination task to 
test behavioral pattern separation, mice whose abGC population had been suppressed by either 
irradiation (Sahay et al, 2011a) or genetic means (Nakashiba et al, 2012; Tronel et al, 2012) all 
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performed worse than controls at discriminating between highly similar contexts. Furthermore, 
using two spatial separation memory tasks, the radial arm maze and a nose-poke touch screen 
task, Clelland et al (2009) showed irradiated mice performed worse than sham mice during tasks 
that required them to chose between spatially close choices, while no impairment was seen when 
the choices were more distant.  These results are complemented by work that shows increasing 
the number of abGCs in the DG by specifically inhibiting their apoptosis or elevating levels of 
neurogenesis through running improves the animal’s ability to perform context and spatial 
pattern separation, respectively (Creer et al, 2010; Sahay et al, 2011a).  
 While these experiments show the importance of abGCs for learning during 
discrimination tasks, impairments in pattern separation may result in more than just cognitive 
deficits.  A dysfunction in memory generalization could underlie the pathological fear responses 
seen in anxiety disorders such as post-traumatic stress disorder (PTSD) and panic disorder.  In 
PTSD patients, overgeneralization could account for the fear response triggered by stimuli 
similar but distinct from their traumatic memory.  This theory of overgeneralization has been 
tested in patients suffering from panic disorder using a fear-generalization paradigm that assesses 
fear by measuring the startle blink reflex to a conditioned danger cue and generalization stimuli 
that parametrically vary from the danger cue.  Panic patients displayed stronger fear 
generalization, responding to stimuli with up to three degrees of dissimilarity to the conditioned 
danger cue, while control subjects only generalized their fear to stimuli with one unit of 
dissimilarity (Lissek et al, 2010).  Since neurogenesis is highly regulated by an individual’s 
emotional state, reductions in neurogenesis due to stress either before or after a traumatic event 
could result in a deficit in pattern separation leading to overgeneralization of fear that then 
evolves into a pathological condition.  The role cognition may play in an individual’s emotional 
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state may also help to understand the development of depression as cognitive deficits manifest in 
depressed patients along with the more hallmark symptoms relating to mood and behavior. 
The experiments described above demonstrate the importance of adult hippocampal 
neurogenesis in modulating specific aspects of cognition and mood, but so far experiments aimed 
at studying the function of new neurons have relied heavily on ablation techniques.  While 
ablation methods can test the necessity of abGCs in behavior, they also remove all abGCs from 
the circuit making it impossible to definitely determine which of their properties allow them to 
uniquely impact behavior. Neurogenesis has also been increased, but many of the interventions 
used can also have a wide range of effects elsewhere in the central nervous system (i.e. 
environmental enrichment, exercise, AD treatment) and the question of how newborn neurons 
are able to modify hippocampal output in a way that is distinct from mature GCs still remains.  
To answer this question, an alternative approach that allows for the modification of adult-born 
neurons instead of just altering their number has to be utilized. 
 During the maturation process, immature neurons exhibit distinct characteristics that 
could underlie their ability to influence behavioral output.  In addition to different gene 
expression patterns and morphological features, newborn neurons exhibit unique 
electrophysiological properties including periods of enhanced synaptic plasticity. Notably, 4-6 
week old GCs exhibit increased LTP amplitudes relative to mature GCs. LTP in the perforant 
path requires activation of NMDA receptors. This family of receptors forms heterotetramers 
consisting of 2 obligatory NR1 subunits and 2 NR2 subunits. There are 4 NR2 subtypes: 
NR2A,B,C and D, with NR2B being the predominant subunit expressed during early 
development.  The development of abGCs recapitulates a number of aspects of early 
development, including this preferential expression of the NR2B subunit.  It has been shown that 
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this enhanced potentiation seen in 4-6 week old neurons can be blocked with antagonists that are 
specific for NMDA receptors containing the NR2B subunit, demonstrating that this transient 




The primary goal of this thesis will be to explore the contribution abGCs’ heightened 
synaptic plasticity makes to hippocampal function.  This will be achieved using a transgenic 
mouse approach that will allow for the conditional deletion of NR2B from abGCs, which 
effectively eliminates newborn neurons’ enhanced plasticity.  To expand on these findings in 
future experiments, a mouse line that provides greater temporal control of abGCs’ activity was 
generated and characterized.  The specific aims are as follows: 
 
I. Generate and characterize mice in which NR2B is deleted from abGCs. 
II. Test the effects of NR2B deletion on cognitive and mood-related behaviors at baseline. 
III. Test the effect of NR2B deletion on the behavioral and neurogenic response to chronic 
antidepressant treatment. 
IV. Generate and characterize mice in which abGCs can be temporally inhibited. 
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CHAPTER 2 
Deletion of the NR2B Subunit of NMDA Receptors on Adult-born Granule Cells in the 
Dentate Gyrus Impairs Neurogenesis-dependent Hippocampal Function 
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PART I 




N-methyl-D-aspartate (NMDA) receptors are ligand-gated cation channels that are 
activated by the brain’s main excitatory neurotransmitter, glutamate, and the co-agonist, glycine.  
NMDA receptors (NMDARs) participate in diverse processes such as synaptic transmission, 
plasticity, and excitotoxicity (Cull-Candy et al, 2001; Dingledine et al, 1999; Schoepfer et al, 
1994).  In addition to being selectively activated by NMDA, a synthetic amino acid derivative, 
NMDARs differ from other types of ionotropic glutamate receptors in a number of important 
ways.  NMDARs slowly open and close their channels with activation/deactivation kinetics at 
least 2 orders of magnitude larger than AMPA receptors (Cull-Candy et al, 2001).  Amongst the 
cations flowing into the cell through the channel is Ca2+, which can act as a second messenger in 
neurons, activating signaling cascades involved in phosphorylation, gene transcription, and 
protein synthesis – steps necessary for the induction of synaptic plasticity.   Another unique 
feature is their voltage-dependent block by magnesium ions.  For Mg2+ to be removed and 
channels to open, the membrane potential near the channel must first be depolarized (Monyer et 
al, 1994).  As such, activating NMDARs requires two events to occur close in time: glutamate 
must bind to the NMDAR and the cell containing the NMDAR must be sufficiently depolarized.  
Thus, the process of NMDAR activation acts as a coincidence detector sensing temporally close 
activity in pre- and post-synaptic cells (Seeburg et al, 1995).  The ability to detect synchronous 
activity and then transform that information into enhanced synaptic strength positions NMDARs 
to play a key role in mechanisms underlying learning and memory such as long-term 
potentiation. 
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 NMDARs are formed from an ensemble of four subunits encoded by three gene families: 
NR1, NR2, and NR3.  Only one NR1 gene exists, while there are four NR2 genes (A-D), and 
two NR3 genes (A-B).  All NMDARs contain two NR1 subunits with either two NR2 subunits or 
one NR2 and one NR3 subunit (Cull-Candy et al, 2001). The NR1 subunit is expressed 
throughout the brain whereas the expression of other subunits varies between brain regions and 
substantially changes over the course of development (Monyer et al, 1994). NR2B and NR2D 
are expressed prenatally while NR2A and NR2C only begin to appear near birth.  In the adult rat, 
NR2B is predominantly expressed in the forebrain, NR2D expression decreases to very low 
levels, NR2A is the most widely distributed subunit, and NR2C is mainly found in the 
cerebellum.  These NR2 subunits confer the NMDAR with different kinetic and pharmacological 
properties.  For example, the Mg2+ block sensitivity differs between receptor subtypes with 
NR2A- and NR2B-containing receptors requiring about a 20 mV greater depolarization to 
achieve maximal current than NR2C- or NR2D-containing receptors (Monyer et al, 1994).  
Deactivation varies significantly as well with NR2D conferring a substantially longer 
deactivation time than the other subunits, NR2A-containing receptors deactivate the quickest, 
while NR2B and NR2C fall between the two (offset decay time constant - NR2D: 4800 ms > 
NR2B: 400 ms ~ NR2C: 382 ms > NR2A: 118 ms) (Monyer et al, 1994).  NR3 subunits appear 
to act as dominant-negative in the receptor complex suppressing NMDAR activity (Ciabarra et 
al, 1995; Das et al, 1998; Nishi et al, 2001). The variation in receptor expression over the course 
of development and the heterogeneity in channel properties suggest different subtypes may serve 




NMDA Receptors Involvement in Adult Neurogenesis 
Relying on what was known from developmental neurogenesis, early adult neurogenesis 
research examined the effect stress and GR activation had on the process and found that their 
observed neurogenesis suppressing effects were mediated by NMDARs.  Systemic NMDAR 
activation decreased proliferation and the overall number of newly generated GCs while 
NMDAR antagonists increased proliferation and neurogenesis (Cameron et al, 1995; Nacher et 
al, 2001; Okuyama et al, 2004).  NR2B-containing NMDARs appear to be involved in this 
negative regulation of neurogenesis as treatment with an NR2B specific antagonist was sufficient 
to increase hippocampal proliferation (Hu et al, 2008).  Further implicating NMDARs in 
neurogenesis are studies showing that the induction of LTP - which in the DG requires NMDAR 
activation - enhances proliferation perhaps by activating quiescent NSPCs (Bruel-Jungerman et 
al, 2006; Chun et al, 2006; Kameda et al, 2012).  The downside to these studies is that they 
allow for unrestricted NMDAR activation/deactivation without targeting any specific cell type in 
the HPC.  Effects could be the result of direct NMDAR activity in abGCs or neurogenesis could 
be indirectly influenced by the activity of mature GCs and/or other cell types in the area.  In fact, 
there is evidence suggesting activity-dependent release of BDNF from mature cells increases 
differentiation of NPCs (Babu et al, 2009).  Alternative approaches to studying NMDARs’ effect 
on neurogenesis have resulted in conflicting data. Using an in vitro technique that isolated NPCs 
from other cell types showed NPCs respond to glutamate by increasing the fraction of new cells 
that became neurons (Deisseroth et al, 2004).  NMDAR antagonists could block this effect.  
Here, NMDAR activation promotes neurogenesis while in the previously mentioned studies 
NMDAR activation decreased neurogenesis suggesting that stimulation restricted to the NPCs 
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themselves has a substantially different effect than unrestricted activation/blockade which 
includes the influence of surrounding cell types as a part of the net effect. 
 
Evidence for functional NMDA Receptors in NPCs and abGCs 
For NMDARs to directly act upon NPCs, these cells must contain functional NMDARs.  
Immunohistochemical analysis performed in rat has found NR1 and NR2B expression in type 1 
and type 2a cells and immature abGCs but not in type 2b/3 cells, though the GFAP-expressing 
cells classified as “type 1” in this study could also potentially be astrocytes (Nacher et al, 2007).  
Another study that used nestin-GFP mice was unable to detect NR1 expression in nestin-GFP-
positive cells, which should correspond to the cells labeled type 1 and 2 in the previous study 
(Petrus et al, 2009).  Given the conflicting data, further studies are needed to definitely determine 
NMDAR subunit expression in neural progenitors and immature neurons.  This information will 
be useful to determine exactly which stages of development can be influenced by direct NMDAR 
activity. 
Another approach to take is to determine when cells begin to respond to excitatory input 
through NMDARs.  Isolated NPCs, maintained in culture without any other living cells, respond 
to glutamate and NMDA with elevations in intracellular Ca2+ (Deisseroth et al, 2004).  Yet, only 
52% of mitotic cells examined in the newborn or adult GCL exhibit synapses on cell bodies or 
processes (Kaplan and Bell, 1984).  In post-mitotic immature GCs, glutamatergic perforant path 
inputs do not begin to appear until cells are approximately 18 days old.  However, 7 days old 
cells respond to the focal application of glutamate indicating that functional receptors are present 
before the arrival of afferent connections (Esposito et al, 2005).  This study did not specifically 
target NMDAR but it does suggest that, if present, initial NMDAR activity may be non-synaptic.  
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NMDA Receptor Subunit Knock-out Experiments 
The experiments described above either lack cell type specificity or involve in vitro 
preparations. Studies that take a genetic approach to manipulate NMDAR expression in newborn 
neurons are helping to shed light on the cell-autonomous and non-cell-autonomous role 
NMDARs play in modulating neurogenesis in the intact brain.  Using a retrovirus-mediated, 
single-cell gene knockout technique, newborn neurons lacking the obligatory NR1 subunit, and 
thus functional NMDARs, were found to have a significantly reduced survival rate during the 2 
to 3 week period after virus injection (Tashiro et al, 2006).  As cell death occurs throughout the 
neurogenesis process, this result suggests that early survival mechanisms are independent of 
direct NMDAR activity within newborn neurons whereas later survival does rely on that activity.  
When abGCs lacking NR1 are rescued from apoptosis by over-expressing a pro-survival protein, 
the resulting neurons with increased mushroom spine density but overall decreased spine density 
(Mu et al, 2015).  Deleting NR1 from 4-week-old abGCs did not affect survival or overall spine 
density, but once again increased mushroom spine density was observed.  These studies 
demonstrate that NMDAR activity regulates multiple processes in newborn neurons across many 
stages of development including survival and circuit integration.  While not limited to newborn 
neurons, the particular role NR2A-containing NMDARs play in neurogenesis has been studied as 
well using constitutive NR2A knockout mice (Kitamura et al, 2003).   In these experiments, 
neurogenesis was measured in mice that recently had access to a running wheel and those that 
did not.  Baseline proliferation rates were similar between wildtype and knockout mice.  
However, mice lacking NR2A did not exhibit the exercise-induced enhanced proliferation seen 
in wild-type mice suggesting basal proliferation and stimulus-induced proliferation may be 
regulated by different mechanisms.  NR2B-containing NMDARs are also found in the HPC and 
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the experiments in this chapter will detail the characterization of a mouse line in which the 
NR2B subunit can be conditionally deleted from NSCs and their progeny using an inducible Cre-
loxP system. 
 
Inducible Cre-loxP System 
 Conventional gene targeting strategies that produce germline deletion can often result in 
embryonic lethality or cause developmental alterations that obscure the function of a gene in 
adulthood.  To improve upon this approach, a conditional gene-targeting technique that restricts 
gene inactivation in a cell-type specific manner was developed and can be used to restrict gene 
knockout in the mouse brain (Gu et al, 1994; Tsien et al, 1996). Two 34-bp loxP (locus of 
crossing [x-ing]-over of bacteriophage P1) sites that are recognized by the site-specific DNA 
recombinase, Cre (causes recombination or cycalization recombination), are inserted into the 
target gene such that wild-type gene transcription occurs in the absence of Cre (Feil et al, 2009).  
Recombination and irreversible deletion of the region between the loxP sites only takes place in 
the presence of the reaction’s catalyst, Cre.  The design of this system initially requires two 
strains of mice: a floxed target strain and a cell-type specific Cre transgenic strain.  Crossing 
these two strains results in gene inactivation according to the pattern of expression of the Cre 
transgenic line.  While this approach is much more specific than conventional knockout 
strategies, the Cre expressed in these lines is constitutively active.  Thus, this system does not 
allow for tight temporal control of recombination.  
Further improvements have been made by creating ligand-dependent Cre recombinases 
which are still expressed in a cell-specific manner but only become active following 
administration of their ligand, providing an additional level of specificity by allowing one to 
control the time recombination begins (Feil et al, 1996; Feil et al, 1997; Metzger et al, 1995).  
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The experiments performed in this thesis rely on the CreERT2 system in which Cre recombinase 
is fused to the ligand-binding domain of the human estrogen receptor that has been mutated such 
that it binds 4-hydroxytamoxifen, the metabolite of the synthetic drug tamoxifen, but not 
endogenous estradiol (Dranovsky et al, 2011; Feil et al, 1997; Indra et al, 1999).  In the absence 
of tamoxifen, the Cre recombinase is held in the cytoplasm of the cell in which it is expressed by 
its heat shock protein chaperones.  Administration of tamoxifen results in ligand binding, release 
of the HSPs exposing the estrogen receptors nuclear localization signal, and translocation of the 
Cre recombinase to the nucleus where it can then recombine its loxP-flanked target DNA thereby 
generating a null allele (Fig 2.1.1) (Feil et al, 2009; Indra et al, 1999).   
 
 
Figure 2.1.1 Inducible Cre-LoxP system. CreERT2 is held in the cytoplasm by its heat hock 
protein (HSP) chaperone.  Binding of the exogenous drug tamoxifen (TMX) to the Cre complex 
releases it from the HSP and causes translocation of the Cre to the nucleus where only then it can 





In this section, the following aim will be addressed: 
I. Generate and characterize mice in which NR2B is deleted from abGCs. 
Briefly, the experiments presented here will detail the characterization of adult hippocampal 
neurogenesis in mice that lack the NR2B subunit of the NMDAR in their young abGCs.  
Electrophysiological features of these mice will also be examined.  The results reveal that 
NR2B-containing NMDAR activity in abGCs is required for young abGCs’ enhanced plasticity.  
NR2B deletion also decreased the dendritic complexity abGCs but left all other aspects of 
neurogenesis intact.  Thus, this mouse line represents a novel tool that can be used to study the 




NestinCreERT2 and NR2Bf/f mice were generated as previously described (Dranovsky et al, 
2011; von Engelhardt et al, 2008).  Experimental male mice were generated by breeding 
NestinCreERT2;NR2Bf/f with NR2Bf/f mice.  For labeling abGCs, 
NestinCreERT2;NR2Bf/+;ROSA26  f  stopEYFP/ f  stopEYFP were bred with NestinCreERT2;NR2Bf/+ to 
generate NestinCreERT2;NR2Bf/f;ROSA26  f  stopEYFP/ +and 
NestinCreERT2;NR2B+/+;ROSA26  f  stopEYFP +controls. 8-10 week-old mice were injected with 
3mg tamoxifen (TMX) (VEH solution of corn oil/10%ethanol) I.P./day for 5 consecutive days. 
Previous work with this strain revealed that a brief pulse of TMX does not affect HPC-dependent 
behavior six weeks later (Sahay et al, 2011a). All experiments were approved by the IACUC at 




For survival experiments, 48hr after the last TMX or VEH injection, BrdU was injected i.p.  (150 
mg/kg).  For all experiments, mice were perfused (4% paraformaldehyde), brains postfixed, 
cryoprotected, and sections (35µm) of the entire DG were labeled for BrdU, GFAP, NeuN, DCX, 
Ki67 or GFP as previously described (Sahay et al, 2011a)(Rat-anti-BRDU 1:100 Serotec, 
Rabbit-anti-GFAP 1:1500, DAKO, mouse-anti-NeuN, 1:500, Chemicon, goat-anti-DCX, 1:500, 
SantaCruz; rabbit-anti-Ki67, 1:100, Vector). Experimenters blind to treatment counted (at 20X) 
BrdU, DCX and Ki67 cells in every 6th section throughout the DG, and DCX cells exhibiting 
tertiary dendrites were counted.  For co-labeling of BRDU/NeuN/GFAP, confocal scans 
(FluoView1000,Olympus) at 40X were taken of 60 BrdU cells/treatment across the anterior-
posterior (AP) axis of the DG. For EYFP/DCX counts, 120 DCX+ cells were imaged across the 
AP axis of the DG to determine co-labeling with EYFP, excluding type-1 cells determined by 
their radial-glia morphology. Sholl analysis was conducted as previously described (Sahay et al, 




400um transverse hippocampal slices were incubated in an interface chamber at 32°C and 
perfused with oxygenated artificial cerebrospinal fluid (ACSF) (in mM: 11NaCl, 2.5KCl, 
1.3MgSO4, 2.5CaCl2, 26.2NaHCO3, 1NaH2PO4, 11glucose). Slices equilibrated for 2h before a 
bipolar stimulating electrode was placed in the MPP and evoked field potentials were recorded in 
the molecular layer using a glass capillary microelectrode (1–3MΩ) filled with ACSF. Isolation 
of the MPP was confirmed by assessing paired-pulse depression (PPD) of the MPP/DG synaptic 
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connection at 50ms, which generated the highest level of depression (McNaughton, 1980).  
Input–output curves were obtained after 10min of stable recordings. The stimulation intensity 
that produced 1/3 of the maximal response was used for the test pulses and tetanus. After 15min 
of stable baseline (once every 20s), LTP was induced with a four trains of 1s each, 100Hz within 
the train, repeated every 15s.  Responses were recorded every 20s for 60min after LTP induction. 
The same protocol was used to elicit and record LTP of mature GCs except that 10µM 


















Results and Figures 
Mice in which exon 6 of the NR2B gene was flanked by two loxP sites (NR2B2lox) 
(Doganci, 2007; von Engelhardt et al, 2008) were bred with NestinCreERT2 mice in which the 
TMX regulated Cre-recombinase (CreERT2) is expressed under the control of a nestin promoter 
fragment (Dranovsky et al, 2011).  TMX injection in adult mice excises sequences between the 
loxP sites selectively in neural stem cells and transit-amplifying progenitors to generate abGCs 
lacking NR2B (iNR2BNes). Using enhanced yellow fluorescent protein (EYFP) as a surrogate for 
NR2B recombination and marker for abGCs (Fig 2.1.3 A-B), we found that 71.9 +/- 7.2% of 
doublecortin (DCX)-positive neurons expressed EYFP six weeks after TMX induction. 
 
Figure 2.1.2 Experimental design to delete NR2B from abGCs. Floxed NR2B mice are 
crossed with NestinCreERT2 mice in which the tamoxifen (TMX) regulated Cre-recombinase 
(CreERT2) is expressed under the control of a nestin promoter fragment. Nestin drives expression 
of CreERT2 only in neural stem and progenitor cells.  Addition of tamoxifen induces 
recombination and deletion of NR2B in these neural stem cells.  As the mouse ages, the progeny 
of the neural stem cells lacking NR2B will differentiate and begin to mature.  The effect, if any, 
this deletion has on the neurogenesis process that is occurring during this time will be examined.  
Six weeks after induction, the 4-6 week old granule cell population of mice will lack NR2B and 
these mice will be tested in a number of assays to determine if this manipulation has any 





Figure 2.1.3 Assessment of Nestin-CreERT2-driven recombination. A-B 3-mouse design 
using an inducible reporter, EYFP, to measure GC survival and TMX-induced recombination 
with (B) representative images of YFP and DCX expression six weeks after TMX injection 
(scale bar represents 100um).  C. Total number of adult born GCs did not differ between NR2B 
deficient and WT littermate controls six weeks after TMX injection as measured by total 
numbers of EYFP cells. Data are mean +/- SEM. 
 
 
We next assessed whether NR2B is required for young abGC survival. In animals 
expressing the EYFP reporter, young abGC numbers did not significantly differ between NR2Bf/f 
and NR2B+/+ littermates (Fig 2.1.3C, unpaired t-test, n=3/geno, t4=0.79, p=0.49).  In addition, 
BrdU experiments indicated that NR2B deletion did not affect survival of 2, 4, 6 or 8 week-old 
neurons, as no difference was seen in number of BrdU positive cells, or phenotype of cells born 
after NR2B deletion (Fig 2.1.4B,E, n=3-7/treatment, unpaired t-test, 2wk, t4=1.3,  p=0.3, 4wk, 
t4=0.6, p=0.6, 6wk t7=-1.4, p=0.2, 8wk, t11=-1.7, p=0.13,percent BRDU/NeuN t4=1.87, p=0.14).   
There was also no difference between iNR2BNes and controls in progenitor proliferation as 
measured by Ki67-positive cells (Fig 2.1.4D, n=5 TAM, 4 VEH, unpaired t-test, t7=-1.5, 
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p=0.18), or in generation of immature DCX-positive neurons (Fig 2.1.4F, n=5 TAM, 4 VEH, 
unpaired t-test, t7=-0.7, p=0.52). We next assessed dendritic complexity of abGCs lacking 
NR2B.  Although within the DCX population the number of cells that exhibited tertiary dendrites 
did not differ between TMX and VEH treatment (Fig 2.4.1G, n=5 TAM, 4 VEH, unpaired t-test, 
t7=-0.8, p=0.44), Sholl analysis on the dendrites of EYFP+ neurons from NR2Bf/f and NR2B+/+ 
littermates six weeks after TMX injection revealed a decrease in dendritic complexity after 
deletion of NR2B (Fig 2.1.4H-I, N=12-15 cells/3mice/treatment, Mann-Whitney U test, radius = 




Figure 2.1.4 Deletion of NR2B in abGCs does not affect neurogenesis in the DG. A. Genetic 
and experimental timeline for neurogenesis measurement. B. No effect on cell survival as 
measured by BrdU number at specified times post-injection.  C. Representative images for BrdU 
(NeuN-green, BrdU-red, GFAP- white) and DCX experiments (scale bar: top 30um, bottom 
100um). D. No effect of treatment on total Ki67 immunoreactive cells. E. No significant 
difference in phenotype of BrdU cells 8 weeks after induction.  F-G.  No significant difference in 
total number of DCX cells, or DCX+ cells with tertiary dendrites. H-I. Sholl analysis revealed a 
decrease in dendritic complexity in abGCs lacking NR2B (left: representative images and 
tracings, scale bar 20um). Data are mean +/- SEM. 
 
 
To determine the consequence of NR2B deletion in adult-born neurons on synaptic 
plasticity in the DG, we measured neurogenesis-dependent ACSF-LTP in slices taken 6-7 weeks 
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after VEH or TMX treatment.   Deletion of NR2B did not disrupt the input-output relationship 
(Fig 2.1.6B, n=12 slices/genotype, repeated measures ANOVA, treatment effect F(1,22)=0.85, 
p=0.37, treatmentXintensity interaction F(19,418)=1.1, p=0.38) or paired-pulse depression of 
fEPSPs evoked by MPP stimulation (Fig 2.1.6C, t21=1.08, p=0.29).  However, ACSF-LTP 
induction by high frequency stimulation (HFS) (four 1 s, 100 Hz trains every 15 s) was absent in 
iNR2BNes slices (Figure 2.1.6B, repeated measures ANOVA, last 10 minutes treatment effect 
F(1,22)=25.5, p<0.001).  In contrast, LTP obtained in the presence of the GABAA receptor 
antagonist bicuculline did not differ between groups (Figure 2.1.7B, n=4 VEH, 7 TMX, repeated 
measures ANOVA, last 10 minutes treatment effect F(1,9)=0.9, p=0.37). These results suggest that 
the mature GCs exhibit normal LTP and that the deficit in ACSF-LTP is due to loss of NR2B in 
the immature neuron population.  Therefore, these iNR2BNes mice provide  a model to test the 
contribution of the enhanced synaptic plasticity of immature neurons to behavior. 
 
 
Figure 2.1.5  Normal baseline synaptic transmission in the DG of iNR2BNes mice.   A. 
Experimental timeline for electrophysiology experiments.  No differences in (B) input-output 
relationship or (C) paired pulse depression (50ms ISI) of MPP inputs to the DG after deletion of 




Figure 2.1.6 Impaired ACSF-LTP in the DG of iNR2BNes mice.  A. Experimental timeline for 
electrophysiology experiments. B.  Significantly impaired ACSF-LTP in slices from iNR2BNes 
mice as compared to controls.  Inset: representative average traces before and after HFS, scale 





Figure 2.1.7  Unaltered bicuculline-LTP in the DG of iNR2BNes mice.   A. Experimental 
timeline for electrophysiology experiments. B. No difference in magnitude of LTP in slices in 
the presence of 10um bicuculline. Inset: representative average traces before and after HFS, scale 




This section outlines the neurogenic and electrophysiological characterization of a novel 
mouse line that allows for the inducible deletion of the NR2B subunit from abGCs in the HPC.  
Deletion is induced with the administration of TMX.  This manipulation is highly penetrant, 
resulting in a recombination efficiency of 72%.  The effectiveness of this was further 
demonstrated by the complete loss of ACSF-LTP in these mice confirming previous results that 
have pharmacologically shown this particular form of LTP to be NR2B-dependent.  Before 
discussing the electrophysiological findings further, the effect on neurogenesis will be 
considered. 
The total number of abGCs (EYFP+) did not differ between iNR2BNes and CTRL mice.  
Neither did immature abGC number (DCX+) indicating the level of neurogenesis in these mice 
were the same.  Taken together, this also shows that NR2B deletion did not alter the temporal 
pattern of DCX expression, which can be used as a marker for the maturation process as it is 
expressed early on in abGCs, but is down regulated as a neuron matures. 
A significant number of new neurons die up until the age of 4 weeks.  Early survival 
mechanisms appear to be independent of direct NMDAR activity, while it appears to be critical 
for the survival of 2-3 week old neurons (Tashiro et al, 2006).  To determine if NR2B-containing 
NMDARs play a critical role in this mechanism, we measured survival at multiple time points.  
Neither early nor late stage survival was affected by NR2B deletion demonstrating that activity 
through other receptors present in these cells is sufficient to promote their survival.  Another 
possibility stems from the different gene-targeting approaches used in this study and in Tashiro 
et al (2006). Here, NR2B was deleted using a transgenic strategy that affects the majority of 
young abGCs.  The retroviral technique used for NR1 knockout leads to a more heterogeous 
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population of abGCs where a significant portion of the young abGCs still contains NR1.  Thus, 
the abGCs in iNR2BNes mice are on a level playing field in terms of competing for activity-
dependent survival.  This could be a significant difference as pharmacologically blocking 
NMDARs in surrounding neurons increased the survival of NR1 knockout neurons suggesting 
part of the survival mechanism is competitive. 
Cell fate was examined by assessing the proportion of new cells born (BrdU+) that 
differentiated into neurons (NeuN+/BrdU+) and no effect was found here either.  A study by 
Deisseroth et al (2004) showed an activity-dependent increase in the proportion of newly 
generated cells with a neuronal phenotype when isolated NPCs were directed stimulated in vitro.  
From this it would follow that removing an NMDAR from NPCs may lead to decreased 
neurogenesis; however, this is not what was observed here nor did it occur in the full NMDAR 
knockout described above.  This does not exclude the possibility that such a mechanism for 
enhancing neurogenesis exists but it does suggest that it does not come into play under baseline 
physiological conditions.  
No effect of NR2B deletion was found on proliferation, which is again consistent with 
the findings from the NR1 knockout study.  This further confirms that the altered proliferation 
seen after pharmacological manipulation of NMDAR activity is an indirect effect due to the 
surrounding cell types’ response to NMDAR activity. Proliferation is often cited as being 
affected by NMDAR activity (see Introduction).  Our result does not exclude this possibility but 
it does make further clarification of which population of NMDARs are involved in this effect 
necessary. 
Maturation of newborn neurons was not severely altered by NR2B deletion as the overall 
number of DCX+ cells exhibiting a more mature morphology measured by the presence of 
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tertiary dendrites was the same for both iNR2BNes and control mice.  However, when examining 
dendritic complexity more closely by performing Sholl analysis we were able to detect that 
iNR2BNes mice had reduced dendritic complexity. 
Electrophysiologically, mice displayed normal baseline synaptic transmission in the DG 
following NR2B deletion as measured by their paired-pulse ratio and input/output curves. To 
isolate the contribution abGCs make to hippocampal synaptic plasticity, two distinct forms of 
perforant path LTP were examined.  abGCs are required for a small but stable form of LTP 
called ACSF-LTP, which is induced in the DG in the absence of GABA blockers and is 
abolished when neurogenesis is ablated (Snyder et al, 2001).  Pharmacological studies have 
shown ACSF-LTP is also dependent on the activation of NR2B-containing NMDARs since 
antagonists specific for that receptor block the induction of ACSF-LTP.  That finding was 
confirmed here as ACSF-LTP was absent in iNR2BNes mice. Thus, by removing NR2B from 
abGCs we were able to eliminate these cells’ enhanced plasticity.  Further confirming the 
specificity of our manipulation, synaptic plasticity in the mature GC population was shown to be 
intact as there was no difference between groups in the form of LTP obtained in the presence of 
the GABA receptor antagonist, bicuculline.   
Overall, iNR2BNes mice generate the same number of new neurons in adulthood as control 
mice.  These neurons survive and mature with only a slight reduction in dendritic complexity.  
However, a potentially important electrophysiological property of these neurons, i.e. their 
enhanced synaptic plasticity, has been eliminated.   From an electrophysiological standpoint, 
iNR2BNes mice resemble mice with ablated neurogenesis, while from all other neurogenic 
standpoints examined they most resemble wild-type mice.  Consequently, these mice provide a 
novel model to test the extent to which abGCs’ enhanced plasticity contributes to hippocampal-
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dependent behaviors. The experiments set out in the next chapter will test whether or not this 
manipulation has an effect on behavior at baseline, while the chapter following after that will 




The Role of NR2B in Mood-related and Cognitive Behaviors Under Baseline Conditions
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Introduction 
Adult hippocampal neurogenesis, a unique form of DG plasticity, is regulated by 
experience, and when manipulated can have specific effects on behavior (see General 
Introduction).  Recent hypotheses have suggested that the enhanced synaptic plasticity exhibited 
by 4-6week old abGCs allows them to uniquely contribute to hippocampal circuit function, and 
thus behavior. Studies hint that this theory may be correct.  The time course for behavioral 
alterations following either genetic or x-ray ablation of neurogenesis was examined in a study 
which found that behavioral effects only appeared 4-6 weeks after ablation (Denny et al, 2012).  
Knocking out Klf-9, a transcriptional regulator of neuronal maturation, alters late stage 
maturation of abGCs leading to a decrease in neurogenesis-dependent synaptic plasticity, a 
subtle increase in anxiety-like behavior, and an impairment in CFD learning (Scobie et al, 2009).  
A direct assessment of this hypothesis will be tested here using the mouse line described in Part I 
of this chapter.  
 
Behavioral Paradigms to test Mood 
Initial behavioral characterization began by evaluating the affective state of these mice.  As 
discussed in Chapter 1, the DG is highly sensitive to stress and plays a role in regulating anxiety 
and mediating AD action.  As such, altering the neurogenesis that takes place within the DG may 
also affect emotional processes.  Neurogenesis itself is highly regulated by the emotional state of 
an animal.  However, the contribution it makes to baseline anxiety- and depression-like 
behaviors is debatable.  Mice with either ablated or impaired neurogenesis have displayed 
anxiety- and depressive-like behaviors in the Light-Dark box, NSF test, FST, and sucrose 
preference test (Revest et al, 2009; Scobie et al, 2009; Snyder et al, 2011).  Yet, other studies 
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have found that blocking neurogenesis does not alter baseline anxiety- or depression-related 
behavior in the Open Field test (OFT), Elevated Plus Maze (EPM), Novelty Suppressed Feeding 
(NSF) test, the Light-Dark Box, and the Forced Swim test (FST) (Airan et al, 2007; David et al, 
2009; Santarelli et al, 2003; Saxe et al, 2006).  Likewise, increasing neurogenesis genetically 
does not impact baseline measures of emotionality (Sahay et al, 2011a).  Given this variation, it 
is important to examine the affective state of our mice.   
 
Anxiety-like Behavior 
The behavioral paradigms used in this study to assess affective stated focus on two types of 
emotional behavior: anxiety-like behavior and AD-like behavior.  Anxiety is an emotional 
response to a potential future threat.  The expression of anxiety can be assessed in an 
ethologically-based manner, taking advantage of the unconditioned approach-avoidance conflict 
that mice feel when presented with the opportunity explore a novel environment (Belzung and 
Griebel, 2001; Ramos, 2008).  The natural tendencies of mice are to favor movement along walls 
or enclosed areas and avoid the perceived threat of open spaces.  Anxiolytic drugs reduce the 
aversion to open spaces, promoting exploration of those areas, while anxiogenic drugs increase 
that aversion and animals spend less time exploring in open spaces (Hogg, 1996).  Tests like the 
OFT (Prut and Belzung, 2003), EPM (Lister, 1987), and NSF test (Samuels and Hen, 2011), 
which are used in this study, present animals with an environment that consists of areas with 
walls that are perceived as “safe” and open areas that are perceived as “threatening.”  Measuring 





Depression is a complex psychiatric disorder that encompasses a collection of varying 
symptoms (Krishnan et al, 2008; Matthews et al, 2005).  Assessing the symptomology of 
depression in mice is difficult; in fact, many symptoms such as feelings of worthlessness and 
recurrent thoughts of death are impossible to test.  Other symptoms that could be easily measured 
such as psychomotor, sleep, and appetite disturbances can occur in either direction in depression 
making them not uniformly useful (Duman, 2010).  Aspects of a depressive-like state that can 
potentially be evaluated include helplessness or despair measured by motor response to stress 
(learned helplessness, forced swim test, tail suspension test), anhedonia measured by response to 
rewarding stimuli (sucrose preference test), and social withdrawal measured by social interaction 
(social interaction test). Reproducing a feature of the human illness provides a model with face 
validity.  Construct validity is harder to ensure in depression models because the underlying 
cause and pathogenesis of depression is still unknown and may potentially be variable from 
patient to patient as well.  Therefore, knowing one has fully recreated the disease process in a 
mouse is not possible.  As such, current models of depression rely heavily on the ability to 
accurately detect treatments that are useful clinically, i.e. models with predictive validity. One of 
the most commonly used tests to screen for AD efficacy is the FST (Castagne et al, 2011).  The 
FST involves placing a mouse in a container of deep water from which it cannot escape.  After 
an initial period of escape-directed activity, the mouse will adopt an immobile posture.  This 
immobility has been linked to depression-like behavior representing to some behavioral despair, 
passive coping in response to a stressful situation, or the feeling of entrapment when one wants 
to escape but is unable to do so.  However, this behavioral significance has all been assigned 
retrospectively after determining that rodents given clinically effective ADs, either acutely or 
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chronically, spend less time immobile (Cryan and Mombereau, 2004; Cryan et al, 2005b).  As 
such it may be more appropriate to call this test a model of AD action instead of a model of 
depression.  Still, this test is reliable, reproducible, and displays a high degree of predictive 
validity demonstrated by its sensitivity to varying types of ADs including tricyclics, monoamine 
oxidase inhibitors, selective serotonin reuptake inhibitors and electroconvulsive shock (Dalvi and 
Lucki, 1999).  The ability of ADs to reduce immobility in the FST has been show to require 
neurogenesis in rats, but was found to be neurogenesis-independent in mice; therefore, altering 
neurogenesis may not impact behavior in this test (Airan et al, 2007; David et al, 2009).   
Another effective paradigm for testing AD action is the previously described NSF test 
(Samuels et al, 2011).  While classically used to assess anxiety-related behavior, this test is also 
sensitive to chronic - but not acute - AD treatment (Bodnoff et al, 1988; Wang et al, 2008). Thus, 
it reflects the time course for clinical effectiveness in humans and provides a better model to 
study the mechanisms underlying AD action (Dulawa and Hen, 2005).  It should not be 
surprising that a test that is sensitive to changes in anxiety levels also responds to ADs 
considering the significant comorbidity of major depression and anxiety disorders (Fava et al, 
2000; Kaufman and Charney, 2000).  In fact, this could even be seen to strengthen the validity of 
the test since the development of anxiety disorders and depression may be related considering the 
overlap in symptoms, similar genetic risk factors, similar brain areas affected, and the ability of 
the same drug to treat both disorders (Duman, 2010; Oathes et al, 2015).  Importantly for the 
studies presented in this thesis, neurogenesis is required to see an AD response in the NSF test 




Behavioral Paradigms to Test Cognitive Function 
Novel Object Recognition Test 
Cognitive function was also examined with Novel Object Recognition (NOR), Contextual 
Fear Conditioning (CFC), and Contextual Fear Discrimination (CFD).  These particular tests 
were chosen because they have been shown to rely on the DG and evidence suggests that adult 
neurogenesis may play a role in these behaviors.  The NOR task is a memory test that exploits 
animals preference to explore a novel object over a familiar one.  The ability of an animal to 
distinguish between a novel and familiar object as measured by spending a greater amount of 
time approaching and exploring the novel object is an indication that a memory for the familiar 
object has been encoded and recalled by the animal (Ennaceur, 2010).  This preference is 
unconditioned and requires no external motivation, reward, or punishment (Antunes and Biala, 
2012; Ennaceur, 2010).  The HPC plays a role in novelty processes that involve spatial or 
contextual information, with the DG playing a critical role in this function (Hunsaker et al, 2008; 
Lee et al, 2005).  When neurogenesis is ablated either genetically or with irradiation, mice 
display an increased preference for the novel object after a short delay between training and 
testing indicating abGCs contribute to the information processing involved in NOR (Denny et al, 
2012). Blocking neurogenesis in adult rats also leads to impairment in baseline levels of novel 
object recognition memory following an intermediate delay between training and testing and 
inhibits the enhancement of long-term novel object recognition memory that follows 





Contextual Fear Conditioning 
Fear conditioning is a form of associative learning that occurs when two stimuli, an 
aversive unconditioned stimulus (US) and a neutral conditioned stimulus (CS), are presented 
together.  An animal learns to associate the CS with US and, eventually, the CS alone will 
produce a fear response.  In the CFC paradigm used in this study, the US is a foot shock and the 
CS is the context in which the mouse was shocked.  Learning occurs quickly, requiring only one 
exposure to elicit a conditioned response, which can be assessed by measuring freezing.  
Acquisition of the context-shock association requires the HPC and interference with the DG 
alone can impair this process (Kheirbek et al, 2013).  Adult neurogenesis’ link to CFC is not 
quite as clear with some studies finding that altering adult neurogenesis has no effect on CFC 
(Clark et al, 2008; Deng et al, 2009; Dupret et al, 2008; Sahay et al, 2011a; Shors et al, 2002; 
Zhang et al, 2008), while others show it does (Hernandez-Rabaza et al, 2009; Imayoshi et al, 
2008; Ko et al, 2009; Saxe et al, 2006; Warner-Schmidt et al, 2008).  Still others find 
neurogenesis only effects behavior in some but not all CFC paradigms (Drew et al, 2010; 
Winocur et al, 2006). 
 
Contextual Fear Discrimination 
CFD is more sensitive to hippocampal changes than CFC (Frankland et al, 1998). During 
CFC, processing the multimodal stimuli that make up a context into a unified representation that 
can be paired with a US is dependent on the HPC (Anagnostaras et al, 2001).  However, 
evidence suggests that when the HPC is offline, other strategies supported by non-hippocampal 
systems - that would otherwise normally be suppressed - can be adopted for learning.  In 
particular, mice with hippocampal damage may use a single cue within the context to associate 
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with the US.  When placed back into the context it will appear as though mice have learned the 
task as well as normal mice; however, if the same cue is presented within a neutral context, 
freezing will occur there as well revealing this strategy to be less effective than the hippocampal-
based contextual strategy (Frankland et al, 1998).  In this way, CFD can detect more readily 
when hippocampal function is compromised because it requires mice to discriminate between 
two similar contexts, which share several overlapping cues including the salient shock grid floor. 
Since the most efficient strategy for learning this test relies not only on encoding a full context, 
but also discriminating between two similar contexts, it seems likely that pattern separation, a 
function attributed to the DG by computational models of the hippocampal circuit, would come 
into play as well.  This test is not only sensitive to manipulations that alter the entire GC 
population in the DG (mature and immature GCs) (McHugh et al, 2007), but alterations in CFD 
are also seen when just the immature abGC population is targeted.  This effect is bidirectional as 
ablation of neurogenesis impairs CFD while genetically enhancing neurogenesis improves CFD 
(Nakashiba et al, 2012; Sahay et al, 2011a).  This suggests abGCs play a critical role in 
mediating pattern separation in the DG.    
 
In this section, the following aim will be addressed: 
II. Test the effects of NR2B deletion on cognitive and mood-related behaviors at baseline. 
 
The experiments presented here will detail the behavioral characterization of mice that lack the 
NR2B subunit of the NMDAR in their young abGCs.  The results reveal that eliminating NR2B-
containing NMDARs from abGCs does not alter baseline anxiety or AD-like behavior.  
However, iNR2BNes mice differed from controls in measures of cognitive function.  These mice 
	  60	  
were able to learn in the CFC test but were impaired in the more difficult CFD test.  Mice also 
exhibited a decreased novelty exploration phenotype which impaired their performance in the 
NOR test.  Overall, these results indicate that the NR2B-dependent plasticity of abGCs is 





NestinCreERT2 and NR2Bf/f mice were generated as previously described (Dranovsky et al, 
2011; von Engelhardt et al, 2008).  Experimental male mice were generated by breeding 
NestinCreERT2;NR2Bf/f with NR2Bf/f mice. 8-10 week-old mice were injected with 3mg 
tamoxifen (TMX) (VEH solution of corn oil/10%ethanol) I.P./day for 5 consecutive days. 
Previous work with this strain revealed that a brief pulse of TMX does not affect HPC-dependent 
behavior six weeks later (Sahay et al, 2011a). All experiments were approved by the IACUC at 
Columbia University and the New York State Psychiatric Institute. 
 
Behavioral experiments 
All behavioral experiments were conduced in male mice 14-16 weeks of age.  For each test, time 
after TMX or VEH injection is noted in the figures or text.  
Open field 
Mice were placed in an acrylic open-field chamber 40cm long×40cm wide×37cm high with 
illumination set to 16-20 lux (low lux) or 600 lux (high lux). Data were collected in 5 min bins 
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during 60 min trials and analyzed for total distance traveled as well as time and distance traveled 
in center.   
Forced swim test, novelty suppressed feeding and elevated plus maze 
FST, NSF and EPM were conducted as previously described (David et al, 2009; Dulawa et al, 
2004; Sahay et al, 2011a) 
Novel object recognition 
Naive mice were placed in a storage container (45×30×30cm) with woodchip bedding, and 
videotaped from above at a light intensity of 16-20lux.  Two objects were placed at either end of 
the arena (a slide box, a clear funnel or a white ceramic shoe, randomized presentation).  Mice 
explored two objects for 4 trials of 5min, with a 3min inter-trial interval (during which the box 
would be wiped clean and the bedding changed), then one object was replaced with a novel 
object.  An experimenter blind to the treatment condition analyzed videotapes, and total 
approaches, investigation time and grid crossings were measured for each of the trials. 
Fear conditioning 
Conditioning took place in Coulbourn fear conditioning boxes that contained one clear plexiglass 
wall, three aluminum walls and a stainless steel grid floor. In the one-trial CFC, the training 
context (A) included a houselight and fan, and anise scent was placed under the grid floor. 180s 
later, mice received a single 2s foot shock of 0.75mA. Mice were taken out 15s after termination 
of the foot shock and returned to their home cage. The box was cleaned with Sanicloths between 
runs. Digital video cameras recorded the session, FreezeFrame and FreezeView software 
(Actimetrics) were used for recording and analyzing freezing behavior. For the dissimilar context, 
C, the grid floor was covered with a plastic panel and cage bedding. The chamber walls were 
covered and made circular using plastic inserts, the house fan and lights were turned off, and a 
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mild lemon scent was placed below the grid floor. The chamber door was left ajar during testing. 
70% ethanol was used to clean the chamber between runs.  
Naïve mice were used for CFD.  The training context, A, was the same as used above for 
one-trial fear conditioning. The dissimilar context, C, was as described above, and the similar 
(no-shock) context, B, shared many features of the training context including an exposed 
stainless steel grid floor, but differed in that two plastic inserts were used to cover the walls and 
make them circular, the house fan and lights were turned off, and the chamber door was left ajar 
during testing. A lemon scent was used as an olfactory cue, and 70% ethanol was used to clean 
the grids between runs. Mice were brought into the testing room in transport buckets by the same 
experimenter who had handled the mice for the training context. After 2h, mice were placed in 
the similar context, in which they were left for 180s and were never shocked.  Measurement of 
the freezing levels in both the training context (3-min pre-shock) and the similar context (3min) 
each day allowed the assessment of freezing in the two contexts.  The order of presentation of 
contexts was randomized across days.  The nearly identical context, A’, only differed from A 
with regard to the shape of the wall, which was made circular with two plastic inserts.  Context A 
was always presented first, followed by context A’. 
 
Results and Figures 
iNR2BNes mice were tested in a number of anxiety- and AD-related behavioral assays. In 
neither low or high lux open field testing did the iNR2BNes mice differ from controls in 
locomotor activity, habituation, or percent time in center, but in the low lux condition they 
showed a trend for less distance traveled in the center of the arena (Fig 2.2.1A-F, low lux, 
n=13/treatment, total distance traveled: treatment effect unpaired t-test, t24=0.15, p=0.9, 
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treatmentXtime interaction F11,264=1.19, p=0.29, percent time in center ,  t24=-1.5, p=0.15, 
percent center distance,  t24=-2.03, p=0.05, high lux, total distance traveled: treatment effect, 
t10=0.14, p=0.9, treatmentXtime interaction F10,110=0.89, p=0.55, percent time in center, 
treatment effect, t10=-0.5, p=0.63, percent center distance,  t10=-0.7, p=0.9).  In addition, as seen 
in irradiated animals at baseline (David et al, 2009; Santarelli et al, 2003), iNR2BNes mice did not 
significantly differ from control mice in immobility time in the FST, in open arm time in the 
EPM or latency to feed in the NSF test (Fig 2.2.1G-I, n=6/treatment, FST, treatment effect 
F(1,10)=0.01, p=0.9, treatmentXtime interaction F(5,50)=0.6, p=0.7, EPM, t10=1.9, p=0.08, NSF 
n=12-13/treatment, Kaplan-Meier Survival analysis, Mantel-Cox log-rank test, p=0.6, unpaired t-
test t23=1.2, p=0.26).  
 
 
Figure 2.2.1  iNR2BNes  mice in depression/anxiety-related behavioral assays. A-F. Open 
field test under low and high lux conditions with total distance traveled (A,D), percent center 
distance (B,E) and percent center time (C,F). G. Elevated Plus Maze. H-J. Novelty suppressed 
feeding task.  K. Forced swim test.  iNR2BNes mice did not differ from controls in FST, EPM or 
NSF.  Data are mean +/- SEM. 
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 Recently, arresting adult neurogenesis has been shown to impact behavior in the novel 
object recognition test (Bruel-Jungerman et al, 2005; Denny et al, 2012; Jessberger et al, 2009). 
To test whether impaired DG plasticity in iNR2BNes mice influences performance in the novel 
object recognition test, mice were allowed to explore two objects for 5 minutes for 4 consecutive 
trials, then one object was replaced with a novel object, and number of approaches to the novel 
object were measured (Fig 2.2.2A). iNR2BNes mice explored the objects and the arena less than 
control mice during early training trials, yet they habituated to arena and objects similar to 
control mice (Fig 2.2.2C-D, N=12/treatment, total object approaches: repeated measures 
ANOVA genotype effect F(1,22)=6.03, p=0.02, genotype X trial interaction F(3,66)=0.34, p=0.8; 
arena grid crossings (trials 1-5), ANOVA genotype effect F(1,22)=6.23, p=0.021, geno X trial 
interaction F(4,88)=0.75, p=0.56).  When the familiar object was replaced with a novel object, 
iNR2BNes did not discriminate between the two objects. (Fig 2.2.2B, repeated measures ANOVA 
genotype effect F(1,22)=5.6, p=0.03, genotypeXobject interaction F(2,22)=12.2, p=0.002, 
discrimination ratio (novel-familiar/total) VEH=0.495+/-.08, TMX=0.023 +/-.13, p=0.005), 




Figure 2.2.2  Impaired novelty exploration in iNR2BNes mice.  A. Experimental design for 
novel object recognition.  B-C Total approaches to the objects during training trials and testing 
reveal iNR2BNes mice explored the novel objects significantly less than control mice. D. During 
training for the novelty recognition task, iNR2BNes mice explored the arena less during early 
training trials, yet habituated to the arena as controls. Asterisks represent p<0.05, data are mean 
+/- SEM.  
 
We next tested iNR2BNes in a one-trial CFC.  iNR2BNes mice did not differ from control 
mice in time spent freezing in the shock context “A” 24 hours after training, or in a significantly 
different context presented 48 hours after training suggesting that rapid encoding of contextual 
information was unaffected (Fig 2.2.3B, n=25 VEH, 24 TMX, repeated measures ANOVA, 




Figure 2.2.3 iNR2BNes mice display normal one trial contextual fear conditioning.  A. 
Experimental design for one trial contextual fear conditioning. B.  iNR2BNes  mice did not differ 
from controls in an one-shock contextual fear conditioning protocol and did not generalize 
freezing to a novel context.  Data are mean +/- SEM.  
 
To assess contextual discrimination, iNR2BNes mice were tested in fear discrimination 
tasks that require mice to distinguish between two contexts whose similarity has been 
systematically varied such that in one test they must distinguish between two contexts that are 
relatively dissimilar (Fig 2.2.4 A-B), while in another they must distinguish between two similar 
contexts (Fig 2.2.4 C-E), and in yet another test they must distinguish between two nearly 
identical contexts that only differ in one external cue (Fig 2.2.4 F-G). Both groups of mice could 
efficiently discriminate between the two dissimilar contexts (Fig 2.2.4 B, n=6/group, treatment 
effect, F(1,20)=0.9, p=0.4, ,context effect, F(1,20)=40.8, p<0.001, genotypeXdayXcontext 
interaction F(2,40)=0.04, p=0.96).  Yet, when tested to discriminate between two similar contexts, 
freezing scores revealed that iNR2BNes mice took longer to learn the task, suggesting impaired 
fine discrimination in iNR2BNes mice (Fig 2.2.4 D, n=15-17/treatment, repeated measures 
ANOVA, dayXgenoXcontext interaction F(7,210)=2.39, p=0.023, VEH: context effect F(1,28)=7.68, 
p=0.01, dayXcontext interaction F(7,196)=7.23, p<0.0001, TMX: context effect F(1,32)=2.6, p=0.12, 
dayXcontext interaction F(7,224)=2.13, p=0.04).  By day 4, control mice could efficiently 
discriminate between the contexts, while iNR2BNes required 8 days to significantly discriminate 
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between the contexts (Fig 2.2.4 E, day 4, repeated measures ANOVA, treatmentXcontext 
interaction F(1,30)=5.6, p=0.02).  In the nearly identical contexts, after 20 training sessions, neither 
iNR2BNes nor controls could learn the task, indicating that for this strain of mice the task was too 
difficult (Fig 2.2.4 F-G). 
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Figure 2.2.4  Impaired contextual fear discrimination in iNR2BNes mice.  A. Experimental 
design for a discrimination task between two highly different contexts.  B. iNR2BNes  mice did 
not differ from controls in discriminating between two different contexts. C. Experimental 
design for a discrimination task between two similar contexts.  D. iNR2BNes mice were slower to 
discriminate two similar contexts than VEH treated controls.  E.  VEH treated controls could 
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discriminate by the 4th day of training, while iNR2BNes could not discriminate until the 8th day of 
training. F. Experimental design for a discrimination task between two nearly identical contexts. 
G. Neither VEH treated controls nor iNR2BNes mice could discriminate between contexts when 
the two contexts were nearly identical.  Asterisks represent p<0.05, data are mean +/- SEM.  
 
Conclusions 
This section outlines the behavioral characterization of a novel mouse line that allows for 
the inducible deletion of the NR2B subunit from abGCs in the HPC.  This characterization began 
by testing these mice in a number of anxiety- and AD-related behavioral assays.  No significant 
alteration in behavior was seen in the OF test, EPM, NSF test, or FST.  Initial analysis of the OF 
test under low lux conditions suggested a possible trend for decreased center exploration and 
therefore increased anxiety in iNR2BNes mice.  However, when the test was repeated in high lux 
conditions further increasing the anxiogenic nature of the center area, no differences were 
detected between groups.  Overall, there results support previous findings that altering 
neurogenesis does not alter baseline affective state (Airan et al, 2007; David et al, 2009; Sahay et 
al, 2011a; Santarelli et al, 2003; Saxe et al, 2006).   
iNR2BNes mice were impaired in the novel object recognition task in which they were 
tested.  They failed to show a preference for the novel object during the test trial. While arrest of 
adult neurogenesis has been shown to impact novelty recognition in mice (Denny et al, 2012) 
and rats (Jessberger et al, 2009), a number of studies have specified a role for the perirhinal 
cortex in object recognition memory (Winters and Bussey, 2005), suggesting that the HPC may 
only play a role in object memory when contextual cues are used to support recognition (Winters 
et al, 2004). As iNR2BNes mice were tested in the presence of extra-maze cues, this may have 
contributed to their decrease in novelty recognition. However, the interpretation of this 
impairment is difficult as the mice also displayed a deficit in exploration of both the objects and 
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arena during the training trials.  Both groups habituate to the same level of object exploration as 
demonstrated by similar object approaches in trials 3-4, but iNR2BNes mice do not display the 
initial enhanced exploration that is seen in control mice when the arena and objects are still novel 
during trials 1-2.  This suggests the impairments seen in this test are due to differences in novelty 
exploration and conclusions about object recognition memory cannot be made. 
Multiple studies indicate that the DG and young abGCs in particular play a role in pattern 
separation (Clelland et al, 2009; Nakashiba et al, 2012; Sahay et al, 2011a). Ablation of adult 
neurogenesis impairs appetitive spatial pattern separation as measured in a two choice touch-
screen task and a nonmatching to place radial arm maze task (Clelland et al, 2009).  More 
recently, it has been shown that either increasing or decreasing levels of adult neurogenesis has 
bidirectional effects on the ability to distinguish between similar contextual representations in a 
fear discrimination task (Nakashiba et al, 2012; Sahay et al, 2011a). Here, this task has been 
improved to more accurately assess behavioral pattern separation by testing mice in multiple 
CFD tests that systematically vary the similarity between contexts so that the dependence on DG 
pattern separation is varied across testing.   These results show that iNR2BNes mice are impaired 
in CFD, in line with what was found in irradiated mice (Nakashiba et al, 2012; Sahay et al, 
2011a). 
While our contextual discrimination task does not directly test the computational 
definition of pattern separation, our behavioral results are consistent with the study by Leutgeb et 
al (2007) that did directly assess cellular activity in the DG and CA3.  First, they had shown that 
even minimal changes in environmental shape can alter activity in the DG; however, this 
orthoganalization of input was not initially translated to CA3, demonstrating that the DG is not 
able to overcome pattern completion processes in CA3 at very high levels of input similarity.   
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Behaviorally, we saw this when neither group of mice was able to discriminate between the 
nearly identical contexts. Second, as the enclosures in Leutgeb et al (2007) became more 
different, rate remapping began to occur in CA3 as well suggesting the DG is eventually able to 
oppose pattern completion and transfer an orthoganalized representation to CA3. This too is 
consistent with our behavioral data, which shows that when the difference between contexts is 
slightly increased, control mice are able to discriminate contexts while iNR2BNes mice with 
altered neurogenesis in the DG are still impaired at learning the task suggesting that the 
enhanced plasticity of abGCs plays a critical role in pattern separation.  Finally, Leutgeb et al 
(2007) showed that when changes in environment are more substantial, the population of active 
cells changes in CA3 but not in the DG, suggesting large environmental differences can be 
encoded via the EC’s direct projection to CA3. Again, this translates to our behavioral data 
where we see that the altered neurogenesis/DG function in iNR2BNes mice does not impair their 
ability to distinguish between two highly different contexts as pattern separation at this level is 
likely occurring independently of the DG. 
The results presented in this section suggest that the critical window of heightened 
plasticity of young neurons is necessary for their contribution to fine contextual discrimination. 
Thus, these studies indicate that the main contribution of adult–born neurons to hippocampal 
function occurs during their critical 4-6 week period of heightened plasticity and that this 
heightened plasticity modulates the DG/CA3 circuit to facilitate pattern separation.  
It should be noted that the SGZ is not the only neurogenic region in the adult mouse brain.  
Using this particular genetic approach means that NR2B will also be deleted form newborn 
neurons in the SVZ.  However, ablation of adult-born olfactory interneurons achieved using a 
Nestin-CreERT2 mouse line similar to the one used in this thesis did not significantly affect 
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olfaction (Imayoshi et al, 2008).  Innate olfactory responses and odor discrimination were intact 
as was the mouse’s ability to acquire and retain odor-associated memory. Thus, it seems unlikely 
that the behavioral paradigms used in this thesis would be affected by the deletion of NR2B from 
adult-born olfactory interneurons.     
An additional caveat that requires careful consideration is that recombination also occurs 
ectopically outside of the neurogenic areas with the nestin CreERT2 mouse line used in this study 
(Sun et al, 2014).  This leakiness could be an issue when attempting to interpret behavioral data 
as behavior is going to reflect the complex interaction that occurs between multiple regions of 
the brain.  If one of those regions has aberrant NR2B deletion in a portion of its cells, the 
observed behavioral changes may not be entirely due to alterations in the population of interest. 
Sun et al (2014) found ectopic reporter expression in approximately half of CA1 neurons and in 
nearly a quarter of neurons in CA3 and temporal cortical layer 5.  Labeling of neurons in cortical 
layers 2/3 and non-neuronal cell labeling was quite low (below 5%). Sparse labeling of astroglia 
was also detected in the striatum and thalamus of mice with or without tamoxifen. Reporter 
expression in neurons in this area was also sparse and dependent on tamoxifen treatment.  The 
most prominent recombination occurred in the cerebellum with nearly complete reporter 
expression in the GCL, scattered expression in Purkinje neurons, and the occasional cell likely 
representing interneurons appearing in the molecular layer.   
Because the mouse line used in this study relies on a knockdown strategy as opposed to 
inducing the expression of an exogeneous protein driven by a ubiquitous promoter (as is the case 
in the Sun et al (2014) study), ectopic CreERT2 expression will only be a factor at the 
intersection of CreERT2 and NR2B expression.  Recombination in the studies presented in this 
thesis is induced in the adult mouse when NR2B expression has been significantly down-
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regulated following development.  The adult NR2B mRNA expression pattern has been 
characterized by Monyer and colleauges (Monyer et al, 1994; von Engelhardt et al, 2008).  The 
area of greatest ectopic CreERT2 expression is in the cerebellum.  Fortunately, NR2B mRNA is 
not expressed here in adult mice.  NMDARs in this area are composed exclusively of NR1, 
NR2A, and NR2C subunits (Monyer et al, 1994).  Therefore, any alteration in behavior is not 
likely due to deletion of NR2B in the cerebellum as expression of this subunit is already 
endogenously suppressed in this area.  However, NR2B mRNA expression does persist in other 
areas throughout adulthood including all principal cell layers of the HPC (DG, CA1-3), different 
cortical layers, thalamus, caudate putamen, and amygdala.  Thus, overlap between NR2B mRNA 
expression and significant ectopic Cre expression occurs in CA1 and cortex.  Therefore, deletion 
of NR2B in these areas could potentially confound our behavioral data.   
Inactivation or lesion of CA1 results in deficits in contextual fear memory (Daumas et al, 
2005; Lee and Kesner, 2004). Therefore, if CA1 processing were significantly impaired by 
ectopic deletion of NR2B in the area, one would expect to see a deficit in CFC, but this was not 
observed in our mice.  Additionally, pharmacologically blocking NR2B in CA1 had no effect on 
acquisition of contextual fear memory suggesting the mechanism that underlies CA1’s 
involvement in contextual fear memory is not critically dependent on NR2B, though it should be 
noted that this pharmacological blockade was not able to target the entire CA1 structure (Zhao et 
al, 2005).  Our behavioral result in CFD phenocopies mice with targeted ablation of 
neurogenesis further linking the outcome to our manipulation of abGCs; however, a more 
specific gene targeting approach would ideally be used to unequivocally confirm this conclusion.  
A more specific NestinCreERT2 line exists; however, recombination efficiency in this line is very 
low and may not drive recombination in a large enough cohort of abGCs to see a behavioral 
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effect (Lagace et al, 2007; Sun et al, 2014). Retroviral delivery of Cre also suffers from low 
efficiency (Tashiro et al, 2006; Yang et al, 2011).  Currently, protocols for induction of 
recombination using CreERT2 mice involves systemic administration of tamoxifen.  Sun et al 
(2014)’s study demonstrated that very little tamoxifen-independent recombination occurs in the 
mouse line used here; therefore, it might be worthwhile going forward to attempt locally infusing 
tamoxifen into the DG to provide additional spatial control over recombination.  Future studies 
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Introduction 
Major Depression Disorder 
Major depression is a mood disorder that is heterogeneous in terms of severity, age of 
onset, and symptoms that present which along with depressed mood and decreased pleasure in 
daily activities can include irritability, sleep and/or weight disturbances, cognitive impairments, 
and thoughts of death or suicide that negatively impact occupational and social functioning on a 
regular basis for at least two weeks. Typically, treatment involves a pharmacological 
intervention.  AD drugs were introduced in the 1950s and have since been refined to have fewer 
side effects, but little advancement has been made in improving efficacy with only ~50% of 
patients achieving full remission (Berton and Nestler, 2006; Holsboer, 2008).  Most are based on 
the fortuitously discovered tricyclic and monoamine oxidase inhibitor (MAOI) compounds and 
fall under the class of Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin 
Norepinephrine Reuptake Inhibitor (SNRI), which acutely act to increase serotonergic and/or 
noradrenergic systems in the brain.  However, relief from symptoms requires several weeks of 
chronic treatment and the changes occurring during this time that underlie the therapeutic effects 
are still unknown (Berton et al, 2006).   
 
Antidepressants and Adult Hippocampal Neurogenesis 
AD treatment increases levels of adult neurogenesis in the HPC, and these newborn 
neurons have been shown to be necessary for some of the behavioral effects of ADs seen in 
rodents.  In addition, the maturation timeline of adult neurogenesis correlates with the onset of 
behavioral responses to ADs (David et al, 2009; Santarelli et al, 2003; Surget et al, 2008; Wang 
et al, 2008). ADs also enhance a neurogenesis-dependent form of LTP in the DG evoked by 
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medial perforant path stimulation under intact GABAergic tone (ACSF-LTP) (Malberg et al, 
2000; Wang et al, 2008). Thus, a potential mechanism by which abGCs may contribute to AD 
behavioral efficacy is by providing extra plastic units to the DG circuit. While ablation methods 
can test the necessity of abGCs in behavior, these techniques remove all abGCs from the circuit 
and do not allow for the determination of which abGC properties are required for behavior.  In 
the previous chapter, it was demonstrated that the enhanced plasticity of 4-6 week old abGCs is 
necessary for fine contextual discrimination, but it has yet to be determined whether NR2B-
containing NMDARs also play a role in AD response.  Therefore, in this section, the following 
aim will be addressed: 
 
III. Test the effect of NR2B deletion on the behavioral response to chronic antidepressant 
treatment. 
 
The experiments presented in this section intend to examine the contribution abGCs’ enhanced 
plasticity makes to the effectiveness of chronic AD treatment with the SSRI, FLX.   This is once 
again accomplished using the mouse line characterized in Part 1 of this chapter to conditionally 
delete NR2B from abGCs in the DG.  Here, we show that deletion of the NR2B subunit 
significantly attenuates a neurogenesis-dependent behavioral response to FLX, and additionally 
may block FLX’s ability to enhance young abGCs’ maturation and subsequent integration into 







NestinCreERT2 and NR2Bf/f mice were generated as previously described (Dranovsky et al, 
2011; von Engelhardt et al, 2008). Experimental male mice were generated by breeding 
NestinCreERT2;NR2Bf/f with NR2Bf/f mice. 8- to 12-week-old mice were injected with 
tamoxifen (TMX, 3mg dissolved in a solution of corn oil and 10% ethanol) or vehicle (VEH, 
corn oil/10% ethanol solution) intraperitoneally (i.p.) once per day for 5 consecutive days. 
Previous work with this strain revealed that a brief pulse of TMX does not affect HPC-dependent 
behavior 6 weeks later (Sahay et al, 2011a). All experiments were approved by the Institutional 




For behavior and neurogenesis measures, AD treatment began approximately 6 weeks after the 
last TMX injection. BrdU was injected (150 mg/kg, i.p. dissolved in saline) once per day for two 
days just prior to the start of AD treatment.  For dendritic morphology analysis, AD treatment 
began approximately 5 weeks after TMX administration and BrdU (75 mg/kg, i.p. dissolved in 
saline) was injected four times over 8 hours the day before AD treatment began. For all mice, 
FLX (18mg/kg/day in water) or VEH (water) was delivered by oral gavage and in the drinking 
water (160mg/mL) at a schedule of 5 consecutive days gavage followed by 2 consecutive days of 





All behavioral experiments were conducted in male mice 18 -24 weeks of age.  
Novelty-Suppressed Feeding. 
In the Novelty Suppressed Feeding (NSF) test, chronic AD treatment decreases latency to feed in 
the center of a novel arena after overnight food deprivation (Samuels et al, 2011).  However, in 
mice with ablated neurogenesis, chronic AD treatment is no longer effective at lowering the 
latency to feed.  Therefore, NSF represents a neurogenesis-dependent behavioral assay for AD 
response (David et al, 2009; Santarelli et al, 2003).  Mice were food restricted for 22-24 hours 
and testing began when an animal was placed in the corner of a brightly lit (~1250 lux) plastic 
box (50 cm long x 28 cm wide x 15 cm deep) covered with the same type of bedding used in the 
animal’s homecage.  A single pellet of food (regular chow) had been positioned on a platform in 
the center of the box prior to the start of the test. The latency to eat (defined as the mouse sitting 
on its haunches and biting the pellet with the use of forepaws) was timed.  Immediately after the 
latency was recorded, the food pellet was removed from the arena.  Animals that did not eat 
within 10 minutes were censored during the statistical analysis.  At the end of the session, 
animals were placed in their home cage and the amount of food consumed in 5 minutes was 
measured (home cage consumption).  Each mouse was weighed before food deprivation and 
before testing to assess the percentage of body weight lost.  Percent body weight lost and home 
cage consumption served as relative measures of animal hunger.  
 
Tail Suspension Test.  
The TST is a behavioral despair test during which the mobility of mice suspended by their tail is 
measured.  A depressed-like state is characterized by greater immobility while ADs are able to 
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decrease immobility (Cryan et al, 2005b).  Sessions lasted 5 minutes and were video recorded.  
Scoring was done by an observer blind to induction and treatment.   
 
Elevated Plus Maze.  
Mice were placed in the center of the maze consisting of both open and closed arms and were 
given five minutes to explore.  The test was video recorded and activity was measured using 
TopScan software.  Their preference for open (anxiogenic) or enclosed (anxiolytic) spaces was 
used to assess anxiety (Hogg, 1996). 
 
Immunohistochemistry 
For all experiments, mice were perfused (4% paraformaldehyde), brains postfixed, 
cryoprotected, and sections (35 µm) of the entire DG were labeled for BrdU, GFAP, NeuN, 
doublecortin (DCX), Ki67, or GFP [rat-anti-BrdU, 1:100 (Serotec); rabbit-anti-GFAP, 1:1500 
(DAKO); mouse-anti-NeuN, 1:500 (Millipore Bioscience Research Reagents); goat-anti-DCX, 
1:500 (Santa Cruz Bioscience); rabbit-anti-Ki67, 1:100 (Vector)], as previously described (Sahay 
et al, 2011a).  An experimenter blind to induction and treatment counted Ki67+, BrdU+, and 
DCX+ cells, as well as DCX+ cells exhibiting tertiary dendrites, in every sixth section 
throughout the DG.  For colabeling of BrdU with NeuN or GFAP, confocal scans 
(FluoView1000; Olympus) at 40× were taken of BrdU+ cells across the anteroposterior axis of 
the DG.  For the morphological analysis of immature neurons, z-stack images of BrdU+/DCX+ 
cells were traced and imported into Adobe Illustrator CS5 where neurons were reconstructed 
using the tracing tool. Images of the reconstructed neurons were opened in Fiji (http://fiji.sc/Fiji) 
where dendritic length was measured using the freehand trace tool and Sholl analysis was 
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Statistical significance was assessed by ANOVA or, in the case of planned comparisons, by 
unpaired two-tailed Student’s t-test using Statview Software.  Results in figures are mean ± 
SEM.  A multivariate Cox Proportional Hazards model with an interaction term between 
induction and treatment was used to analyze the effects of two variables in the NSF test using 
SAS Software.  Sholl Analysis was analyzed using the nonparametric Mann-Whitney U-test.  A 
complete statistical summary for all experiments is included in Tables 1-2. 
 
Results and Figures 
In order to examine the impact young abGCs’ enhanced plasticity has on behavioral and 
neurogenic responses to chronic AD treatment, we specifically deleted the NR2B subunit from 
those neurons in adult mice using the mouse line introduced in Part I of this section.  TMX 
injection leads to recombination in NSCs and thus the deletion of NR2B in the NSCs and their 
progeny (iNR2BNes).   Littermates injected with VEH served as our controls (CTRL) (2.3.1A).  
Approximately 70% of immature, DCX-expressing neurons in iNR2BNes mice are born from 
NSCs that have undergone recombination (Chapter 2, Part 1) (Kheirbek et al, 2012b).  In 
addition, slices from iNR2BNes mice lack neurogenesis- and NR2B-dependent ACSF-LTP (Fig 
2.1.6).  Chronic FLX treatment began 6 weeks after TMX or VEH administration in order to 





Figure 2.3.1 Experimental timeline.  A. Genetic design for the deletion of NR2B from abGCs. 
TMX administration into NestinCreERT2 x NR2Bf/f mice eliminates the NR2B subunit from 
neural stem cells and all of their progeny. Crossing these mice to an additional inducible EYFP 
reporter line labels cells that underwent recombination, thus acting as a surrogate for NR2B 
deletion.  Representative 10X images show cells are restricted to the lower portion of the granule 
cell layer near the subgranular zone, consistent with the expression pattern of immature abGCs 
(scale bar = 100um). B. Experimental timeline: For behavior (top), adult NestinCreERT2 x 
NR2Bf/f mice were injected with either TMX (iNR2BNes) or VEH (CTRL).  Six weeks later FLX 
or VEH treatment began. Behavioral testing began after four weeks of chronic antidepressant 
treatment. For dendritic complexity analysis (bottom), mice were sacrificed after three weeks of 






Four weeks after beginning chronic FLX treatment, iNR2BNes mice were tested in anxiety 
and depression-like behavioral assays. Mice were tested in the NSF test, in which AD efficacy 
has been shown to require adult neurogenesis (David et al, 2009; Santarelli et al, 2003).  The 
effect of FLX on feeding latency was significantly attenuated in iNR2BNes mice as compared to 
control mice (Fig 2.3.2A-B).  Individual comparisons revealed a robust effect of FLX in control 
mice, and a modest, but significant effect of FLX in iNR2BNes mice (Fig 2.3.2C).  Deletion of 
NR2B alone did not impact latency to feed (Fig 2.3.2C).  The observed differences in latency to 
feed in iNR2BNes mice were not due to changes in appetite as all groups exhibited similar levels 
of home cage food consumption and weight loss during the overnight food deprivation (Fig 
2.3.2D).  This indicates that loss of NR2B from abGCs causes a blunting of the FLX effect in a 




Figure 2.3.2 Deletion of NR2B attenuates the decrease in latency to feed in the NSF test 
after chronic antidepressant treatment.  A. Scattergram shows the latency to feed for each 
individual mouse in the cohort. Results from a multivariate Cox proportional hazards model with 
an interaction term between induction and treatment showed that FLX’s reduction in latency to 
feed in was significantly attenuated in iNR2BNes mice.  B. Cumulative survival plot comparing 
only those mice that received FLX treatment.  CTRL mice exhibit a lower latency to feed than 
iNR2BNes mice.  C. Cumulative survival plots comparing CTRL mice (left), iNR2BNes mice 
(middle), and VEH-treated mice (right).  FLX significantly lowered the latency to feed in each 
group, with the greatest stratification seen in CTRL mice, while NR2B deletion alone did not 
affect latency to feed.  D. No significant difference was observed in home cage consumption 
(left) or % weight change (right). HR=Hazard Ratio. * p < 0.05, # p < 0.0001   
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We also determined whether FLX treatment or NR2B deletion altered anxiety-related 
behavior in the EPM.   All groups showed similar levels of open arm exploration (as measured 
by time spent in the open arms, open arm entries, and distance traveled in the open arms) (Fig 
2.3.3A-C).  Furthermore, total exploration of the maze was similar for all the animals (Fig 
2.3.3D).  Together this shows that neither AD treatment nor NR2B deletion altered anxiety-like 
behavior in this test.   
 
 
Figure 2.3.3 NR2B deletion did not impact anxiety-related behavior in the EPM. No 
difference among groups was observed in open arm exploration as measured by A. time spent in 
the open arms, B. number of open arm entries, or C. distance traveled in the open arms.  D. The 




Next, we tested mice in the Forced Swim Test (FST), a neurogenesis-independent 
behavioral assay for AD response (David et al, 2009).  However, mice on FLX displayed hind 
limb rigidity impairing their ability to swim (Fig 2.3.4A-B).  This is a common feature of the 129 
mouse strain that results from SSRI treatment’s stimulation of the serotonergic system. When 
swimming or floating normally, a mouse’s feet remain under its body.  Mice displaying hind 
limb rigidity have their hind limbs outstretched behind them, adopting a “Superman” pose.  
Since this immobility is a result of a physical constraint on the animals as opposed to an altered 
stress response, behavior does not likely reflect the therapeutic efficacy of FLX rendering this 




Figure 2.3.4 FLX induced hind limb rigidity in this strain of mice.  A-B. FLX-treated mice 
display higher levels of immobility due to hind-limb rigidity.  Results from the FST cannot be 
used to assess the antidepressant efficacy of FLX in this strain of mice. 
 
 
This side effect of SSRI treatment does not affect the tail suspension test (TST), which is 
basically a “dry” version of the FST; therefore, mice were run in this test next.  Mice on FLX 
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were less immobile over time than VEH-treated mice (Fig 2.3.5A) and spent significantly less 
time immobile during the final two minutes of the test compared to VEH-treated mice with no 
significant interaction between induction and treatment (Fig 2.3.5B).  This indicates that 





Figure 2.3.5 NR2B deletion did not affect FLX’s ability to lower immobility in the TST. A. 
VEH-treated mice display increasingly higher levels of immobility as the test progresses, while 
FLX-treated mice are less immobile over time.  B.  NR2B deletion did not impact FLX’s ability 
to lower immobility during the last two minutes of the test. * p < 0.05, ** p < 0.01  
 
 
We next assessed the neurogenic effects of FLX in iNR2BNes and CTRL mice. The 
number of proliferating Ki67+ cells did not significantly differ among groups, revealing that 
neither NR2B deletion nor FLX treatment altered the number of proliferating cells at the time of 
sacrifice (Fig 2.3.6C).  To assess the effect of FLX on survival, mice were injected with BrdU 
just prior to the start of AD treatment and surviving cells were counted 6 weeks later.  Here, we 
found that the overall number of BrdU+ cells was lower after NR2B deletion; however, FLX still 
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increased survival in both CTRL and iNR2BNes mice (Fig 2.3.6D).  To determine the phenotype 
of BrdU+ cells, tissue sections were triple labeled for BrdU, NeuN (a neuronal marker), and 
GFAP (a glial marker).  As expected, the majority of BrdU+ cells colabeled with NeuN, though 
FLX treatment slightly increased the proportion of cells that were neuronal (Fig 2.3.6E).   
 
Figure 2.3.6 Effects of FLX on proliferation, survival, and cell fate in iNR2BNes mice. A. 
Representative images of BrdU in the dentate gyrus (scale bar = 100um) and B. BrdU+/NeuN+ 
cells (left) and BrdU+/GFAP+ cells (right) (scale bar = 10um). C. No effect on proliferation was 
observed as measured by Ki67 expression.  D. FLX increased survival of abGCs in both CTRL 
and iNR2BNes mice, though overall survival was lower in iNR2BNes mice.  E. The majority of 
BrdU+ cells colabeled with the neuronal marker, NeuN.  FLX treatment increased the percentage 
of BrdU+ cells that were neuronal. * p < 0.05, ** p < 0.01, # p < 0.0001 
 
Doublecortin (DCX), which is transiently expressed in newly generated neurons, was 
measured to quantify the number of immature neurons in the DG (Brown et al, 2003; Couillard-
Despres et al, 2005). While FLX increased the number of DCX+ cells in control mice, this effect 
was blunted in iNR2BNes mice (Fig 2.3.7B).  DCX+ cells undergo significant morphological 
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changes as they mature.  To determine if our manipulations altered this maturation process we 
counted the subset of DCX+ cells that had reached a more mature stage of development as 
exhibited by the presence of tertiary dendrites. While FLX increased the number of DCX+ cells 
with tertiary dendrites in control animals, this effect was less pronounced in iNR2BNes mice (Fig 
2.3.7C).  Finally, we measured the effect of FLX on dendritic structure by analyzing the 
dendrites of 3-week-old DCX+ cells.  Once again, we found that FLX increased dendritic length 
and complexity in control mice but not in iNR2BNes mice (Fig 2.3.8). 
 
 
Figure 2.3.7 Effects of FLX on young abGC number and maturation in iNR2BNes mice. A. 
Representative images of DCX expression in the dentate gyrus (scale bar = 100um).  B. The 
number of immature neurons and C. immature neurons with tertiary dendrites increased 




Figure 2.3.8 FLX increased dendritic complexity in CTRL but not iNR2BNes mice. A. 
Representative tracings of 3-week-old abGCs (scale bar = 20um). B. There was a trend for 
fluoxetine to increase total dendritic length of 3-week-old DCX+ abGCs in CTRL mice but not 
iNR2BNes mice.  C. Sholl analysis revealed FLX increased dendritic complexity in CTRL mice 
but not NR2BNes mice.  D. NR2B deletion alone did not affect the dendritic complexity of 3-
week-old DCX+ abGCs.  * p < 0.05, ** p < 0.01 
 
 
To determine if abGC maturation correlated with the behavioral response to FLX, we 
compared the number of DCX+ cells with tertiary dendrites in FLX-treated mice to outcomes in 
our behavioral tests.  We found a trend for greater tertiary dendrite number to correlate with a 
lower latency to feed in the NSF test (Fig 5=2.3.9A) in FLX-treated mice.  When looking at the 
TST, which has been suggested to be independent of levels of neurogenesis, higher tertiary 
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dendrite numbers were not predictive of a larger FLX response (Fig 2.3.9B).  Tertiary dendrites 
were not related to behavioral outcomes in VEH-treated mice in either test.    
 
 
Figure 2.3.9 Trend for dendritic complexity in FLX-treated mice to correlate with 
behavioral response in the neurogenesis-dependent NSF test. A. Higher numbers of immature 
neurons with tertiary dendrites tended to correlate with a lower latency to feed in NSF in FLX-
treated mice (right) but not those mice that received VEH (left). B. Similar correlations were not 




















In this study, we have determined the consequence of altering young neurons’ physiology 
on FLX efficacy without eliminating the young neurons themselves in an attempt to uncouple the 
neurogenic effects of FLX from the distinct physiological contribution abGCs make to the 
hippocampal circuit.  By conditionally deleting the NR2B subunit from abGCs of mice prior to 
the onset of their AD treatment, we reveal a blunting of the behavioral response to chronic FLX.  
This suggests that eliminating abGCs’ enhanced plasticity decreases their ability to influence DG 
output resulting in an AD response that is less robust than seen in CTRL mice.  Control 
experiments revealed the specificity of this effect, as NR2B deletion did not impact the effect of 
FLX in a neurogenesis-independent behavioral assay (TST) or in an assay that was insensitive to 
FLX in this strain of mice (EPM).    
Our efforts to isolate the contribution of abGCs’ unique physiology from the neurogenic 
effects of FLX were not entirely successful as the results presented here also reveal slight group 
differences in neurogenesis. Surprisingly, we found that the survival of abGCs in iNR2BNes mice 
was lower than in CTRL mice.  Previous work with this line of mice examined survival at 
multiple time points and found no impairments due to NR2B deletion (Fig 2.1.4B)(Kheirbek et 
al, 2012b). However, unlike that previous study, the mice used here were subject to a repeated 
stressor in that FLX and VEH were provided by oral gavage 5 days of every week.  Oral gavage 
is associated with substantial and prolonged increases in corticosterone levels in mice and as 
such is considered a stressful procedure (Dalm et al, 2008).  Interestingly, chronically elevating 
glucocorticoid levels in C57BL/6 mice by treating them with exogenous corticosterone alters 
their sensitivity to chronic AD treatment.  Non-corticosterone treated mice do not display any 
increases in proliferation, survival, or young cell number in response to chronic ADs; these 
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neurogenic effects only appear in corticosterone-treated mice (David et al, 2009).  Similarly, the 
mice in this study may have only become sensitive to the influence NR2B deletion has on 
survival with the addition of chronic stress.  NMDARs have been shown to mediate cell survival 
in 2-3-week-old abGCs (Tashiro et al, 2006).  Under non-stressful conditions, activity through 
other receptors (presumably non-NR2B-containing NMDARs) present in these cells is sufficient 
to promote their survival, while it appears that stress increases the pressure on this cell survival 
mechanism such that the remaining receptors can no longer completely compensate for the lost 
NR2B-containing NMDARs. Despite the overall lower survival seen in iNR2BNes mice, FLX 
was still effective at increasing survival relative to VEH-treated animals.  Examination of the 
fate of BrdU+ cells showed that the percentage of BrdU+ cells that colabeled with NeuN 
increased with FLX treatment – mimicking effects on cell fate seen after enrichment (Dranovsky 
et al, 2011). 
Our analysis indicated that FLX-induced increases in dendritic complexity were 
predictive of behavioral efficacy in the NSF test (Fig 2.3.9).  Interestingly, FLX effects on 
dendritic complexity were attenuated in iNR2B mice, which did not display as robust a 
behavioral response to FLX as CTRL mice. These results suggest that manipulating young 
neurons’ plasticity attenuates FLX’s ability to facilitate maturation thereby impacting behavioral 
response. This supports a hypothesis where chronic FLX’s efficacy may be dependent on 
accelerating the dendritic development of abGCs as they differentiate which would serve to 
increase the number of young abGCs that are functionally integrated into the DG circuit (Wang 
et al, 2008). 
It is particularly interesting that eliminating NR2B from young abGCs does not 
completely block the AD actions of FLX that are considered to be neurogenesis-dependent.  This 
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may be due to the fact that iNR2B mice do not entirely lack FLX-induced increases in levels of 
neurogenesis, only the ability to add highly plastic units to the DG circuit. Alternatively, the 
remaining effects of ADs may be independent of neurogenesis.  FLX has shown some residual 
behavioral effects following ablation that is similar to the attenuation in FLX efficacy seen in 
NR2BNes mice (Wu and Hen, 2014).  There is also accumulating evidence that mature GCs in the 
DG are involved in the effects of ADs too (Samuels et al, 2015).   
Possibly linking these two hypotheses is the suggestion that young abGCs may modulate 
the activity of mature GCs within the DG. In the absence of neurogenesis, some studies have 
found that activity in the DG increases (Burghardt et al, 2012; Ikrar et al, 2013; Lacefield et al, 
2012), whereas increasing levels of neurogenesis has been found to decrease DG activity (Ikrar 
et al, 2013).  While the exact mechanism for this is unknown, it has been hypothesized that 
young abGCs may differentially modulate the local DG circuits (Lacefield et al, 2012; Sahay et 
al, 2011b).  It should be noted that our immunohistochemical analysis indicates that abGCs in 
iNR2BNes mice still survive and mature into neurons, and thus may still be capable of influencing 
the hippocampal network in a manner that does not require enhanced plasticity.  Further 
experiments are necessary to determine whether these cells lacking NR2B can impact local and 
downstream circuits like control cells.  
Because we are once again looking at behavior the issue of ectopic NR2B deletion should 
be considered.  The concerns presented in the previous section still stand.  However, once again, 
the effect of NR2B deletion is consistent with a deficit in neurogenesis-dependent function, 
suggesting the decreased efficacy of chronic FLX treatment is a due the deletion of NR2B 
specifically from abGCs and not merely a result of ectopic NR2B deletion.  Future studies are 
planned to attempt to quantify the extent of aberrant NR2B deletion in the areas of ectopic 
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CreERT2 expression.      
Our results reveal that NR2B-containing NMDARs in young abGCs contribute to the 
efficacy of chronic AD treatment.  This may be due to increasing the number of highly plastic 
units in the DG, enhancing the integration of young neurons into the DG/hippocampal circuit, or 
it is possible that both effects contribute to AD action.  Each scenario supports the idea that FLX 
increases the ability of abGCs to participate in DG output by increasing the chance that new 
neurons will be activated during DG stimulation. However, due to the close link between activity 
and maturation that appears to be enhanced with FLX treatment (Fig 2.1.4H-I; Fig 2.3.8) (Ge et 
al, 2006), a different approach with greater temporal resolution is needed to separate neurogenic 
effects of FLX from the physiological contribution abGCs make to hippocampal output.  With 
this in mind, a mouse line in which abGCs could be acutely inhibited was generated.  The 
experiments in the next chapter will detail the molecular and behavioral characterization that has 
begun in these mice.
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Chapter 3 
Chemogenetic approach to modulating the Gi/o-coupled GPCR cascade in granule cells in 
the dentate gyrus across multiple time scales
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Introduction 
A number of different methodologies have been used to test the functional role of adult-
generated neurons in the HPC. Anti-mitotic agents or radiological methods have been used to 
inhibit neurogenesis (Madsen et al, 2003; Shors et al, 2001), yet limited specificity and 
undesirable side effects such as impact on overall health and local inflammation suggest that 
these techniques may not be optimal (Dupret et al, 2005; Monje et al, 2003).   Interventions that 
increase hippocampal neurogenesis, including environmental enrichment, exercise, and chronic 
AD treatment (Kempermann et al, 1997; Malberg et al, 2000; van Praag et al, 1999) can involve 
a wide range of non-neurogenesis-dependent behavioral effects, limiting their potential use for 
understanding how abGCs modulate hippocampal function .  Genetic approaches for 
inhibiting/enhancing neurogenesis, while significantly cleaner, can only answer questions about 
the consequences of chronic ablation/enhancement of young neurons (Sahay et al, 2011a; Saxe et 
al, 2006). Of particular concern is the realization that chronic ablation can lead to compensatory 
changes in the HPC obscuring the real contribution of young neurons to behavior (Singer et al, 
2011). The previous chapter of this thesis took a more targeted approach than ablation by only 
eliminating abGCs’ enhanced synaptic plasticity and not the neurons themselves; however, 
conditional deletion of the NR2B protein is still a chronic manipulation that slightly impaired 
maturation at baseline and following chronic AD treatment.  New strategies are required to 
regulate the activity of abGCs in a temporally specific manner in order to test whether young 
neurons drive the AD behavioral response, or if it is their long-term modification of existing 
circuitry that contribute to alterations in mood.  Ideally, such strategies could be applied to any 
cell population, not just abGCs.   
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Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) 
Recent technical advances in receptor engineering has made much more precise spatial 
and temporal control of adult-born neurons possible.  One such technical advance is the 
generation of evolved G-protein coupled receptors (GPCRs). A family of mutated muscarinic 
acetylcholine receptors (mAChRs) have been developed which are activated by the biologically 
inert, highly bioavailable compound, clozapine N-oxide (CNO) (Fig 3.1) (Armbruster et al, 
2007).  These designer receptors exclusively activated by a designer drug (DREADDs) were 
generated by the introduction of two mutations (Tyr3.33/Ala5.46) in a highly conserved area of 
the mAChR family and have been applied to three classes of muscarinic receptors, each of which 
couples to different G-protein signaling cascades (Dong et al, 2010).    The experiments 
presented in this chapter will use hM4Di, the DREADD coupled to the inhibitory Gi/o cascade.  
The β/γ subunit of Gi/o-coupled receptors can activate the relatively ubiquitous G-protein 
inwardly rectifying potassium ion (K+) (GIRK) channel and induce physiologically relevant 
neuronal silencing via hyperpolarization of the membrane potential which leads to inhibition of 
spontaneous and depolarization-evoked firing (Armbruster et al, 2007; Dong et al, 2010). hM4Di 
activity also initiates other signaling events downstream of the Gi/o protein, including activation 
of the ERK/MAPK pathway suggesting these mutant receptors retain the coupling properties of 
their WT counterpart (Armbruster et al, 2007). Further analysis of hM3Dq-expressing cells 
showed that CNO treatment results in signaling outcomes very similar to those seen after 
acetylcholine activates wild-type hM3 receptors including recruitment of G-protein-independent, 
beta-arrestin-mediated signaling (Alvarez-Curto et al, 2011).  Presumably, this fidelity to WT 
signaling is true for hM4Di as well. 
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Figure 3.1 DREADDs are a family of mutated muscarinic acetylcholine receptors 
(mAChRs) activated by the biologically inert, highly bioavailable compound, clozapine N-
oxide.  Endogenous mAChRs bind their native ligand, acetylcholine, with no appreciable affinity 
for CNO while mutated mAChR binds CNO but not acetylcholine.  The DREADD used in the 
experiments presented in this chapter couple to the Gi/o signaling cascade. Adapted from 
(Conklin, 2007). 
   
 
Importantly for studies presented in this chapter, the functionality of this receptor in 
regulating behavior has been validated in vivo.  The first study to do this showed that systemic 
injection of CNO in mice virally expressing hM4Di in striatopallidal (indirect pathway) neurons 
increased behavioral sensitization after repeated exposure to amphetamine, while in those 
expressing hM4Di in striatonigral (direct pathway) neurons, CNO inhibited locomotor 
sensitization (Ferguson et al, 2011).  This effectively demonstrated that hM4Di can be expressed 
in vivo, is tolerated by neurons, and can decrease neuronal activity to elicit a behavioral response. 
This result has since been confirmed in many additional cell types both within and outside of the 
CNS (reviewed in Urban and Roth (2015)).  hM4Di has also been utilized to control physiology 
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and behavior in Drosophila (Becnel et al, 2013).  The transgenic hM4Di mouse line employed in 
this thesis was generated in the Dymecki lab.  Lab members there used this line to express 
hM4Di in serotonergic neurons and demonstrated the ability of CNO to inhibit serotonergic 
neuron firing in culture, while an injection of CNO into these mice acutely modulated respiration 
and body temperature (Ray et al, 2011), thereby validating this transgenic approach to 
expressing DREADDs. 
IP injection of CNO leads to changes in neuronal activity that can be detected within 5-10 
minutes.  Peak responses occur around 45-50 minutes after injection regardless of the dosage 
used (Alexander et al, 2009).  These effects on neuronal activity are long lasting and translate to 
long-lasting behavioral and physiological effects (Alexander et al, 2009; Krashes et al, 2011).  
Despite this extended activity, CNO is depleted from the bloodstream relatively quickly.  Plasma 
concentrations peak 15 minutes after a single 1 mg/kg IP injection of CNO and are very low 2 
hours later (Guettier et al, 2009).   This suggests that CNO may accumulate in tissue or 
alternatively, signaling activated downstream of DREADDs may persist longer than actual 
DREADD activation.  
While the temporal resolution of DREADDs is not as fine when compared to optogenetic 
techniques that can provide control of neuronal activity on the level of milliseconds, the longer 
period of activity along with the ease of administering CNO makes DREADDs ideally suited for 
studies that aim to examine the effect of modulating GPCR signaling at different time scales.  
This is translationally relevant as many FDA-approved drugs target GPCRs, with effective 
treatment depending on chronic GPCR activation (Urban et al, 2015).  Studies have been 
performed validating the use of CNO to chronically activate DREADDs.  Mice trangenically 
expressing hM3Dq in principal neurons within the forebrain were given 2 CNO doses 24 hours 
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apart and gamma activity was monitored at both time points revealing the same 
electrophysiological response at each time point with both injections equally increasing the 
power of gamma activity in the HPC for the same duration of time (Alexander et al, 2009).  
Krashes et al (2011) virally-expressed hM3Di in Agouti-related protein (AgRP) neurons in the 
arcuate nucleus of the hypothalamus which are thought to be involved in regulating energy 
homeostasis.  This study found that chronic, 5-day stimulation via twice daily CNO injections 
increased fat stores due to increased food intake and decreased energy expenditure.  This was 
reversible as weight progressively declined following CNO withdrawal and returned to normal 
levels within 5 days.  DREADDs have also been used in studies outside of the central nervous 
system.  Jain et al (2013) used hM3Dq transgenic mice to selectively express this receptor in 
pancreatic beta-cells and found that 4 weeks of chronic CNO treatment administered either by 
daily ip injections (1mg/kg) or through the animals’ drinking water (0.25 mg/ml) progressively 
improved beta-cell function and glucose homeostasis in mice. Chronic activation of hM4Di has 
also been used to modulate neurotransmitter release and neuronal activity in the developing 
striatum (Kozorovitskiy et al, 2012).  In one such experiment, hM4Di virally-expressed in 
developing MSNs of either the direct or indirect pathway were activated by twice daily ip 
injections of CNO (1mg/kg) for 1 week.  Chronically inhibiting developing direct pathway 
MSNs decreased both striatal activity and MSN excitatory synapse number.  The opposite was 
true for chronic inhibition of developing indirect pathway MSNs: striatal activity increased, as 
did MSN excitatory synapse number.   While DREADDs are likely bound to the same regulatory 
processes as WT GPCRs such as phosphorylation, desensitization, internalization, and down-
regulation (Alvarez-Curto et al, 2011), chronic CNO treatment has still proven effective using 
both the hM3Dq and hM4Di class of DREADDs suggesting that if any regulatory actions are 
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taking place they are only modulating activity, not eliminating it.  Sustained activity may be a 
consequence of DREADD expression strategies that may potentially result in high receptor 
levels and, consequently, large receptor reserves (Urban et al, 2015).  Experiments discussed in 
this chapter will further explore the effectiveness of chronic hM4Di activation in adult-born and 
mature GCs. 
 
5-HT1A Receptors are GPCRs coupled to the Gi/o signaling cascade 
Selective serotonin reuptake inhibitors (SSRIs) such as FLX can increase activity of the 
5-HT1A serotonin receptor (5-HT1AR), a Gi/o-coupled GPCR, at postsynaptic targets.  Chronic 
treatment with the 5-HT1A-selective agonist, 8-OH-DPAT, is sufficient to lower the latency to 
feed in the NSF test and increase cell proliferation in the DG (Santarelli et al, 2003).   Yet, it 
remains unknown which target region drives the behavioral responses to ADs and whether 
selectively driving 5-HT1AR-mediated signaling cascades in a specific region is sufficient for 
eliciting behavioral responses to ADs. Recently it has been shown that expression of these 
receptors in DG GCs is required for effective AD treatment in mice (Samuels et al, 2015). Like 
5-HT1ARs, the hM4Di receptor is Gi/o-coupled, but it is only activated by the exogenous drug, 
CNO. One of the goals of this chapter will be to test whether selective stimulation of Gi/o-
coupled GPCR signaling cascades in DG GCs leads to an AD-like behavioral response in mice. 
This will be accomplished using CNO to chronically activate hM4Di receptors selectively 
expressed in DG GCs. Mice will then be tested in a number of anxiety and depression-related 
behavioral assays to see if this treatment is sufficient to confer an anti-anxiety and/or an AD-like 
response in mice.  Results from this experiment will hopefully help to dissect the locus of action 
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of ADs and address how 5-HT1ARs contribute to the behavioral responses seen in mice 
following chronic AD treatment. 
 
Chronic corticosterone model of stress-induced anxiety/depression 
While ADs can greatly alter mood in depressed or anxious patients, healthy individuals 
not suffering from these symptoms do not display such responses (Barr et al, 1997; Gelfin et al, 
1998).  Consistently, mouse strains exhibit different sensitivities to ADs (Dulawa et al, 2004).  
The anxious BALB/c strain of mice responds to chronic AD treatment delivered via drinking 
water as do the 129SvEv strain (Dulawa et al, 2004; Santarelli et al, 2003). However, the non-
anxious C57BL/6 strain does not respond to AD treatment under these baseline conditions 
(David et al, 2009).  Thus, BALB/c and 129SvEv mice represent a convenient strain to use to 
assess AD treatment in mice. Yet, C57BL/6 mice are frequently used in behavioral studies and 
many transgenic mouse lines are derived at least in part from this strain of mice, including the 
hM4Di transgenic mouse line that will be used in the experiments outlined in this chapter.  
Therefore, the ability to induce an anxiety/depression-related phenotype that is responsive to AD 
treatment in mouse strains that do not endogenously display such characteristics would be highly 
beneficial.  Individuals suffering from disorders that elevate their glucocorticoid levels present 
with depressed mood ((David et al, 2009), Chapter 1).  Mirroring this effect, chronically 
elevating glucocorticoid levels in mice by treating them with exogenous corticosterone (CORT) 
induces anxiety/depression-like changes in behavior, neurochemistry, and brain structure (David 
et al, 2009).  C57BL/6 mice that were administered CORT (35ug/ml/day) for 4-weeks displayed 
anxiety-like phenotypes in the OFT and NSF test, though no alterations in FST immobility were 
seen.  This behavior was reversed following chronic AD treatment.  Interestingly, neurogenesis-
	  106	  
related effects of chronic AD treatment parallel the behavioral effects as AD treatment only 
significantly increased proliferation, survival, and young neuron number in mice treated with 
corticosterone.  These effects of AD treatment on neurogenesis were not seen in non-
corticosterone-treated mice.  Thus, chronic CORT treatment represents a model of stress-induced 
anxiety/depression that can be used in order to study AD action in mice that would otherwise not 
respond to AD treatment.   
 
The experiments presented in this chapter will address the following aim:  
IV. Generate and characterize mice in which DG GCs can be temporally inhibited.  
 
Briefly, the experiments presented here will detail the effectiveness of CNO to acutely and 
chronically modulate the activity of hM4Di-expressing GCs in the HPC via hM4Di receptors, 
which are DREADDs coupled to the Gi/o-protein cascade.  Results show that acute CNO 
treatment in mice expressing hM4Di in DG GCs can impair encoding of contextual fear memory.  
Chronically treating these mice had an anxiogenic effect in the OFT, but otherwise mice were 
comparable to controls.  Chronic CNO treatment in mice expressing hM4Di in young abGCs 
effectively decreased these cells’ dendritic complexity, but did not alter proliferation or early 
survival. Thus, hM4Di DREADDs represent a novel tool that can be used to modulate activity of 
neurons in a temporally restricted manner, allowing for both acute and chronic manipulations of 







Four mouse lines were employed in these studies: ROSA26-CAG-loxP-mCherry-STOP-loxP-
hM4Di-HA (hM4Distopflox) mice (Ray et al. 2011), TMX-regulated Nestin-CreERT2  (Dranovsky 
et al, 2011), (proopiomelanocrotin-bacterial artificial chromosome (BAC) driven Cre mouse line 
(POMC-Cre) (McHugh et al, 2007), and ROSA26-loxp-STOP-loxp-EYGP mice (EYFPstopflox) 
(Srinivas et al, 2001).  Experimental mice were generated by breeding either Nestin-CreERT2; 
hM4Distopflox mice or POMC-Cre; hM4Distopflox mice with hM4Distopflox mice.  For labeling 
recombined cells, Nestin-CreERT2; hM4Distopflox or POMC-Cre; hM4Distopflox mice were crossed 
to EYFPstopflox mice. 11-12 week-old Nestin-CreERT2; hM4Distopflox mice were injected with 3mg 
tamoxifen (TMX) or vehicle (VEH) solution of corn oil/10% ethanol I.P./day for 5 consecutive 
days. Previous work with this strain revealed that a brief pulse of TMX does not affect HPC -
dependent behavior six weeks later (Sahay et al, 2011a). All experiments were approved by the 
IACUC at Columbia University and the New York State Psychiatric Institute. 
 
Drugs 
For survival analysis, BrdU was injected (150 mg/kg, i.p. dissolved in 0.9% NaCl) once per day 
for 2 days 24 h after the last tamoxifen or vehicle injection.  For chronic CNO treatment, mice 
were administered 2 IP injections of CNO daily (5mg/kg in 0.5% DMSO, 0.9% NaCl; morning 
and night) for 2 weeks (Nestin-CreERT2; hM4Distopflox), for 1 week prior to behavioral testing 
during which time twice daily injections were also administered for the subchronic POMC-Cre; 
hM4Distopflox group, or for 4 weeks prior to behavioral testing during which time twice daily 
injections were also administered for the chronic POMC-Cre; hM4Distopflox group.  For acute 
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CNO treatment, mice were administered a single IP injection of CNO (10 mg/kg in 0.5% DMSO, 
0.9% NaCl) 30 minutes prior to behavioral testing.  
 
Immunohistochemistry 
For all experiments, mice were perfused (4% paraformaldehyde), brains postfixed, cryoprotected, 
and sections (35µm) of the entire DG were labeled for BrdU, Ki67, DCX, and GFP as previously 
described (Denny et al, 2014; Sahay et al, 2011a) (Rat-anti-BrdU 1:100 Serotec; rabbit-anti-Ki67, 
1:100, Vector; goat-anti-DCX, 1:500, SantaCruz; chicken anti-GFP 1:500 Abcam, ab13970). 
Experimenters blind to treatment counted (at 20X) BrdU+ or Ki67+ cells in every 6th section 
throughout the DG, and DCX cells exhibiting tertiary dendrites were also counted.  For Sholl 
analysis, BrdU+/DCX+ neurons were scanned using a FluoView 1000 (Olympus) confocal 
microscope at 40X. Images of collapsed z-stacks were traced and scanned into Adobe Illustrator, 
where dendritic trees were reconstructed using the tracing tool. Concentric circles with 10µm 
radius increments were created using the polar grid tool and overlaid on the reconstructed 
neurons.    The center of the concentric circles was defined as the center of the neuron’s soma.  




Mice were placed in an acrylic open-field chamber 40cm long×40cm wide×37cm high with 
illumination set to approximately 20 lux. Data were collected in 5 min bins during 60 min trials 
and analyzed for total distance traveled and rearing events as well as time and distance traveled 
in center.   
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Forced swim test, novelty suppressed feeding and elevated plus maze 
FST, NSF and EPM were conducted as previously described (David et al, 2009; Dulawa et al, 
2004; Sahay et al, 2011a) 
Fear conditioning 
Conditioning took place in Coulbourn fear conditioning boxes that contained one clear plexiglass 
wall, three aluminum walls and a stainless steel grid floor. In the one-trial CFC, the training 
context (A) included a houselight and fan, and anise scent was placed under the grid floor. 180s 
after entering the chamber, mice received a single 2s foot shock of 0.75mA. Mice were taken out 
15s after termination of the foot shock and returned to their home cage. The box was cleaned 
with Sanicloths between runs. Digital video cameras recorded the session, FreezeFrame and 
FreezeView software (Actimetrics) were used for recording and analyzing freezing behavior.  
 
Statistical Analysis 
Statistical significance was assessed by unpaired two-tailed Student’s t-test, Mann-Whitney U 
test, one-way ANOVAs, or repeated measures ANOVA were appropriate using Statview 
Software.  Significant main effects and/or interactions were followed by Fisher’s PLSD post hoc 
analysis, unpaired t-tests, or one-way ANOVAs as appropriated.  Kaplan-Meier survival analysis 
was used to analyze the NSF test with mice that never ate during the 10 minute testing period 
censored. The Mantel-Cox log-rank test was used to evaluate differences between experimental 





Results and Figures 
Acute activation of hM4Di in DG GCs  
Experiments were conducted with the aim of determining the ability of CNO + hM4Di to 
induce behaviorally relevant levels of inhibition in GCs acutely in vivo. Since abGCs’ online 
contribution had not yet been demonstrated at the time these experiments were conducted (Gu et 
al, 2012), validation of acute inhibition was assessed by targeting hM4Di expression to both the 
immature and mature populations of GCs. Data generated from the Hen lab at this time 
demonstrated that acute inhibition of the dorsal portion of this cell population via optogentic 
methods leads to an impairment in encoding of contextual fear memory (Kheirbek et al, 2013); 
therefore, experiments were designed in an attempt to recapitulate these results with hM4Di 
activation.  hM4Distopflox mice were crossed to a POMC-Cre mouse line to drive expression of 
hM4Di in both developmentally and adult-born GCs, thus targeting the entire GC population 
(McHugh et al, 2007).  Experimental cohorts consisted of POMC-Cre; hM4Distopflox mice 
(POMC/hM4Di) and their littermate controls, hM4Distopflox (CTRL). An additional cohort of 
animals was generated by crossing mice to the reporter line, ROSA26-stopflox-EYFP (Fig 
3.2A).  EYFP expression was used as a surrogate for recombination and hM4Di expression (Fig 
3.2B).  Thus, recombination was confirmed by both the loss of mCherry from the GCL and the 





Figure 3.2 POMC-Cre-dependent recombination in DG GCs.  A. Genetic design for hM4Di 
and EYFP expression in developmentally and adult-born DG GCs. B. mCherry and EYFP 
expression in 12 week old mice.  20X image reveals very little overlap in expression. 
 
The consequence of GC inhibition on baseline locomotion and anxiety-like behavior was 
tested in the open field.  Mice were given an interperitoneal (IP) injection of CNO (10mg/kg), 
then 30 minutes later were placed in an open field chamber under high lux illumination (800 
lux).  Locomotor activity was assessed by measuring habituation and total distance traveled (Fig 
3.3A, n = 4 CTRL, 6 POMC/hM4Di, repeated-measures ANOVA, genotype × time interaction: 
F(11,88) = 2.350, p<0.0137; unpaired t-test, t8 = 1.949, p = 0.0872 (inset)), while total time in the 
center (Fig 3.3B, unpaired t-test, t8 = -0.060, p = 0.9536) and percent center distance traveled 
(Fig 3.3C, unpaired t-test, t8 = -0.247, p = 0.8114) was used as a measure of anxiety. Although 
POMC/hM4Di mice were slightly less exploratory at the beginning of the test, the overall total 
distance traveled was not significantly different between groups and neither were center 
measures.  These results suggest POMC/hM4Di mice’s baseline locomotor activity and anxiety 
levels do not differ from controls.  Mice were also tested in the EPM.  Though there appears to 
be a trend for POMC/hM4Di mice to not show as strong a preference for the closed arms as 
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CTRLs, this trend did not reach significance (Fig 3.3D, open arm time: unpaired t-test, t8 = -
1.451, p = 0.1849; closed arm time: unpaired t-test, t8 = 1.705, p = 0.1266). 
 
 
Figure 3.3 Activation of hM4Di in mature GCs during anxiety-related behavioral assays. A. 
OFT with locomotor activity measured in 5 min increments (inset, total distance traveled), B. 
center time, and C. % center distance traveled.  Initial exploratory behavior was higher in control 
mice but total measures over the course of 60 min did not significantly differ.  D. No significant 
difference between groups was observed in time spent in the open or closed arms of the EPM.    
* p < 0.05.  
 
 
 To test whether inhibition of DG GCs impacts contextual fear learning as has been 
previously shown using optogenetic techniques (Kheirbek et al, 2013), mice were administered 
CNO 30 minutes prior to being placed in the fear conditioning apparatus. The mice were allowed 
to explore the context after which they received a single foot shock (Fig 3.4A-B, unpaired t-test, 
t8 = -0.587, p = 0.5733). Mice were then removed from the box and returned to their home cage.  
24 hours later, mice were tested for freezing to the context in the absence of CNO.  
POMC/hM4Di mice froze significantly less than controls on this test day, suggesting inhibition 
of GCs via hM4Di activation during CFC training impairs encoding and/or consolidation of 
contextual fear (Fig 3.4B, unpaired t-test, t8 = 3.027, p = 0.0164). Mice were retrained in the 
absence of CNO and then tested for retrieval of contextual fear with CNO on board. 
	  113	  
POMC/hM4Di mice and controls did not differ in freezing scores on day 3, suggesting mature 
GCs are not necessary for the retrieval of contextual fear memory (Fig 3.4B, unpaired t-test, t8 = 
-0.833, p = 0.4291).  This data indicates that GCs are involved in the encoding and/or 
consolidation of contextual fear memories, and reveals the functionality of hM4Di and the 





Figure 3.4 Activation of hM4Di in mature GCs impairs contextual fear memory.  A. 
Experimental design for testing encoding and/or consolidation and retrieval of contextual fear 
conditioning memories.  B. Activation of hM4Di with CNO impaired encoding and/or 
consolidation but not retrieval of contextual fear memories. * p < 0.05.  
 
 
Chronic activation of hM4Di in newly generated abGCs  
A histological approach that takes advantage of abGCs activity-dependent maturation 
was employed to evaluate CNO’s ability to chronically activate hM4Di receptors in young 
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abGCs in vivo.  Validation of this was important in the event that young abGCs do not make an 
online contribution to AD-related behavior, but instead are required for their long-term 
modification of existing circuitry.  First, as an initial test of recombination in 
hM4Distopflox/NestinCreERT2 mice, this line was further crossed to an EYFPstopflox reporter line 
allowing EYFP expression to be used as a surrogate for hM4Di recombination and marker for 
abGCs (Fig 3.5A).  In this design, EYFP expression was observed in the SGZ and lower portion 
of the GCL.  This was accompanied by a loss of the mCherry expression and minimal overlap 
between the two signals (Fig 3.5B). 
 
 
Figure 3.5 NestinCreERT2-dependent recombination in abGCs. A. Genetic design for hM4Di 
and EYFP expression in abGCs. B. mCherry and EYFP expression 5 weeks after TMX 
induction.  20X collapsed z-stacked image reveals very little overlap in expression. 
 
The role of activity dependent maturation of neuronal circuits is well documented, and 
development of abGCs recapitulates many of the processes of postnatal development. 
Modulating excitability of young neurons by regulating chloride conductance after genetic 
ablation of the chloride pump, NKCC1, has been shown to impact the maturation of abGCs (Ge 
et al, 2006).  Data presented earlier in this thesis showed that conditional deletion of the NR2B 
subunit of the NMDAR in abGCs, which eliminates newborn neurons enhanced plasticity, also 
impaired maturation at baseline and following FLX treatment (Fig 2.1.4H-I, Fig 2.3.8). 
	  115	  
Therefore, to verify that hM4Di activation in immature abGCs in vivo leads to inhibition and can 
inhibit cells for extended periods of time, ihM4Di mice were chronically treated with CNO for 2 
weeks after tamoxifen induction, and the effect this had on dendritic morphology as well as 
progenitor proliferation and survival of abGCs was measured (Fig 3.6A).  As it has been shown 
that hM4Di activity persists for approximately 9 hours after CNO administration, chronic 
inhibition was achieved by administering 2 IP injections of CNO daily (5mg/kg in 0.5% DMSO, 
0.9% NaCl; morning and night) for 2 weeks (Krashes et al, 2011). 
BrdU was administered to mice just prior to CNO treatment.  Counts of BrdU+ cells 
showed no difference in survival between CTRL and ihM4Di groups (Fig 3.6B, unpaired t-test, n 
= 3/treatment, t4 = 0.60, p = 0.58) and there was no difference in proliferation as measured by 
Ki67 (Fig 3.6C, unpaired t-test, t4 = -0.61, p = 0.58).  Sholl analysis was performed to measure 
dendritic complexity. This analysis revealed that 2-week-old abGCs (BrdU+/DCX+) in ihM4Di 
mice had decreased dendritic complexity compared to CTRL mice (Fig 3.6D-E, n = 3 ihM4Di, 2 
CTRL, 5-10 cells/mouse, Mann-Whitney U-test, radius 100um: U = 93.000, p = 0.0325) 
demonstrating that chronic CNO treatment in ihM4Di mice impairs maturation of abGCs. 




Figure 3.6 Chronic activation of abGCs.  A. Experimental design.  Two weeks of chronic 
CNO treatment had no effect on B. cell survival as measured by BrdU or C. proliferation as 
measured by Ki67. D. Sholl analysis revealed a decrease in dendritic complexity in ihM4Di 
mice.  E. Representative tracings of two-week-old GCs. * p < 0.05 
 
 
Chronic activation of hM4Di in DG GCs 
 The ability of CNO to chronically inhibit hM4Di receptors was next applied to 
POMC/hM4Di mice.  A recent report has shown that 5-HT1ARs in DG GCs are required for the 
behavioral effects of FLX seen not just in the NSF test but also the EPM and FST (Samuels et al, 
2015).  So far this thesis has focused on the role young neurons play in AD action, but this robust 
effect that was seen in multiple behavioral tests highlights the importance of the mature GC 
population in AD response.  Additionally, the involvement of 5-HT1ARs in AD action suggests 
that Gi/o-coupled GPCR cascade in the DG is critically involved in mediating AD response.  The 
experiments here will test whether activating this cascade using the hM4Di receptor is sufficient 
to produce an AD response.  
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 POMC/hM4Di mice and their littermate controls represent a mixed strain of mice that 
were derived from C57BL/6J, 129S4/SvJaeSor, and FVB backgrounds (McHugh et al, 2007; 
Ray et al, 2011).  Different strains of mice exhibit different sensitivities to chronic AD treatment 
(Dulawa et al, 2004); therefore, before preceding with chronic CNO treatment it was important 
to determine the conditions under which an AD response can be observed in this strain of mice 
using an already established AD drug (FLX).  Results from pilot experiments are summarized in 
Table 1.  Under conditions where no exogenous stress was applied and FLX was administered 
via drinking water, mice only displayed an increase in exploratory behavior and percent center 
distance traveled in the OFT, but no alteration in measures of anxiety was observed in the EPM 
and no AD-like response was seen in the FST or NSF test.  When the stress associated with oral 
gavage was added to the experimental conditions (Dalm et al, 2008), mice treated with FLX 
displayed trends for decreased anxiety in the EPM (but not OFT) and increased AD response in 
the FST.  However, mice were still unresponsive in the NSF test, a behavioral assay of chronic 
FLX treatment. Mice displayed a relatively non-anxious phenotype in both treatment groups in 
this test implying greater anxiogenic conditions were needed to increase this strain’s sensitivity 
to AD treatment.  To achieve this, a new cohort of mice were tested, which received chronic 
corticosterone treatment throughout the duration of the experiment, beginning 4 weeks prior to 
the start of AD treatment.  The initial dose of CORT given (35ug/mL) was still unable to bring 
control mice to the ceiling of the NSF test so a higher dosage was then tried.  Under these 




Table 3.1  The POMC/hM4Di mouse strain requires exposure to a high level of stress to see 
behavioral effects of FLX.  Pilot studies assessing the anxiolytic and antidepressant-like 
response to FLX under various levels of stress in the POMC/hM4Di line of mice. These results 




 5-HT1A autoreceptors present on serotonergic neurons in the raphe control serotonergic 
tone through feedback inhibition.   It has been hypothesized that this feedback inhibition may 
underlie the delay of therapeutic action of SSRIs (Gardier et al, 1996).  Modulating DG GCs via 
hM4Di receptors bypasses the increased feedback inhibition associated with the initial exposure 
to an SSRI. It was hypothesized that if Gi/o-coupled GPCR signaling were sufficient to induce an 
AD response in mice, the time frame for such a response may occur earlier than seen with 
traditional SSRI treatment.  Therefore, two groups of mice were tested: one received a sub-
chronic (~7 day) treatment of CNO, and the other received a chronic (~26) day treatment.  
Results from these experiments are presented below. 
Mice were tested in a number of assays to measure anxiety- and AD-related behavior 
following 7 days of sub-chronic CNO treatment (Fig 3.7A).  In the OFT, measures of exploration 
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were conflicting as habituation and overall distance traveled did not differ between groups (Fig 
3.7B, n = 5/genotype, repeated-measures ANOVA, genotype × time interaction: F(11,88) = 0.788, 
p = 0.6516; unpaired t-test, t8 = 1.084, p = 0.3102 (inset)), but the number of rearing events was 
significantly reduced in POMC/hM4Di mice (Fig 3.7C, unpaired t-test, t8 = 2.474, p = 0.0385). 
Center measures were analyzed to assess anxiety.  POMC/hM4Di mice consistently displayed a 
trend for anxiogenic behavior relative to CTRL mice traveling less distance in the center, 
spending less time in the center, and entering the center area less than controls (Fig 3.7D-F, % 
center distance: unpaired t-test, t8 = 1.488, p = 0.1750; center time: unpaired t-test, t8 = 1.253, p = 
0.2455; center entries: unpaired t-test, t8 = 1.410, p = 0.1963).  However, no significant 
difference was observed in time spent in the open or closed arms of the EPM with both groups 
showing a preference for the closed arms (Fig 3.7G, closed arm time: unpaired t-test, t8 = 0.087, 
p = 0.9326; open arm time: unpaired t-test, t8 = -0.376, p = 0.7169).  Sub-chronic CNO treatment 
did not lower the latency to feed in the NSF test (Fig 3.7H, Kaplan-Meier Survival analysis, log-
rank tests could not be computed because the POMC/hM4D group did not contain any 
uncensored observations; unpaired t-test, t8 = -1.000, p = 0.3466 (inset)), nor did it lower 
immobility in the TST (Fig 3.7I, repeated-measures ANOVA, genotype × time interaction: F(5,40) 
= 1.237, p = 0.3098; unpaired t-test, t8 = 0.500, p = 0.6304 (inset)).  Overall, results showed a 
potential anxiogenic effect in the OFT but not the EPM.  Since no AD-like response was seen in 
the NSF test or TST, a new cohort of mice was chronically treated with CNO for 4 weeks to see 
if additional time was needed for a behavioral effect to manifest in these tests (Fig 3.8A).   
	  120	  
 
Figure 3.7  Measures of anxiety and antidepressant-like response following subchronic 
activation of hM4Di in mature GCs.  A. Experimental timeline. B. OFT with distance traveled 
measured in 5 min increments (inset, total distance traveled).  Total distance traveled did not 
differ between groups. C. POMC/hM4Di mice displayed less rearing events than control mice. 
D-F. Center measures revealed a trend for increased anxiety in POMC/hM4Di mice. G. 
However, no significant difference between groups was observed in time spent in the open or 
closed arms of the EPM. H-I. Subchronic CNO treatment did not lower the latency to feed in the 
NSF test, nor did it lower immobility in the TST. * p < 0.05 
 
Measures of exploratory behavior in the OFT were not effected by either chronic (4 
week) CNO or FLX treatment as total distance traveled and rearing events were similar in all 
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groups (Fig 3.8B-C, n = 15 CTRL, 17 POMC/hM4Di, 4 FLX, total distance: ANOVA, F(2,33) = 
0.908, p = 0.4133; rearing: ANOVA, F(2,33) = 1.322, p = 0.2803).  The trend for increased anxiety 
in POMC/hM4Di initially seen after sub-chronic CNO treatment was found to be significant 
when measured at this time point.  Interestingly, this effect was replicated and appears even more 
robust in mice treated with chronic FLX (Fig 3.8D-F, % center distance: ANOVA, F(2,33) = 
6.412, p = 0.0044; Fisher’s PLSD, CTRL vs POMC/hM4D, p = 0.0095, CTRL vs FLX, p = 
0.0042; center time: ANOVA, F(2,33) = 5.856, p = 0.0067; Fisher’s PLSD, CTRL vs 
POMC/hM4D, p = 0.0069, CTRL vs FLX, p = 0.0107; center entries: ANOVA, F(2,33) = 3.785, p 
= 0.0331; Fisher’s PLSD, CTRL vs FLX, p = 0.0189).    Once again, the anxiogenic effect was 
unique to the OFT as no significant difference in time spent in the open or closed arms of the 
EPM was observed between groups (Fig 3.8G-H, n = 15 CTRL, 16 POMC/hM4Di, 4 FLX, open 
arm time: ANOVA, F(2,32) = 0.090, p = 0.9145; closed arm time: ANOVA, F(2,32) = 0.302, p = 
0.7412).   
Mice were also assessed for AD-like behavior in the TST and NSF test.  FLX treatment 
significantly reduced immobility in the TST (Fig 3.9B-C, repeated-measures ANOVA, 
treatment: F(2,33) = 4.171, p = 0.0243, treatment × time interaction: F(10,165) = 2.599, p = 0.0059; 
ANOVA, last 4 minutes, F(2,33) = 6.193, p = 0.0052; Fisher’s PLSD, CTRL vs FLX, p = 0.0023, 
POMC/hM4D vs FLX, p = 0.0019), but chronic hM4Di activation did not alter behavior.  A 
similar effect was seen in the NSF with FLX significantly reducing latency to feed in the novel 
arena following overnight food deprivation, while chronic hM4Di activation did not effect 
latency (Fig. 3.9D, n = 12 CTRL, 13 POMC/hM4Di, 4 FLX; CTRL vs FLX: Kaplan- Meier 
Survival analysis, Mantel-Cox log-rank test, p <  0.0001; CTRL vs hM4Di: Kaplan- Meier 
Survival analysis, Mantel-Cox log-rank test, p=0.1594; ANOVA, F(2, 26) = 44.351, p < 0.0001; 
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Fisher’s PLSD, CTRL vs FLX, p < 0.0001, POMC/hM4D vs FLX, p < 0.0001). Results in this 
test are not ideal, as it appears the overall drive for food may have been greater in FLX-treated 
mice demonstrated by both a lower latency to feed in the home cage and greater home cage food 
consumption (Fig 3.9E, % weight loss: ANOVA, F(2,26) = 3.184, p = 0.0580; Fisher’s PLSD, 
POMC/hM4Di vs FLX, p = 0.0208; latency home cage: ANOVA, F(2,26) = 5.827, p = 0.0081; 
Fisher’s PLSD, CTRL vs FLX, p = 0.0030, POMC/hM4Di vs FLX, p = 0.0044; home cage food 
consumption: ANOVA, F(2,26) = 15.560, p < 0.0001; Fisher’s PLSD, CTRL vs FLX, p < 0.0001, 
POMC/hM4Di vs FLX, p < 0.0001).  However, CTRL and POMC/hM4Di mice still ate in their 
home cage and ate much faster there than in the novel arena suggesting that these mice were 




Figure 3.8  Measures of anxiety-related behavior following chronic activation of hM4Di in 
mature GCs.  A. Experimental timeline. B-C. Total distance traveled and rearing events in the 
OFT did not significantly differ between groups. D-E. Both POMC/hM4Di mice and FLX-
treated mice displayed a decrease in % center distance traveled and time spent in the center 
compared to controls.  F. While POMC/hM4Di mice showed a trend for decreased center entries, 
this measure was only significant in FLX-treated mice.  G-H. No significant difference between 
groups was observed in time spent in the open or closed arms of the EPM. * p < 0.05, ** p < 




Figure 3.9  Measures of antidepressant-related behavior following chronic activation of 
hM4Di in mature GCs.  A. Experimental timeline. B-C. Chronic hM4Di activation did not 
lower immobility in the TST, but chronic FLX treatment did.  D. No difference in latency to feed 
was observed between CTRL mice and POMC/hM4Di mice, while FLX treatment significantly 
lowered this measure (inset: average latency novel arena).  E.  Measures of % weight loss, 
latency to feed in the home cage, and home cage consumption show no difference in levels of 
hunger between CTRL and POMC/hM4Di mice.  Measures in FLX-treated mice were 
conflicting with these mice eating significantly more in their home cage than either CTRL or 
POMC/hM4Di mice.   A decreased latency to feed in the home cage was also evident.  Yet, 
FLX-treated mice appeared to lose less weight during food deprivation than POMC/hM4Di 
mice. * p < 0.05, ** p < 0.01, *** p < 0.001, # p < 0.0001, versus CTRL unless otherwise noted. 
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Conclusions 
The experiments presented in this chapter aimed to assess the utility of using DREADD 
receptors to modulate neuronal activity in young abGCs as well as mature GCs.  Cellular and 
behavioral readouts confirm that hM4Di DREADDs can be used to modulate activity of 
hippocampal GCs in a temporally restricted manner, allowing for both acute and chronic 
manipulations of hippocampal GCs.  DREADD technology has been used in many cases as a 
means of turning neurons on or off.  This was the desired outcome of activating DREADDs in 
the first two sets of experiments outlined in this chapter.  Additionally, since DREADDs achieve 
their control of neuronal activity via activation of GPCR downstream signaling pathways, they 
can potentially be used as surrogates for investigating endogenous GPCR activity.  It has 
recently been shown that 5-HT1ARs in the DG are critically involved in mediating the 
behavioral response to the SSRI, FLX.  With this in mind, it was hypothesized that chronic 
activation of Gi/o-coupled GPCR signaling in DG GCs via the hM4Di DREADD could 
potentially mimic 5-HT1AR activation and confer an AD-like response in mice.  Initial studies 
suggest activating this signaling pathway is not sufficient for this purpose; however, it is 
cautioned that considerably more characterization is required before parallels between 
endogenous GPCR activity and DREADD activity can be made.  
Previous work that used optogentic techniques to control GC activity in either the dorsal 
or ventral DG found that acute inhibition of the dorsal DG impairs encoding of contextual fear 
memory (Kheirbek et al, 2013).  Given the established outcome in the CFC paradigm, this test 
was used to determine if CNO treatment could induce behaviorally relevant levels of inhibition 
in POMC/hM4Di mice. Results indicate that CNO treatment on the day of training impairs 
learning in this task, as evident by decreased freezing levels in POMC/hM4Di mice on the first 
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testing day (Fig 3.4B).  This data alone cannot distinguish between impairments in encoding or 
consolidation since the long activation period associated with DREADDs means both the 
encoding and consolidation phase of memory processing was affected by this manipulation. 
However, considering the results from optogentic inhibition, it is likely that the deficits seen in 
this test are due to disrupted encoding in the POMC/hM4Di mice. Anxiety-like behavior was 
also assessed following acute CNO treatment and no significant alterations were seen, which is 
also consistent with the behavior observed during optogentic inhibition of the DG (Fig 3.3) 
(Kheirbek et al, 2013).   
 The ability of CNO to chronically activate hM4Di receptors was confirmed in mice 
where expression of hM4Di was limited to young abGCs.   Dendritic development is a dynamic 
process that is regulated by neuronal activity (Chen and Ghosh, 2005).  Therefore, it was 
hypothesized that if hM4Di receptors are able to chronically inhibit abGCs, a decrease in these 
neurons’ dendritic complexity would be seen, and that was exactly the case.  While dendritic 
development was impaired, no effect on proliferation or survival was seen.  This recapitulates the 
results found in Chapter 2, Section 1 where the only measure of neurogenesis that was impacted 
by NR2B deletion was dendritic complexity.  Interestingly, the impairment of dendritic 
development appears earlier when using DREADDs to enhance inhibition.  Sholl analysis of 
abGCs lacking NR2B was performed at two time points targeting either 3-week-old cells (Fig 
2.3.8) or more mature neurons in mice six weeks following the deletion of NR2B (Fig 2.1.4H-I) 
No significant differences were detected between 3-week-old abGCs lacking NR2B and controls, 
while differences in dendritic complexity were already noticeable in 2-week-old abGCs 
chronically inhibited with CNO.  Calcium signaling plays an important role in mediating 
activity-dependent dendritic development (Chen et al, 2005).  Depolarizing cells can induce 
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calcium influx via NMDARs as well as voltage-gated calcium channels (VGCCs).  Deletion of 
the NR2B subunit would reduce calcium influx via NMDARs, but this wouldn’t directly 
interfere with calcium influx from VGCCs.  It also would not interfere with dendritic 
development at time points prior to the onset of glutamate signaling in abGCs, which doesn’t 
begin until ~2-3 weeks after birth (Esposito et al, 2005; Ge et al, 2006).  However, cell 
hyperpolarization induced by hM4Di receptors could impact calcium signaling more broadly by 
reducing the activity of both VGCCs and NMDARs, thereby causing a deficit in dendritic 
development earlier (Schmidt-Hieber et al, 2004).  A critical control that should be performed to 
more definitively confirm that CNO is chronically activating hM4Di in this situation is to show 
that a single injection of CNO administered at varying points in this 2-week time frame is not 
sufficient to alter dendritic complexity.     
 Having confirmed the effectiveness of CNO to chronically activate hM4Di receptors, 
studies were undertaken to determine if chronic activation of Gi/o-coupled GPCR signaling 
pathways in mature DG GCs is sufficient to induce an AD-like response in mice.  Chronic CNO 
treatment in POMC/hM4Di mice recapitulated the effect of FLX to decrease center measures in 
the OFT, but had no other effect on measures of mood.  This anxiogenic effect of FLX was 
unexpected and initially surprising. However, it may reflect a known side effect of AD treatment. 
Increased anxiety that first presents during the initial stage of AD therapy is commonly reported, 
though it has been poorly characterized (Sinclair et al, 2009).  A review by Sinclair et al (2009) 
assessed the literature on this AD treatment side effect.  They found that incidence rates vary 
greatly, ranging from 4-65% of patients.  While evidence supports the early onset of this side 
effect, its duration is not clear.  In some cases it has been reported to be short-lived—alleviating 
in days—though in other cases it seems to last for months.  These conflicting results likely stem 
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from a number of factors including varying medications prescribed, varying definitions and/or 
assessments of anxiety, varying underlying mood disorders, and the reliance on retrospective 
analysis.  Consistent with the early onset of this side effect, a trend for increased anxiety was 
seen in the small cohort used to assess subchronic CNO treatment.  It has previously been noted 
that FLX’s effect on open field behavior is variable by mouse strain.  BALB/c mice treated 
chronically with FLX did not display altered locomotor activity in the OFT, C57BL/6 
and129SvEv mice showed decreased activity, and DBA/2 mice were more active (Dulawa et al, 
2004).  While no effects on center measures that couldn’t be explained by altered locomotor 
activity were found, this data serves to highlight the influence genetic factors have on treatment 
response to ADs.  Based on this OFT data, the mixed strain used in this study appears to be 
susceptible to increased anxiety following the onset of AD treatment.   
In contrast to these results, increased anxiety was not detected in the EPM.  It should be 
noted that the EPM test was conducted under significantly higher lux (OFT: ~20 lux vs EPM: 
ambient room light) potentially making this test more anxiogenic than the OFT, thereby 
producing a ceiling effect.  However, in an assessment of behavior in rats in the EPM, 
illumination did not critically affect preference for the closed arm (Pellow et al, 1985).  These 
conflicting results suggest additional testing is required to establish the anxiety state in these 
mice.  In both the NSF test and TST, chronic hM4Di activation did not mirror the effect of FLX, 
which significantly decreased the latency to feed in the novel arena and decreased immobility.  
Unfortunately, the results in the NSF test may be confounded by the increased drive for food 
observed in FLX-treated mice.   
The EPM, NSF, and TST assays were chosen to evaluate chronic AD response as it had 
been previously shown that 5-HT1AR activity in the DG mediates the AD behavioral response in 
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these or similar tests (Samuels et al, 2015).  In addition, mice that only display 5-HT1ARs in the 
DG are responsive to FLX, indicating no other population of 5-HT1ARs are necessary for FLX 
responsiveness in these tests. However, additional tests that evaluate other aspects of depression 
symptomology such as helplessness, anhedonia, sociability, and cognitive impairments should be 
considered (Cryan and Holmes, 2005a; Krishnan et al, 2008), but not before more complete 
characterization comparing hM4Di’s expression and activity profile to 5-HT1A in the DG is 
performed (Urban et al, 2015).  While it has been shown that mutant hM3Di signaling is 
comparable to WT hM3 signaling, differences between the hM4Di and 5-HT1A may exist.  
Additionally, the dosage of CNO required to achieve activity comparable to that of 5-HT1ARs in 
mice treated with FLX has not been established and titration experiments should be performed.  
It is also important to confirm that the level of hM4Di expression is similar to 5-HT1AR 
expression.  Since hM4Di expression is driven by a different promoter than 5-HT1ARs, hM4Di 
receptor levels may not accurately reflect 5-HT1AR levels.   
 DREADDs allow for physiologically relevant, non-invasive, reversible modulation of 
neuronal populations using the biologically inert compound CNO.  They represent a tool that is 
ideally suited for investigating the mechanism of action of therapeutics such as ADs whose 
efficacy requires long-term modulation of neuronal circuits, and they may ultimately enhance 
our ability to investigate and treat psychiatric conditions.  Beyond just using this as a means to 
understand the action of current drugs, these receptors have the potential to be used as 
therapeutics themselves.  In a recent study, Dell'Anno et al (2014) showed that transplantation of 
hM3Dq-expressing, induced dopaminergic neurons into Parkinsonian rats could ameliorate 
motor impairments when rats were treated with CNO.  This translational significance highlights 






Adult hippocampal neurogenesis—a unique form of plasticity in the DG—is regulated by 
experience, and when manipulated can have specific effects on behavior.  Different methods 
have been used over the years to study new neurons’ functional role in the HPC, many of which 
focus on ablating neurogenesis.  While ablation methods can test the necessity of abGCs for 
behavior, these techniques remove all abGCs from the circuit and thus do not allow one to 
determine which properties of abGCs are required for behavior.  Such information is required to 
understand the mechanism of their action. Thus, new strategies are needed to determine what 
properties of young abGCs allow them to distinguish themselves from their mature counterparts 
and uniquely impact behavior.   
Recent hypotheses have suggested that the enhanced synaptic plasticity exhibited by 4–6-
week-old abGCs allows them to uniquely contribute to hippocampal circuit function, and thus 
behavior. The primary goal of this thesis was to explore the contribution young abGCs’ 
heightened synaptic plasticity makes to hippocampal function.  This was achieved using a 
transgenic mouse approach that allowed for the conditional deletion of NR2B from abGCs.  
Overall, iNR2BNes mice generated the same number of new neurons in adulthood as control mice 
at baseline.  These neurons survived and matured with only a slight reduction in dendritic 
complexity.  However, a potentially important electrophysiological property of these neurons—
their enhanced synaptic plasticity—had been eliminated.   From an electrophysiological 
standpoint, iNR2BNes mice resemble mice with ablated neurogenesis, while from all other 
neurogenic standpoints examined they most closely resemble WT mice.  Consequently, these 
mice provided a novel model to test the extent to which young abGCs’ enhanced plasticity 
contributes to hippocampal-dependent behaviors. The results reveal that eliminating NR2B-
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containing NMDARs from abGCs does not alter baseline anxiety or AD-like behavior.  
However, iNR2BNes mice differed from controls in measures of cognitive function.  These mice 
were able to learn in the CFC test, but were impaired in the more difficult CFD test.  Mice also 
exhibited a decreased novelty exploration phenotype that impaired their performance in the NOR 
test.  Together, these results indicate that the NR2B-dependent heightened plasticity exhibited by 
4–6-week-old abGCs is necessary for responses to novelty and fine contextual discrimination, 
but does not contribute to baseline emotionality.  
AD treatment increases levels of adult neurogenesis in the HPC, and these newborn 
neurons have been shown to be necessary for some of the behavioral effects of ADs seen in 
rodents.  In addition, the maturation timeline of adult neurogenesis correlates with the onset of 
behavioral responses to ADs.  ADs also enhance a neurogenesis-dependent form of LTP in the 
DG evoked by medial perforant path stimulation under intact GABAergic tone called ACSF-
LTP.  Thus, a potential mechanism by which abGCs may contribute to AD behavioral efficacy is 
by providing extra plastic units to the DG circuit.  This theory was tested by once again using the 
mouse line in which NR2B can be conditionally deleted from abGCs in the DG.  Here, we found 
that deletion of the NR2B subunit significantly attenuated a neurogenesis-dependent behavioral 
response to FLX in the NSF test, and additionally blocked FLX’s ability to enhance young 
abGCs’ maturation and subsequent integration into the hippocampal network.  This suggests that 
eliminating abGCs’ enhanced plasticity decreases their ability to influence DG output resulting 
in an AD response that is less robust than seen in CTRL mice.  Control experiments revealed the 
specificity of this effect, as NR2B deletion did not impact the effect of FLX in a neurogenesis-
independent behavioral assay (TST) or in an assay that was insensitive to FLX in this strain of 
mice (EPM).    
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Our efforts to isolate the contribution of abGCs’ unique physiology from the neurogenic 
effects of FLX were not entirely successful as the results presented here also revealed slight 
group differences in neurogenesis between control mice and mice lacking NR2B in young 
neurons.  Yet, this data still supports the idea that FLX increases the ability of abGCs to 
participate in DG circuit activity by increasing the chance that new neurons will be activated 
during DG stimulation.  This may be accomplished in a number of ways, such as increasing their 
overall number, increasing their potential to make synaptic connections, or increasing their 
ability to strengthen their connections. However, due to the close link between activity and 
maturation that appears to be enhanced with FLX treatment, a different approach with greater 
temporal resolution is needed to separate neurogenic effects of FLX from the physiological 
contribution abGCs make to hippocampal output.  With this in mind, a mouse line in which 
abGCs could be temporally inhibited was also generated.  Cellular and behavioral 
characterization of mice conditionally expressing hM4Di—a mutated muscarinic acetylcholine 
receptor that is insensitive to endogenous acetylcholine, but can be activated by the biologically 
inert, highly bioavailable compound, clozapine N-oxide (CNO)—has begun.  Results show that 
acute CNO treatment in mice expressing hM4Di in DG GCs can impair encoding of contextual 
fear memory.  Chronically treating these mice had an anxiogenic effect in the OFT, but 
otherwise affective behavior in these mice were comparable to controls.  Chronic CNO treatment 
in mice expressing hM4Di in young abGCs effectively decreased these cells’ dendritic 
complexity, but did not alter proliferation or early survival. Thus, hM4Di DREADDs represent a 
novel tool that can be used to modulate activity of neurons in a temporally restricted manner, 
allowing for both acute and chronic manipulations of hippocampal GCs.   
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Dorsoventral Gradients in Adult Neurogenesis  
Recent studies targeting DG GCs have supported a functional heterogeneity within this 
hippocampal subfield, which may help to explain the DG’s ability to regulate both mood and 
cognition.  In an optogenetic study, it was found that the dorsal DG (dDG) controls exploratory 
drive and encoding of contextual fear memories while the ventral DG (vDG) regulates innate 
anxiety (Kheirbek et al, 2012a).  There is also support for anatomical heterogeneity in the DG as 
well.  Studies have shown projections from the EC innervate the DG in a topographic manner 
(Moser et al, 1998) and increased basal network activity in the dDG as measured by immediate 
early gene induction (Piatti et al, 2011). Neuromodulatory influence on the HPC may differ as 
well, as serotonergic input is enriched in the vDG with a concomitant increase in 5-HT1AR 
mRNA levels (Gage and Thompson, 1980; Tanaka et al, 2012).  This suggests that the dorsal and 
ventral DG may represent distinct neurogenic environments (Piatti et al, 2011).  Therefore, the 
subpopulations that make up the pool of newborn neurons in each region may also be distinct 
and differentially effected by environmental and chemical interventions (Kheirbek and Hen, 
2011).  
Under baseline conditions, the dDG has a higher density of immature neurons and a 
faster maturation rate (Jinno, 2011b; Snyder et al, 2009; Snyder et al, 2011). Neurogenesis is 
also known to decline with age, but this reduction occurs more quickly in the vDG (Jinno, 
2011a). In addition to these baseline differences, stress and ADs have a more prominent 
influence on neurogenesis in the vHPC.  Stressed mice exhibit decreased cell proliferation and 
neurogenesis in the ventral portion of the DG, which is reversed by chronic AD treatment 
(Jayatissa et al, 2006; Tanti et al, 2012). In major depressive disorder patients, SSRIs and 
tricyclic AD-induced increases in neuronal precursor cells and dividing cells are localized to the 
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anterior HPC (the human equivalent of the vHPC in rodents) (Boldrini et al, 2009).  On the other 
hand, environmental enrichment promotes proliferation throughout the whole DG, but increases 
in neurogenesis are only seen dorsally (Tanti et al, 2012). Recently, Wu et al (2014) directly 
tested this theory of differential abGC function by using focal irradiation to specifically ablate 
neurogenesis in either the dorsal or ventral DG and confirmed a functional dissociation between 
abGCs along the DV axis . Specifically, only dorsal abGCs are required for CFD, while ventral 
abGCs are necessary for the anxiolytic/AD effects of FLX. 
 
How do abGCs modify hippocampal output? 
Variation in anatomical connectivity along the DV axis continues throughout the HPC 
further supporting the functional segregation that is seen along this axis. In the classic tri-
synaptic circuit, the EC sends information from association cortices via the perforant path to the 
DG. DG GCs then send excitatory mossy fiber projections to CA3 pyramidal neurons, which 
project to CA1 via the Schaffer collaterals, and CA1 sends projections to the subiculum. Of these 
subfields, CA3, CA1, and subiculum can send projections outside of the HPC. It is these 
projections out of the HPC that may have differing effects on behavior, as dorsal hippocampal 
targets are primarily involved in spatial memory tasks and context-reward associations 
(Cenquizca et al, 2007; Luo et al, 2011), while ventral hippocampal targets impact emotional 
expression (Fig 1.4).  Thus, to understand how abGCs mediate the behaviors they do, it is crucial 





abGCs as independent encoding units 
One possibility is that these neurons are independent encoding units that excite 
downstream CA3 neurons with which they make functional synapses as early as 2 weeks of age 
(Gu et al, 2012).  Memory refers to the storage and recall of information learned during 
experiences.  A memory trace or engram refers to the ensemble of neurons that physically 
represent a memory (Josselyn, 2010; Tonegawa et al, 2015).  These neurons are activated during 
learning, thus establishing the population that makes up an engram (encoding). Persistant 
changes in connectivity via synaptic plasticity mechanisms lead to the retention of this memory 
engram (consolidation), which can later be reactivated to recall or recognize facts and events in 
the case of declarative memory or perform skills in the case of procedural memory (retrieval) 
(Tonegawa et al, 2015). While long-term declarative memory is thought to reside outside of the 
HPC, initial encoding and storage depends on this structure (Frankland and Bontempi, 2005).  In 
support of a memory engram in the DG, inactivating only GCs that were previously active during 
fear learning impairs expression of that fear memory (Denny et al, 2014) while their activation 
can elicit fear behavior in a neutral environment (Liu et al, 2012). Immediate early gene 
expression studies have demonstrated that the subset of GCs that are activated during learning 
paradigms are composed of both mature GCs (developmentally- and adult-born) and immature 
GCs (Deng et al, 2013; Jessberger and Kempermann, 2003; Kee et al, 2007; Stone et al, 2011; 
Tronel et al, 2015).  Surprisingly though, only a small percentage of cells active during encoding 
in either the DG or CA3 are reactivated during recall suggesting either that memory traces may 
not be composed of every cell active during an experience or, alternatively, that the system used 
lacks temporal resolution (Denny et al, 2014); therefore, immediate early gene studies alone can 
not allow one to draw definitive conclusions about abGCs involvement in encoding. Yet, during 
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a critical period when abGCs are approximately 4–6-weeks-old, these neurons may be 
particularly specialized to encode memories as they display enhanced LTP both postsynaptically 
at their perforant path inputs and presynaptically at their mossy fiber connection to CA3 (Ge et 
al, 2007; Gu et al, 2012).  Support for this population of young abGCs being recruited to form 
memory traces comes from studies that show they are required for learning a CFC task (Denny et 
al, 2012) while retrieval of a contextual memory can be impaired by silencing them (Gu et al, 
2012).  Activity in young abGCs even appears to be sufficient to encode contextual memory, as 
mice in which the output of mature GCs was inhibited while immature abGC output was left 
intact exhibited enhanced performance in a CFD task and performed as well as controls in a 
spatial delayed nonmatching-to-place task, although it is not clear whether 100% of mature cells 
were silenced in this experiment (Nakashiba et al, 2012).  While mature GCs may not be 
necessary in discrimination tasks, these mice were impaired in pattern completion-mediated 
contextual and spatial recall tasks highlighting the balance that must occur between pattern 
completion and pattern separation in neural networks.   
 
abGCs as modulators of DG inhibitory tone 
Evidence has also accumulated suggesting abGCs may modulate the activity of the 
mature population of GCs. In vivo recordings in mice show that both irradiation and genetic 
ablation of neurogenesis increases the magnitude of gamma bursts in the DG and led to greater 
coordination of single unit activity with these gamma bursts (Lacefield et al, 2012).  Burghardt et 
al (2012) have shown that mice with ablated neurogenesis were impaired in a conflict condition 
of the active place avoidance task, and this impairment was associated with increased immediate 
early gene expression in the dorsal DG, also suggesting abGCs can modulate overall DG 
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network activity. Furthermore, using voltage-sensitive dye imaging, it was found that mice with 
increased neurogenesis exhibited a decrease in the activation of the GCL.  The opposite was seen 
after suppression of adult hippocampal neurogenesis (Ikrar et al, 2013). The mechanism for this 
modulation of inhibition remains unknown, but an attractive candidate would be via modulation 
of local interneurons that may feedback on to the mature population, in turn altering output to 
hypothalamic or amygdalar nuclei to directly impact emotional behavior or to cortical and lateral 
septal areas thereby influencing cognitive function. Temprana et al (2015) have recently reported 
that 4-week-old neurons only exert a modest influence on inhibitory tone in the DG; however, 
Drew et al (2015) have shown that by 6–7 weeks of age, abGCs exert a strong inhibitory 
influence on mature GCs.  Future studies testing the connection between adult hippocampal 
neurogenesis and HPC output will be crucial for understanding how the HPC is involved in 
mood regulation and cognition.   
 
How do abGCs mediate pattern separation in the DG? 
In light of this data, several theories to explain abGCs role in pattern separation have 
been proposed that either highlight abGCs’ function as encoder such as the one put forward by 
Aimone and collegues that suggests young abGCs enhance the resolution of memories with 
pattern separation resulting as a byproduct of this enhanced resolution (Aimone et al, 2011) or 
highlight abGCs’ role as a modulator of mature GCs, thus influencing the mature GCs’ firing 
probability and firing rate through feedback inhibition and enhancing a key feature of the DG 
that computationally supports its ability to pattern separate—its sparse coding scheme (Sahay et 
al, 2011b).  However, let us consider a more inclusive theory that draws on both of these aspects 
of abGC function (McAvoy et al, 2015). McAvoy et al (2015) propose that abGCs enhance 
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pattern separation by providing a unique population of encoding units that become specifically 
tuned to a particular experience such that subsequent exposures induce highly input-specific 
reactivation while at the same time they enhance the sparseness in the DG through feedback 
inhibition (Fig 4.1). Because young abGCs are more excitable than mature GCs and subject to 
less inhibition (Marin-Burgin et al, 2012; Schmidt-Hieber et al, 2004) their input specificity is 
much lower than mature GCs and as such may be particularly well suited to encode novel 
information.  As these abGCs mature, their input specificity can increase as synaptic inputs 
become more refined during their period of enhanced synaptic plasticity (McAvoy et al, 2015; 
Piatti et al, 2013).  In this scenario, the process of neurogenesis would contribute to the 
formation of a mature GC population that is sharply tuned to respond to distinct environmental 
features that were experienced during their maturation stage. With more neurogenesis, more 
environmental features can be spread out over a larger number of neurons decreasing overlap and 
further increasing input specificity.  This theory suggests mature GC are preferentially involved 
in encoding familiar information while immature GCs help to encode novel information.  In line 
with this theory of experience-specific tuning, studies have shown that young abGCs present 
during water maze training are preferentially activated when re-exposed to the water maze (Kee 
et al, 2007). While young GCs may allow for more information to be encoded, this 
promiscuously active population of cells (relative to mature GCs) would not be consistent with 
the classical pattern separation theory which proposes that orthoganilization of information 
involves the recruitment of distinct populations of cells. Interestingly, broadly tuned GCs are 
consistent with the lack of global remapping detected in studies done by Leutgeb et al (2007) and 
Alme et al (2010), which showed the same population of GCs responded to both small and large 
differences in environment with different rates of activity, suggesting the cells being recorded 
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from in those studies may have been young abGCs.  This has led to a theory that old neurons 
may retire from a network (Alme et al, 2010); however, in vivo recording only allows for 
sampling of a very small subset of the GC population. Furthermore, these experiments were 
conducted in animals simply exploring an environment with no incentive for learning the context 
or behavioral readout to prove any sort of discrimination learning had occurred.  Other 
approaches that have examined the DG on a population level have found different environments 
or tasks activating distinct populations of neurons, while repeated exposures to the same 
environment or task activated the same subset of GCs (Chawla et al, 2005; Deng et al, 2013; 
Denny et al, 2014; Satvat et al, 2011).  Studies are currently underway in the lab to compare the 
activity of young abGCs and mature GCs in vivo with calcium imaging.  Preliminary results 
indicate that both mature GCs and young abGCs display contextual selectivity, but that young 






Figure 4.1 An illustrative model depicting how levels of adult hippocampal neurogenesis 
contribute to and regulate population-based coding in the DG to minimize interference 
between engrams of two similar contexts. A. Context A and B contain unique, similar, and 
overlapping features.  B. Initial exposure to context A at time t1 when neurogenesis levels are 
high results in the activation of 4–6-week-old abGCs (blue circles), which recruits feedback 
inhibition promoting sparse activation of developmentally-born GCs that respond to the features 
of context A.  The engram for context A at time point t2 contains both the developmentally-born 
GCs that encode features of context A and abGCs that have refined their synaptic inputs during 
their period of enhanced synaptic plasticity to acquire high input sensitivity to context A.  C. 
Initial exposure to context B when neurogenesis levels are high results in the activation of abGCs 
and the reactivation of developmentally-born GCs that respond to the overlapping features 
between context A and B (* denotes reactivation).  These GCs recruit feedback inhibition 
promoting sparse activation of developmentally-born GCs that respond to the unique features of 
context B.  This sparse activity lowers that chances that GCs that have encoded the unique 
features of A (A1) that are similar to unique features in context B (B2) are re-activated for 
encoding of those context B features.  D.  With low levels of neurogenesis, exposure to context 
A at time t1 activates a smaller number of 4–6-week-old abGCs resulting in less feedback 
inhibition and a greater number of developmentally-born GCs responding to features of context 
A.  The engram for context A at time point t2 is made up of both developmentally-born GCs that 
encode features of context A and abGCs that display less input specificity as they have been 
subject to less competition for synaptic input.  Therefore, specificity for features for context A 
have been spread out over a few number of cells with the same cell responding to more than one 
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feature.  E.  Initial exposure to context B when neurogenesis is low results in the activation of 
abGCs and the re-activation of developmentally-born GCs that respond to the overlapping 
features between context A and B.  Additionally, because of reduced feedback inhibition during 
encoding of context A and now again during encoding of context B, the likelihood that 
developmentally-born GCs that have encoded features of context A (A1) that are similar to 
features of context B (B2) are reactived upon exposure to context B has increased.  As a result, 
the engram for context B has significantly more overlap with the engram for context A when 
compared to the engram overlap in a situation with high levels of neurogenesis. Diagram taken 
from McAvoy et al (2015). 
 
By increasing inhibitory tone in the DG, abGCs may contribute to this region’s sparse 
activity, which is a key feature of the DG that computationally supports its ability to pattern 
separate.  This sparse coding scheme helps decorrelate inputs since only a small fraction of all 
DG GCs is needed for encoding a memory.  Consequently, the chance that the same cell will be 
active in two small subsets of the overall GC population is low.  If these active subsets were 
larger as would be the case with lower levels of neurogenesis, then the chance for overlap would 
be greater.  Conversely, increasing neurogenesis could lead to even sparser coding, thereby 
further decreasing the likelihood of overlap.  Alternatively, if immature abGCs support pattern 
separation while mature GCs support pattern completion as proposed by Nakashiba et al (2012), 
then abGCs ability to impose even greater inhibition on mature GCs may help them promote 
pattern separation over pattern completion.   
Using this framework, how would NR2B deletion in abGCs impair pattern separation?  
Analysis of iNR2BNes mice’s abGCs show that while these cells still mature they exhibit 
decreased dendritic complexity, possibly reflecting impaired integration into the DG network 
(Fig 2.1.4). Since neurons from the EC synapse onto GCs’ dendrites, decreased dendritic 
complexity may equate to less input reaching a neuron and a smaller chance of being activated 
during a behavioral experience. In this way, NR2B deletion may act to inhibit the activity of the 
abGC population and be akin to scenarios where neurogenesis is lowered or ablated.  This is 
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consistent with the data presented in this thesis with NR2B deletion replicating the deficit in 
CFD that is seen following reduction of neurogenesis in the HPC (Fig 2.2.4) (Clelland et al, 
2009; Sahay et al, 2011a) and the reduced efficacy of ADs in a neurogenesis-dependent 
behavioral task (Fig 2.3.2 ) (David et al, 2009; Santarelli et al, 2003). 
Another consequence of this framework is that it suggests that while young abGCs are 
beneficial for learning novel tasks or environments their contribution to pattern separation would 
increase as they mature and gain higher input specificity (Kropff et al, 2015).  This maturation 
process which involves strengthening some input connections while decreasing others as GCs 
compete with one another over EC input would take time, which is a particularly interesting 
point to consider in the context of the CFD task used in this thesis to assess behavioral pattern 
separation, as the task takes several days to learn and consequently the abGC maturation that 
occurs during this time may underlie the delay it takes to learn the task.  Results presented here 
show that iNR2BNes mice are eventually able to successfully perform the pattern discrimination 
task, but only with an additional 4 days of training (Fig 2.2.4).  This may be because a less 
efficient abGC-independent approach has been adopted to learn the paradigm, or perhaps the 
delay in pattern separation reflects an overall delay in maturation processes in NR2B-deficit 
abGCs.  Indeed, analysis of iNR2BNes mice’s abGCs show these cells still mature, but perhaps 
their decreased dendritic complexity reflects a slower rate of dendritic maturation.  abGCs in 
iNR2BNes mice no longer display enhanced plasticity; therefore, the process of strengthening or 
weakening synapses which underlies the generation of abGCs with high input specificity will 
likely be impaired in these mice as well.  Because NR2B deletion doesn’t eliminate all NMDARs 
this refinement of synaptic input may eventually take place, but on a longer time scale thus 
slowing down their performance in a CFD task (Fig 2.2.4).   
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Additional theories of abGC function 
So far, young abGCs role in forming new, distinct memories has been assessed, but their 
role in memory maintenance has also been examined.  Computational models predict that the 
addition of new neurons to a network will degrade existing memories, facilitating their clearance 
from the network (Deisseroth et al, 2004; Meltzer et al, 2005; Weisz and Argibay, 2012).  At a 
cellular level, it does appear that new neurons modify the strength of established connections 
both directly and indirectly.  As new neurons mature, they compete with existing GCs for inputs 
and outputs and end up either sharing these connections with existing GCs or displacing mature 
GCs from their previously established connections (Toni et al, 2007; Yasuda et al, 2011).  This 
structural remodeling is even more pronounced following environmental enrichment (Bergami et 
al, 2015). The role of abGCs as modulators of inhibitory tone may also come into play here as 
the addition of abCGs will indirectly decrease the excitability of mature GCs.  Based on these 
observations, it has been proposed that abGCs regulate forgetting (Frankland et al, 2013).  It was 
predicted that if this were the case, then increasing neurogenesis after a memory had been 
established should accelerate the forgetting of that memory, while decreasing neurogenesis 
following memory encoding should reduce forgetting.  This theory has been tested and 
confirmed in mice that had neurogenesis either increased or decreased following CFC training 
(Akers et al, 2014; Feng et al, 2001).  If memories have already been transferred to the cortex, 
such clearance in the HPC may not result in memory loss.  A role for abGCs in this process of 
systems consolidation has also been proposed.  Kitamura et al (2009) have shown that 
associative fear memory remains hippocampal-dependent longer in mice whose neurogenesis 
was decreased prior to training.  Increasing neurogenesis shortened the hippocampal-dependency 
time without any overall loss of the memory. In line with this view, others have found that 
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abGCs are required for long-term spatial memory (Deng et al, 2009; Jessberger et al, 2009; 
Snyder et al, 2005).  Together, this suggests that abGCs are not only involved in memory 
clearance, but may also mediate the transfer of memories to the cortex for long-term memory 
storage.  
Another interesting hypothesis suggests abGCs may be particularly well suited to aid in 
encoding temporal information.  This theory also draws on young abGCs less discriminatory 
response to EC inputs.  For a short period of time, a subset of abGCs are going to be more 
excitable than the rest of the GC population and may be preferentially incorporated into 
memories generated during that period.  Temporally close events will activate distinct sets of 
mature GCs, but will recruit the same group of immature abGCs—essentially adding a 
component of similarity to memory representations formed close in time.  An appropriate 
behavioral paradigm is needed to further test this theory.   
	  
abCGs as mediators of AD efficacy 
The HPC is not just important for learning and memory, but also plays a role in 
regulating emotion (see Chapter 1).  Previous studies have found that some of the behavioral 
effects of ADs require the presence of intact neurogenesis (David et al, 2009; Santarelli et al, 
2003); however, the exact mechanism underlying this process is still not known.  Increasing 
neurogenesis will alter activity in the DG and the HPC as a whole, ultimately effecting 
downstream structures that are more directly related to emotional processing and have been 
implicated in depression such as the hypothalamus, amygdala, nucleus accumbens, and mPFC 
(Krishnan et al, 2008). As mentioned above, the effect of ADs is more pronounced on abGCs in 
the ventral portion of the DG suggesting these ventral output areas may be particularly affected 
by AD treatment. Consistent with this, it has been shown that mice subjected to unpredictable 
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chronic mild stress (a mouse model of depression) exhibit impaired hippocampal-dependent 
inhibition of the HPA axis (Surget et al, 2011).   FLX restores proper hippocampal negative-
feedback of the HPA axis, but its ability to do so is neurogenesis-dependent (Surget et al, 2011). 
This is particularly significant considering that for depressed patients exhibiting abnormal HPA 
axis activity, the restoration of proper activity within this axis parallels remission and reduces the 
risk of relapse (Appelhof et al, 2006; Holsboer-Trachsler et al, 1991; Ising et al, 2007; Kunugi et 
al, 2006). Whether the abGC-mediated effects of ADs depend on the DGs ability to pattern 
separate is uncertain, but it has been hypothesized by some that this may be the case (Becker and 
Wojtowicz, 2007; Sahay et al, 2011b). In particular, Becker et al (2007) suggest that abGCs are 
required for reestablishing context-appropriate behavioral and emotional responses to stimuli.  
On its own, a lack of neurogenesis is not able to induce depression.  Yet, in the framework of a 
depressed mind that is experiencing cortico-limbic network dysfuntion (Krishnan et al, 2008; 
Mayberg, 2003), neurogenesis is likely compromised and contributing to specific cognitive 
deficits observed in depressed patients.  In particular, depressed patients suffer from spatial and 
declarative memory deficits with episodic memories particularly impaired (Gould et al, 2007; 
Zakzanis et al, 1998), while those memories that are maintained tend to be less detailed and 
specific, reflecting excessive generalization and implicating a potential pattern separation deficit 
(Ganellen, 1988; MacQueen et al, 2003; Sheline et al, 1999).  Further evidence for this comes 
from a study by Shelton and Kirwan (2013) who found an inverse relationship between 
behavioral pattern separation performance and the severity of depression symptoms reported in a 
large group of young adults.  This is particularly problematic for depressed patients who are also 
suffering from a negative processing bias and negative mood state, as memory generalizations 
will favor negative representations of context further exacerbating the situation instead of 
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correcting it.  In this way, current ambiguous experiences, either positive or negative, will be 
aligned within a negative contextual framework instead of resulting in the creation of a new, 
unique representation of that experience followed by an emotionally appropriate response 
dictated by that current experience and not previous negative ones.  Such an emotionally 
inappropriate response is seen in mice freezing to context B in the CFD task.  Context B is 
actually a safe place, but because mice can’t distinguish it from context A they respond to it with 
fear.  Once they are able to distinguish context A from B they appropriately reduce freezing to 
context B.  Mice with impaired pattern separation/greater memory generalization, are not able to 
separate the two contexts from one another and as a consequence continue to respond to a safe 
environment with freezing.  AD-induced increases in neurogenesis may restore depressed 
individuals’ ability to generate discrete contextual episodic memories.  With this function 
restored, hippocampal output will contain a more accurate and consequently unbiased 
representation of context enabling contextually appropriate responses in output areas. In this 
way, abGCs would directly mediate the improvement of cognitive function elicited by ADs in 
depression, but whether this improvement in cognitive function underlies the behavioral effect of 
AD seen in anxiety tests such as the NSF test is not certain.  Targeted ablation of dorsal or 
ventral neurogenesis has revealed a functional dissociation between these two subsets of neurons 
suggesting this might not be the case.  It has been shown that the timely acquisition of a non-
randomized CFD task relies on dorsal neurogenesis, while ventral neurogenesis mediates the 
anxiolytic/AD-like effects of FLX in the NSF test (Wu et al, 2014).  Further supporting this view 
is evidence showing that increasing activity in the ventral DG modulates anxiety, but does so in a 
way that does not alter cognitive ability (Kheirbek et al, 2013).  Increasing neurogenesis with 
FLX treatment will increase the number of highly excitable units in the ventral DG, increasing its 
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activity during behavioral experiences, which may allow the HPC to exert greater control over its 
ventral output regions that control anxiety (Tannenholz et al, 2014).  iNR2BNes mice might have 
shown a reduced—but not altogether blocked—response to FLX in this regard because they have 
a smaller number of fully integrated abGCs in the hippocampal circuit (Fig. 2.3.7, Fig 2.3.8).  
Consistent with this idea we found a trend for the number of abGCs displaying a complex 
dendritic tree to correlate with a lower latency to feed in the NSF test in FLX-treated mice 
regardless of whether they expressed NR2B or not (Fig 2.3.9).  While our manipulation targeted 
NR2B deletion in abGCs along the entire axis of the DG, it would be interesting to further 
dissect the role of this unique form of plasticity by specifically targeting ablation of NR2B to 
either the dorsal or ventral DG.  Additionally, it would be interesting to see if stress were able to 
impair pattern separation in control mice, and to test whether FLX could block or correct this 
impairment.   
 
AD-induced increases in neurogenesis require growth factor signaling 
Chronic FLX treatment stimulates aspects of neurogenesis; yet, this effect appears to be 
attenuated in iNR2BNes mice, especially with respect to its ability to stimulate dendritic growth 
(Fig 2.3.8).  Interventions like electroconvulsive seizure, AD drug treatment, and exercise that 
have a positive effect on mood stimulate the production of growth factors such as BDNF, VEGF, 
and nerve growth factor (NGF) with very prominent increases seen in the DG (Greenwood et al, 
2009; Neeper et al, 1996; Nibuya et al, 1995; Warner-Schmidt et al, 2007).   BDNF and VEGF 
have been shown to be required for both the neurogenic and behavioral response to chronic AD 
treatment as rodents with decreased growth factor signaling are behaviorally insensitive to AD 
treatment or show an attenuated response (Monteggia et al, 2004; Saarelainen et al, 2003; 
Warner-Schmidt et al, 2007), while AD-treatment induced increases in long-term abGC survival 
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are lost when BDNF signaling is compromised (Sairanen et al, 2005) and VEGF signaling is 
required to ADs’ enhancement of proliferation (Warner-Schmidt et al, 2007).  These factors are 
not only required for an AD response, but are also sufficient to induce such a response.  Three 
days of intracerebral ventricular infusion of VEGF was sufficient to induce an AD response on 
its own in learned helplessness and the FST.  A single, bilateral infusion of either BDNF or 
neurotrophin-3 (NT-3) into the DG produced an AD response in the FST that appeared as early 
as 3 days following the infusion and lasted for at least 10 days (Shirayama et al, 2002).   
The role the BDNF receptor, tropomyosin receptor kinase B (TrkB), plays in the process 
of adult hippocampal neurogenesis has been the subject of multiple studies to date (Bergami et 
al, 2008; Donovan et al, 2008; Li et al, 2008), thus the rest of this section will focus on this 
signaling cascade.  In particular, it has been documented that TrkB receptors, which have affinity 
for both BDNF and neurotrophin-4 (NT-4), are expressed relatively highly on type 1 NCS, 
whereas expression on proliferating type 2a/b cells is significantly lower.  Expression increases 
as abGCs mature (a large spike in expression is seen between 6 and 12 days) and virtually all 
mature GCs are TrkB-positive (Donovan et al, 2008).  Others have not found such a decrease in 
TrkB protein expression in the progenitor population and accordingly studies on the role of TrkB 
signaling in proliferation have been mixed (Bergami et al, 2008; Li et al, 2008).  abGCs 
conditionally lacking TrkB have reduced long-term survival, undergoing more cell death in the 
period 4–6 weeks after birth than control abGCs, demonstrating that TrkB signaling mediates 
cell survival during this critical period (Bergami et al, 2008). Axon targeting or length is not 
affected by TrkB deletion when examined in 4-week-old abGCs, though the same cannot be said 
about dendritic morphology.  When the dendrites of abGCs lacking TrkB were analyzed 4 weeks 
following the induction of TrkB deletion, these abGCs displayed reductions in branch numbers, 
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dendritic length, and dendritic complexity indicating that TrkB activity regulates dendritic arbor 
complexity.  abGCs lacking TrkB also showed reduced spine density, though the synapses that 
formed on these spines were morphologically similar to control abGCs.  Deletion of TrkB also 
had electrophysiological consquences, impairing the late phase of ACSF-LTP (Bergami et al, 
2008).  Furthermore, mice lacking TrkB in both NPCs and differentiated GCs in the HPC were 
behaviorally insensitive to chronic AD-treatment and did not display increased proliferation or 
immature neuron number (Li et al, 2008).  These effects on survival, dendritic complexity, LTP, 
and AD sensitivity are quite similar to the ones observed in iNR2BNes mice at baseline or 
following chronic FLX treatment (Fig 2.3.6D, Fig 2.1.4H-I; Fig 2.3.8, Fig 2.1.5, Fig 2.3.2) 
suggesting a link between our manipulation of NR2B expression and BDNF signaling.  Such a 
link would not be surprising given the already established connection between NMDAR activity 
and BDNF signaling.  BDNF signaling can upregulate the mRNA and protein expression of 
NMDAR subunits, increase trafficking of NMDARs to the cell membrane, and enhance the 
activity of NMDARs via phosphorylation (Fig 4.2B) (Caldeira et al, 2007; Lin et al, 1998; Slack 
et al, 2004).  This enhancement of NMDAR activity may allow BDNF signaling to potentiate 
activity-dependent development, while the elimination of NR2B-containing NMDARs would 
likely limit the extent to which these changes could take place.  Because BDNF signaling is 
greatly increased following chronic AD treatment, the impact of this impaired signaling cascade 
on neurogenesis would be more pronounced in mice treated chronically with ADs, which is the 





Linking 5-HT1A receptors on DG GCs to growth factor production 
An issue that has not been addressed yet is the source of this BDNF.  A recent study has 
shown that selectively deleting 5-HT1ARs from DG GCs blocks the FLX-induced increase in 
BDNF mRNA leading to the conclusion that increased 5-HT1AR signaling following chronic 
AD treatment is responsible for increasing BDNF levels in the DG (Samuels et al, 2015). When 
5-HT1ARs where specifically deleted from abGCs leaving expression on mature GCs intact, 
neither the neurogenic nor behavioral response to chronic AD treatment was altered, suggesting 
that 5-HT1ARs in mature GCs are particularly important for responding to FLX treatment.  
Together, this points to a scenario where FLX treatment enhances 5-HT1AR activity on mature 
GCs setting off signaling cascades that result in the increased secretion of growth factors 
including BDNF (Fig 4.2A).  This in turn increases BDNF signaling in nearby abGCs, enhancing 
their survival and maturation in a manor that relies in part on NR2B-containing NMDAR activity 
(Fig 4.2B).  Experiments in Chapter 3 sought to examine whether initiating this cascade of 
events was sufficient to induce an AD response in mice, a theory that is supported by the fact 
that BDNF infusion into the DG is sufficient to produce such a response (Shirayama et al, 2002).  
By chronically activating hM4Di receptors on DG GCs, we hoped to activate a GPCR signaling 
cascade similar to the one activated by 5-HT1ARs.  Both subchronic and chronic activation were 
tested, but neither produced an AD-like response.  Further testing is required before conclusions 
can be drawn from this data.  In particular, it should be confirmed that hM4Di and 5-HT1A 
activate a similar signaling cascade. Additionally, the dosage of CNO required to achieve 
activity comparable to that of 5-HT1ARs in mice treated with FLX has not been established and 
titration experiments should be performed.  It is also important to confirm the level of hM4Di 
receptor expression is similar to 5-HT1AR expression.  
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Another approach to answer this question, which avoids the issues created by activating a 
GPCR that—while similar to 5HT1A receptors—may be different in unknown key ways, is to 
chronically treat mice on a 5-HT1A knock-out background that have 5HT1ARs restored in the 
DG only with the 5-HT1A-selective agonist, 8-OH-DPAT.  Pilot studies doing just that are 
currently underway.  Initial results only reveal potential trends for an AD response in the EPM 
and FST and no appreciable effect in the OFT or NSF test, but larger cohorts are needed to 
determine if these results are real. 
 
Figure 4.2 Proposed model connecting 5-HT1A receptor activation in mature GCs to 
BDNF and NMDA receptor signaling in young abGCs. .A. SSRIs like fluoxetine increase 
serotonin (5-HT) levels throughout the brain.  Serotonin binds to somatodendritic 5-HT1A 
receptors (1A) on mature GCs triggering the release of growth factors such as BDNF.  B. Nearby 
young abGCs respond to this BDNF release resulting in the enhancement of survival and 
maturation.  NMDA receptors also play a critical role in abGC survival and maturation, 
suggesting one way this enhancement may be achieved is through increased NMDA receptor 
(NMDAR) activity as BDNF signaling through TrkB receptors results in the upregulation of 
mRNA and protein expression of NMDA receptor subunits (1), increased trafficking of NMDA 
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receptors to the cell membrane (2), and enhanced activity of NMDA receptors via 
phosphorylation (P) (3).  C. This enhanced NMDA receptor activity could set off autocrine 
BDNF activity as NMDA receptor activity is known to upregulate the mRNA (1a) and protein 
(1b) expression of BDNF.  Activity-dependent release of BDNF (2) can then act in an autocrine 
manner and activate TrkB receptors located on the same cell (3). TF = transcription factor  
Adapted from Samuels et al (2015). 
 
Alternatively (or in addition), NMDAR signaling could be upstream of the BDNF 
signaling cascade as NMDAR activation can upregulate the mRNA and protein expression of 
BDNF, which could act in an autocrine manner to activate TrkB receptors on abGCs (Fig 4.2C) 
(Springer et al, 1994; Zafra et al, 1991).   Recent evidence provides support for this autocrine 
action of BDNF as it has been shown that retroviral-mediated deletion of BDNF from abGCs 
reduced their dendritic growth (Wang et al, 2015).  Interestingly, deleting BDNF from these 
neurons alone abolished the increase in abGCs dendritic growth that was observed in control 
abGCs following voluntary exercise.  This mechanism could potentially underlie AD-induced 
increases in dendritic growth as well. Exercise-induced increases in neurogenesis and BDNF 
production are suppressed in mice lacking the NR2A subunit, implicating NMDAR activity in 
this pathway (Kitamura et al, 2003).  Such a model would require AD treatment to increase 
abGC excitability or increase NMDAR expression in order to increase activity mediated by this 
receptor. One way to increase NMDAR expression would be via BDNF signaling, once again 
putting BDNF signaling ahead of NMDAR activity.  In this scenario, the paracrine action of 
BDNF could set off an enhancement of autocrine BDNF action in abGCs.  To test this 
hypothesis, one could attempt to analyze BDNF or phosphorylated TrkB (pTrkB) expression on 
immature abGCs.  An initial look at pTrkB in the DG shows an interesting pattern of expression 
(Fig 4.3A).  In control mice, there is a trend for increased pTrkB expression following FLX 
treatment (Fig 4.3B).  Surprisingly, the largest difference appears to be between vehicle-treated 
control and iNR2BNes mice, which may perhaps represent a compensatory response of abGCs 
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that lack NR2B, while FLX treatment in these mice may correct this compensatory response (Fig 
4.3B, n = 4 mice/group, 3 DGs/mouse, repeated-measures ANOVA, induction effect F(1,44) = 
2.109, p = 0.1536, treatment effect F(1,44) = 0.508, p = 0.4796, induction × treatment interaction, 
F(1,44) = 10.008, p = 0.0028; CTRL mice: unpaired t-test, t22 = -1.675 p = 0.1081; iNR2BNes mice: 
unpaired t-test, t22 = 2.843, p = 0.0095; VEH-treated mice: unpaired t-test, t22 = -3.653, p = 
0.0014).  These differences appear to be driven by cells in the SGZ suggesting they are neural 
stem cells or neural progenitor cells.  Further characterization needs to be done to confirm this 
hypothesis.  Also, future immunohistochemistry experiments using iNR2BNes mice that express a 
Cre-dependent fluorescent reporter should look at pTrkB expression at different stages of abGC 
maturation following chronic FLX treatment to determine what percentage of these cells are 
pTrkB-positive and the influence FLX treatment and NR2B deletion has on that percentage.   
 
 
Figure 4.3  pTrkB expression in the DG. A. Representative images of pTrkB staining in the 
DG (scale bar = 100um).  B. Deletion of NR2B increased pTrkB staining in VEH-treated 
animals and FLX treatment in these mice reversed this effect.  ** p < 0.01 
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Concluding remarks and future directions 
 The experiments presented in this thesis have demonstrated that the NR2B-dependent 
heightened plasticity exhibited by young abGCs is necessary for novelty responses and fine 
contextual discrimination.  While this feature is not necessary to regulate baseline emotionality, 
NR2B-dependent activity does contribute to some of the behavioral and neurogenic effects of 
chronic FLX treatment.   A new mouse line was generated in order to better understand abGCs 
online contribution to behavior, yet—given recent advancements in in vivo imaging—iNR2BNes 
mice may turn out to be a more useful tool in these endeavors than initially anticipated.  
Miniature head-mounted microscopes allow one to view neuronal activity in freely moving 
animals by monitoring the fluorescence of calcium-sensitive fluorescent indicators, thus abGC 
activity could be monitored in mice performing a behavioral pattern separation task (Ghosh et al, 
2011). This activity could be viewed in control mice and in iNR2BNes mice as well since they 
still contain abGCs—unlike mice with ablated neurogenesis,.  In this way, the activity of a 
population of normal abGCs could be compared to a population of abGCs that are impaired at 
performing a task to determine how that impairment manifests on an activity level, not just 
downstream of that activity, but directly at the source.  Conversely, while hM4Di mice were 
initially generated to look at acute manipulations, their usefulness may lie in their ability to help 
us understand the long-term modifications that underlie the action of therapeutics such as ADs.  
For example, in the chronic FLX experiments reported here, we attempted to alter young abGCs 
enhanced plasticity without altering other aspects of neurogenesis.  However, the FLX-induced 
enhancements of neurogenesis measures such as increased dendritic growth likely contribute 
significantly to the neurogenesis-dependent behavioral response to AD-treatment.  Therefore, to 
compliment the study done in iNR2BNes mice, we could perhaps use ihM4Di mice to inhibit 
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FLX’s enhancement of dendritic complexity without directly eliminating their capacity to exhibit 
enhanced potentiation by treating ihMDi mice concurrently with FLX and CNO.  CNO treatment 
would then end before the onset of behavioral testing so that the only difference between young 
abGCs at that time will be the maturation process they underwent.   
The experiments put forth in this thesis have helped to highlight the importance of 
abGCs’ enhanced plasticity.  The utility as well as potential pitfalls of the mouse models used 
here to test theories of abGC function have also been explored.   Overall, this will hopefully 
provide an improved framework in which future experiments can be developed with the aim of 
uncovering novel insights into the hippocampal circuitry that underlies learning and memory, 
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